LOGO

  MARCH 31, 2022

 

 

  

  

2022 Annual Report

 

 

iShares Trust

· iShares Focused Value Factor ETF | FOVL | NYSE Arca

· iShares U.S. Aerospace & Defense ETF | ITA | Cboe BZX

· iShares U.S. Broker-Dealers & Securities Exchanges ETF | IAI | NYSE Arca

· iShares U.S. Healthcare Providers ETF | IHF | NYSE Arca

· iShares U.S. Home Construction ETF | ITB | Cboe BZX

· iShares U.S. Infrastructure ETF | IFRA | Cboe BZX

· iShares U.S. Insurance ETF | IAK | NYSE Arca

· iShares U.S. Medical Devices ETF | IHI | NYSE Arca

· iShares U.S. Oil & Gas Exploration & Production ETF | IEO | Cboe BZX

· iShares U.S. Oil Equipment & Services ETF | IEZ | NYSE Arca

· iShares U.S. Pharmaceuticals ETF | IHE | NYSE Arca

· iShares U.S. Real Estate ETF | IYR | NYSE Arca

· iShares U.S. Regional Banks ETF | IAT | NYSE Arca

· iShares U.S. Telecommunications ETF | IYZ | Cboe BZX


The Markets in Review

Dear Shareholder,

The 12-month reporting period as of March 31, 2022 saw a continuation of the resurgent growth that followed the initial coronavirus (or “COVID-19”) pandemic reopening, albeit at a slower pace. The global economy weathered the emergence of several variant strains and the resulting peaks and troughs in infections amid optimism that increasing vaccinations and economic adaptation could help contain the pandemic’s disruptions. However, rapid changes in consumer spending led to supply constraints and elevated inflation. Moreover, while the foremost effect of Russia’s invasion of Ukraine has been a severe humanitarian crisis, the invasion has presented challenges for both investors and policymakers.

Equity prices were mixed, as persistently high inflation drove investors’ expectations for higher interest rates, which particularly weighed on relatively high valuation growth stocks and economically sensitive small-capitalization stocks. Overall, small-capitalization U.S. stocks declined, while large-capitalization U.S. stocks posted a strong advance. International equities from developed markets gained slightly, although emerging market stocks declined, pressured by rising interest rates and a strengthening U.S. dollar.

The 10-year U.S. Treasury yield (which is inversely related to bond prices) rose during the reporting period as the economy expanded rapidly and inflation reached its highest annualized reading in decades. The corporate bond market also faced inflationary headwinds, although the improving economy assuaged credit concerns and high-yield corporate bonds consequently declined less than investment-grade corporate bonds.

The U.S. Federal Reserve (the “Fed”), acknowledging that inflation is growing faster than expected, raised interest rates in March 2022, the first increase of this business cycle. Furthermore, the Fed wound down its bond-buying programs and raised the prospect of reversing the flow and reducing its balance sheet. Continued high inflation and the Fed’s new tone led many analysts to anticipate that the Fed will continue to raise interest rates multiple times throughout the year.

Looking ahead, however, the horrific war in Ukraine has significantly clouded the outlook for the global economy, leading to major volatility in energy and metal markets. Sanctions on Russia, Europe’s top energy supplier, and general wartime disruption are likely to drive already-high commodity prices even higher. Sharp increases in energy prices will exacerbate inflationary pressure while also constraining economic growth. Combating inflation without stifling a recovery, while buffering against ongoing supply and price shocks amid the ebb and flow of the pandemic, will be an especially challenging environment for setting effective monetary policy. Despite the likelihood of more rate increases on the horizon, we believe the Fed will err on the side of protecting employment, even at the expense of higher inflation.

In this environment, we favor an overweight to equities, as valuations have become more attractive and inflation-adjusted interest rates remain low. Sectors that are better poised to manage the transition to a lower-carbon world, such as technology and health care, are particularly attractive in the long term. We favor U.S. equities due to strong earnings momentum, while Japanese equities should benefit from supportive monetary and fiscal policy. We are underweight credit overall, but inflation-protected U.S. Treasuries, Asian fixed income, and emerging market local-currency bonds offer potential opportunities for additional yield. We believe that international diversification and a focus on sustainability and quality can help provide portfolio resilience.

Overall, our view is that investors need to think globally, extend their scope across a broad array of asset classes, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit iShares.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

President, BlackRock, Inc.

LOGO

Rob Kapito

President, BlackRock, Inc.

 

Total Returns as of March 31, 2022
     
      6-Month    12-Month
   

U.S. large cap equities
(S&P 500® Index)

  5.92%   15.65%
   

U.S. small cap equities
(Russell 2000® Index)

  (5.55)     (5.79)  
   

International equities
(MSCI Europe, Australasia, Far East Index)

  (3.38)     1.16 
   

Emerging market equities
(MSCI Emerging Markets Index)

  (8.20)     (11.37)  
   

3-month Treasury bills
(ICE BofA 3-Month U.S. Treasury Bill Index)

  0.05    0.07 
   

U.S. Treasury securities
(ICE BofA 10-Year U.S. Treasury Index)

  (6.04)     (3.31)  
   

U.S. investment grade bonds
(Bloomberg U.S. Aggregate Bond Index)

  (5.92)     (4.15)  
   

Tax-exempt municipal bonds
(Bloomberg Municipal Bond Index)

  (5.55)     (4.47)  
   

U.S. high yield bonds
(Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

  (4.16)     (0.66)  

 

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

2  

T H I S   P A G E   I S   N O T   P A R T   O F   Y O U R   F U N D   R E P O R T


Table of Contents

 

     Page  

 

 

The Markets in Review

     2  

Market Overview

     4  

Fund Summary

     5  

About Fund Performance

     33  

Shareholder Expenses

     33  

Schedules of Investments

     34  

Financial Statements

  

Statements of Assets and Liabilities

     72  

Statements of Operations

     76  

Statements of Changes in Net Assets

     80  

Financial Highlights

     87  

Notes to Financial Statements

     101  

Report of Independent Registered Public Accounting Firm

     115  

Important Tax Information (Unaudited)

     116  

Statement Regarding Liquidity Risk Management Program

     117  

Supplemental Information

     118  

Trustee and Officer Information

     120  

General Information

     123  

Glossary of Terms Used in this Report

     124  

 

 

 


Market Overview

 

iShares Trust

Domestic Market Overview

U.S. stocks advanced for the 12 months ended March 31, 2022 (“reporting period”), when the Russell 3000® Index, a broad measure of U.S. equity market performance, returned 11.92%. The strengthening economy supported equities, as high consumer spending drove robust growth, and most remaining coronavirus pandemic-related restrictions were eased. Increased economic activity led to strong corporate earnings as companies reaped the benefits of the recovery. Nonetheless, significant challenges emerged, particularly during the second half of the reporting period, including high inflation, rising interest rates, and the impacts of Russia’s invasion of Ukraine.

The U.S. economic recovery was powered primarily by consumers, who were supported by strong household balance sheets. Prior to the beginning of the reporting period, fiscal stimulus and business closures led to record-high personal savings rates. This allowed consumers to spend at an elevated level throughout much of the reporting period, as pent-up demand was released. The ensuing acceleration in economic activity allowed the U.S. to reach and then surpass its pre-pandemic output level. Hiring increased as businesses restored capacity, and unemployment decreased substantially, falling to 3.6% in March 2022.

The growing economy and rapid increases in consumer spending drove a significant rise in inflation. Supply chains for many goods were disrupted by the pandemic and were unable to quickly adapt to the rapid rebound in demand. In one prominent example of this dynamic, a global shortage of semiconductors created bottlenecks in the production of many goods, including automobiles. Consequently, the price of used cars rose sharply during the reporting period and was a notable factor in overall inflation. Oil prices also rose significantly as demand increased, and the supply of oil was constrained by a lack of investment. The strong job market led to higher wages, particularly at the lower end of the market. These factors led to higher prices in many areas of the economy. By the end of the reporting period the consumer price index, a widely used measure of prices in the U.S., grew at the fastest rate since 1982.

Rising inflation led to a shift in policy from the U.S. Federal Reserve Bank (“Fed”). As the reporting period began, the Fed was using accommodative monetary policy to stimulate the economy. Short-term interest rates were kept at near zero levels, and the Fed used bond-buying programs to stabilize debt markets. However, rising prices led the Fed to tighten monetary policy in the second half of the reporting period in an attempt to prevent runaway inflation. The Fed slowed and then ended its bond-buying activities and discussed plans to begin reducing its balance sheet by selling bonds later in 2022. In March 2022, it raised short-term interest rates and indicated that further increases could be necessary. Interest rates rose significantly in anticipation of further tightening, leading to higher borrowing costs for businesses.

Russia’s invasion of Ukraine in late February 2022 raised the prospect of substantial disruptions to the global economy and increased uncertainty in financial markets. The invasion was met with widespread condemnation and sanctions imposed by many countries on the Russian state, businesses, and individuals. This led to sharp volatility in energy markets, as Russia is a top producer of both oil and natural gas. Furthermore, both Russia and Ukraine are notable exporters of wheat, and the war’s disruption led to concerns surrounding food prices.

 

 

4  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® Focused Value Factor ETF

 

Investment Objective

The iShares Focused Value Factor ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. large- and mid-capitalization stocks with prominent value characteristics, as represented by the Focused Value Select Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year     

Since

Inception

         1 Year    

Since

Inception

 

Fund NAV

    13.20      9.08       13.20     30.20

Fund Market

    13.26        9.13         13.26       30.37  

Index

    13.53        9.41           13.53       31.34  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 3/19/19. The first day of secondary market trading was 3/21/19.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      1,082.30          $       1.30               $     1,000.00          $      1,023.70          $       1.26          0.25

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  5


Fund Summary as of March 31, 2022  (continued)    iShares® Focused Value Factor ETF

 

Portfolio Management Commentary

Large and mid-capitalization stocks with prominent value characteristics advanced sharply for the reporting period as coronavirus pandemic-related insurance claims declined. Investor optimism that the Fed would increase interest rates in response to rising inflation grew, benefiting insurance companies and regional banks.

The financials sector contributed the most to the Index’s return, led by the insurance industry. Revenues and margins in the property and casualty insurance industry reached record highs amid investor optimism that low unemployment and restricted housing supply would lead to housing price increases, supporting higher title insurance premiums. The life and health insurance industry also showed strength amid lower benefits payouts and investor optimism that interest rates would rise. Also contributing to the Index’s return were regional banks, which investors also expected to benefit from rising interest rates due to the increasing spread between the rate they pay on deposits and the rate they charge for loans.

The communication services sector contributed modestly to the Index’s return. In the movies and entertainment industry, streaming subscriptions increased, offsetting the pandemic-led decline in theater attendance. The industry also benefited from the announcement of new licensing arrangements and investor optimism about industry consolidation. The consumer staples sector was also a modest contributor. People prepared more food at home, leading to increased use of grocery delivery services, supporting the food and staples retail industry.

In contrast, the consumer discretionary sector detracted. The global shortage of semiconductors, needed for manufacturing cars, weighed on production and sales in the automobiles industry.

In terms of relative performance, the Index slightly outperformed the broader market, as represented by the Russell 1000® Index. The Index’s research-based selection process is designed to maximize exposure to the value factor. The Index had above-market exposure to value, earnings yield, and low size during the measurement period. Similarly, seeking the maximum exposure to the value factor resulted in incidental exposure to more volatile and less profitable stocks. With the exception of value, these factors detracted from the Index’s relative performance. However, higher relative exposure to the value factor contributed significantly to the Index’s relative performance, almost entirely offsetting the detractors.

The Index is unconstrained at the sector level to maximize exposure to the value factor. Underweight positions in the energy and information technology sectors detracted from relative performance in terms of both stock selection and sector allocation. An underweight in communication services and a very large overweight in the financials sector resulted in strong stock selection and sector allocation.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector  

Percent of   

Total Investments(a)

Insurance

  36.2%

Banks

  20.9   

Diversified Financials

  16.6   

Technology Hardware & Equipment

  9.0   

Retailing

  6.4   

Food & Staples Retailing

  3.5   

Utilities

  2.9   

Health Care Equipment & Services

  2.8   

Automobiles & Components

  1.7   

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

Kroger Co. (The)

  3.5%

First Horizon Corp.

  3.2   

Virtu Financial Inc., Class A

  3.1   

Raymond James Financial Inc.

  2.9   

Vistra Corp.

  2.9   

Arch Capital Group Ltd.

  2.9   

Penske Automotive Group Inc.

  2.9   

Zions Bancorp. N.A.

  2.9   

CVS Health Corp.

  2.8   

Aflac Inc.

  2.8   

 

  (a)

Excludes money market funds.

 

 

 

6  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Aerospace & Defense ETF

 

Investment Objective

The iShares U.S. Aerospace & Defense ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the aerospace and defense sector, as represented by the Dow Jones U.S. Select Aerospace & Defense IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year      5 Years      10 Years             1 Year      5 Years      10 Years  

Fund NAV

    7.00      9.49    14.09%       7.00      57.34      273.66

Fund Market

    7.10        9.51      14.10          7.10        57.50        273.92  

Index

    7.38        9.96      14.56                7.38        60.73        289.37  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      1,065.30          $       2.01                $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a)

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  7


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Aerospace & Defense ETF

 

Portfolio Management Commentary

U.S. aerospace and defense stocks gained for the reporting period amid a gradual recovery in leisure and business air travel as COVID-19 vaccines became widespread and the economy reopened following closures related to the coronavirus pandemic. Manufacturers took steps to minimize the impacts of supply chain constraints, including automating production, contracting with alternative suppliers, and signing long-term contracts with customers. Additionally, the passage of the Department of Defense Appropriations Act, which authorizes national military spending, reaffirmed the U.S.’ continued commitment to defense spending. Other major developed nations, including China and Japan, also reconfirmed or increased their military budgets during the reporting period. Defense spending by many western nations increased late in the reporting period as a consequence of Russia’s invasion of Ukraine.

Aerospace manufacturers contributed to the Index’s return despite a decline in commercial aviation business units during the height of the pandemic. Both original equipment manufacturing and aftermarket purchases of airplanes were volatile as flights were less predictable amid the summer 2021 reopening and COVID-19 variant-driven closures in the fall and winter of 2021. However, strong defense spending supported aerospace and defense companies, further bolstered by the war in Ukraine. Stock buybacks and dividend payments also signaled companies’ strength to investors.

Both missile defense contracts and space exploration collaborations with NASA contributed to revenue growth. Manufacturers of ships and helicopters were also strong, delivering more fighter jets than anticipated for 2021. Despite supply constraints and labor shortages that plagued manufacturers, deliveries of business jets were also higher, as demand for business travel increased amid higher COVID-19 vaccination rates and fewer travel restrictions.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector   Percent of   
Total Investments(a)

Aerospace & Defense

  97.7%

Industrial Machinery

  1.7    

Leisure Products

  0.6    

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

Raytheon Technologies Corp.

  21.3%

Lockheed Martin Corp.

  15.4   

Boeing Co. (The)

  7.7   

Textron Inc.

  4.7   

TransDigm Group Inc.

  4.5   

General Dynamics Corp.

  4.5   

Northrop Grumman Corp.

  4.4   

L3Harris Technologies Inc.

  4.3   

Howmet Aerospace Inc.

  4.2   

Axon Enterprise Inc.

  2.9   

 

  (a)

Excludes money market funds.

 

 

 

8  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Broker-Dealers & Securities Exchanges ETF

 

Investment Objective

The iShares U.S. Broker-Dealers & Securities Exchanges ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the investment services sector, as represented by the Dow Jones U.S. Select Investment Services IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year      5 Years      10 Years             1 Year      5 Years      10 Years  

Fund NAV

    10.38      16.16    16.68%       10.38      111.48      367.56

Fund Market

    10.39        16.19      16.67          10.39        111.73        367.29  

Index

    10.81        16.56      17.06                10.81        115.18        383.11  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      968.20          $       1.91               $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a)

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  9


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Broker-Dealers & Securities Exchanges ETF

 

Portfolio Management Commentary

Stocks of U.S. broker-dealers and securities exchanges rose during the reporting period. Assets under management grew significantly, driving profits and revenues. Broker-dealers’ fees supported gains as stock markets reached record highs amid economic recovery. Also positive were high interest rate spreads, with the potential for even higher profitability as the Fed increased the federal funds rate. Low interest rates and high levels of cash built up during the COVID-19 pandemic fueled a rise in mergers and acquisitions, despite high valuations and the prospect of more deal regulation.

Investment banking and brokerage firms contributed the most to the Index’s return. Higher advisory fees drove higher profits as dealmaking increased to record levels. Global economic growth, continuing fiscal stimulus, and low interest rates combined to fuel the deal frenzy. Wealth management was also constructive, as strong client activity and acquisitions drove higher asset levels and net interest income. Strong advisor recruitment and retention rates also helped bolster assets under management, which drove gains. While low interest rates weighed on consumer banking activity, banks without large consumer lending units and those with diverse revenue streams weathered the economic downturn more successfully than those with more exposure. Independent broker-dealers, not tied to one specific firm, were also constructive, growing their businesses amid major acquisitions and strong equity markets. Advisors made use of new technology, which helped them to win both new clients and more business from existing clients.

Financial exchanges and data stocks also contributed to the Index’s return. Derivatives exchanges benefited from higher trading in interest rate futures. Stock exchanges invested in their faster-growing technological platforms and data services, which generated significant returns.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector   Percent of   
Total Investments(a)

Investment Banking & Brokerage

  77.4%

Financial Exchanges & Data

  22.3   

Asset Management & Custody Banks

  0.3   

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

Charles Schwab Corp. (The)

  19.4%

Morgan Stanley

  19.0   

Goldman Sachs Group Inc. (The)

  6.3   

Raymond James Financial Inc.

  4.8   

LPL Financial Holdings Inc.

  4.8   

Nasdaq Inc.

  4.6   

CME Group Inc.

  4.5   

Intercontinental Exchange Inc.

  4.5   

Cboe Global Markets Inc.

  4.4   

MarketAxess Holdings Inc.

  4.3   

 

  (a) 

Excludes money market funds.

 

 

 

10  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Healthcare Providers ETF

 

Investment Objective

The iShares U.S. Healthcare Providers ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector, as represented by the Dow Jones U.S. Select Health Care Providers IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year      5 Years      10 Years              1 Year      5 Years      10 Years  

Fund NAV

    13.15      17.54    16.43%       13.15      124.32      357.70

Fund Market

    13.04        17.57      16.43          13.04        124.60        357.92  

Index

    13.57        18.01      16.86                13.57        128.84        374.99  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      1,109.40          $       2.05               $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  11


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Healthcare Providers ETF

 

Portfolio Management Commentary

Stocks of healthcare providers advanced strongly during the reporting period. Healthcare providers benefited from technological trends, including an expansion of virtual care during the pandemic and electronic recordkeeping. The prevalence of chronic health conditions (approximately a quarter of U.S. adults have two or more chronic conditions) also motivated digital innovation in remote patient monitoring to help minimize doctor visits and costs. Also positive for healthcare providers was the production and distribution of COVID-19 vaccines, boosters, and treatments across the U.S.

The managed healthcare industry contributed the most to the Index’s return. Strong net earnings drove gains, even as medical costs increased amid government requirements to provide free COVID-19 testing. Also supportive for healthcare companies were value-based models of care that helped providers manage risk while optimizing care delivery. These business units, drawing on data and expertise from insurance operations to provide business advisory services, were also positive. Lower-cost plan providers rebranded, focusing on “whole-person total healthcare powered by digital technologies,” which helped them lower costs, supporting their contribution to the Index’s return. Innovative platforms that allow employers to customize a “digital-first healthcare experience” were also positive for managed care companies, as were increased Medicaid and Medicare Advantage memberships.

Healthcare services companies also benefited the Index’s performance, with managed care plan business units driving the advance. Pharmacy services and retail services increased revenues amid higher foot traffic from COVID-19 vaccinations.

Healthcare facilities operators also contributed meaningfully to the Index’s return. Large hospital chains performed well as their scale helped them expand market share during pandemic-driven slowdowns.

Healthcare technology companies detracted slightly from the index’s gains. Despite higher revenues amid a pandemic increase in membership, net losses at these firms detracted from performance.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector  

Percent of    

Total Investments(a)

Managed Health Care

  44.7%

Health Care Services

  36.4   

Health Care Facilities

  12.2   

Health Care Technology

  6.5   

Life Sciences Tools & Services

  0.2   

 

  (a) 

Excludes money market funds.

 

TEN LARGEST HOLDINGS

 

   
Security  

Percent of    

Total Investments(a)

UnitedHealth Group Inc.

  23.0%

CVS Health Corp.

  14.0   

Anthem Inc.

  8.0   

Cigna Corp.

  4.5   

Centene Corp.

  4.5   

Humana Inc.

  4.4   

HCA Healthcare Inc.

  4.2   

Laboratory Corp. of America Holdings

  3.9   

Molina Healthcare Inc.

  3.1   

Quest Diagnostics Inc.

  2.6   

 

 

12  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Home Construction ETF

 

Investment Objective

The iShares U.S. Home Construction ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the home construction sector, as represented by the Dow Jones U.S. Select Home Construction IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

     Average Annual Total Returns            Cumulative Total Returns  
     1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

    (12.21 )%       13.72      15.47       (12.21 )%       90.20      321.51

Fund Market

    (12.20      13.73        15.47         (12.20      90.24        321.46  

Index

    (11.88      14.19        15.97               (11.88      94.19        340.06  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $        898.10          $       1.85                $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  13


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Home Construction ETF

 

Portfolio Management Commentary

Home construction stocks declined for the reporting period as labor shortages, supply-chain challenges, and higher costs inhibited companies’ ability to keep up with overwhelming consumer demand. Home prices climbed steadily as the mismatch between supply and demand exacerbated the broader rising inflationary environment. Additionally, the impacts of higher interest rates on homeownership affordability and construction financing led to an investor selloff late in the reporting period.

The consumer durables industry in the consumer discretionary sector was the largest detractor from the Index’s performance. As a result of ongoing supply-chain disruptions, homebuilding companies lowered guidance on the number of new homes to be delivered. Supply shortages were reported in a wide variety of building materials and supplies, from windows and doors to kitchen appliances. Delays in the delivery of such goods, coupled with an extreme labor shortage, constrained homebuilding companies’ ability to finish jobs on time and on budget. Construction costs, as measured by the U.S. Census Bureau, rose 17.5% from 2020 to 2021. The price of softwood lumber rose sharply following an increase in Canadian lumber tariffs and lumber production delays from wildfires. Record-high natural gas prices increased production costs of flooring materials and a jump in the price of diesel fuel also translated into higher costs for the transportation of other goods used in homebuilding.

Stocks in the industrials sector also detracted from the Index’s return as supply-chain headwinds similarly impacted producers of building products. The delay in new construction projects lowered sales projections, while an increase in raw material costs raised overall expenses. New commercial projects were also delayed as businesses paused pre-pandemic commitments.

Portfolio Information

 

ALLOCATION BY SECTOR

 

 

 

Sector

   

Percent of   

Total Investments(a)

 

 

 

 

Homebuilding

    63.7%  

Building Products

    14.1     

Home Improvement Retail

    10.7     

Specialty Chemicals

    5.1     

Trading Companies & Distributors

    2.4     

Home Furnishings

    2.1     

Forest Products

    1.0     

Construction Materials

    0.9     

 

 

 

  (a) 

Excludes money market funds.

 

TEN LARGEST HOLDINGS

 

 

 

Security

   

Percent of   

Total Investments(a)

 

 

 

 

DR Horton Inc.

    14.1%  

Lennar Corp., Class A

    12.2     

NVR Inc.

    8.7     

PulteGroup Inc.

    6.1     

Sherwin-Williams Co. (The)

    5.1     

Home Depot Inc. (The)

    4.7     

Lowe’s Companies Inc.

    4.4     

TopBuild Corp.

    3.3     

Toll Brothers Inc.

    3.0     

Masco Corp.

    2.2     

 

 

 

 

14  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Infrastructure ETF

 

Investment Objective

The iShares U.S. Infrastructure ETF (the “Fund”) seeks to track the investment results of an index composed of equities of U.S. companies that have infrastructure exposure and that could benefit from a potential increase in domestic infrastructure activities, as represented by the NYSE® FactSet U.S. Infrastructure IndexSM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

     Average Annual Total Returns            Cumulative Total Returns  
     1 Year    

Since

Inception

           1 Year    

Since

Inception

 

Fund NAV

    14.78     13.87       14.78     68.01

Fund Market

    14.59       13.89         14.59       68.12  

Index

    15.21       14.32               15.21       70.59  

GROWTH OF $10,000 INVESTMENT

(SINCE INCEPTION AT NET ASSET VALUE)

 

LOGO

The inception date of the Fund was 4/3/18. The first day of secondary market trading was 4/5/18.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      1,154.00          $       1.66                $     1,000.00          $      1,023.40          $       1.56          0.31

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  15


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Infrastructure ETF

 

Portfolio Management Commentary

U.S. infrastructure stocks advanced strongly during the reporting period amid solid economic growth and a rebound in industrial production. In November 2021, a bipartisan infrastructure bill was signed into law, benefiting companies that provide products and services related to infrastructure. The $1.2 trillion bill funds investments in bridges and roads, broadband internet, water and energy systems, and other projects.

Utilities stocks contributed the most to the Index’s performance, led by the electric utilities industry. As the economy improved and business activity accelerated, demand for power increased, benefiting the electric utilities industry. While the cost of energy commodities rose substantially, most utilities companies were able to pass along these higher costs to their customers. Utilities providers also increased their investments in renewable energy, and in 2021 the share of energy produced from solar and wind sources grew at the fastest rate on record. The industry also made investments in grid modernization and resilience to manage increased demand as more devices and vehicles use electric power.

Multi-utilities company stocks also gained as one company in the industry completed divestment of some natural gas distribution facilities and announced plans to achieve net-zero carbon emissions by 2035. Increased investment in infrastructure modernization and strong liquidity also benefited the industry.

The materials sector was another source of strength, supported by high demand and the passage of the infrastructure bill. Steelmakers in the metals and mining industry posted strong gains as industrial customers increased their purchases and steel manufacturers were able to raise their prices and use surcharges to offset the impact of costlier inputs. Makers of aluminum also benefited from supply tightening following sanctions on aluminum exporters in Russia, one of the largest producers of aluminum in the world.

Portfolio Information

 

ALLOCATION BY SECTOR

 

 

 

Sector

   

Percent of   

Total Investments(a)

 

 

 

 

Electric Utilities

    19.4%  

Construction & Engineering

    12.4     

Multi-Utilities

    10.7     

Steel

    7.9     

Oil & Gas Storage & Transportation

    7.0     

Building Products

    6.6     

Water Utilities

    5.4     

Gas Utilities

    5.3     

Commodity Chemicals

    3.6     

Specialty Chemicals

    3.0     

Construction Machinery & Heavy Trucks

    2.3     

Trading Companies & Distributors

    2.2     

Railroads

    2.1     

Construction Materials

    1.8     

Aluminum

    1.6     

Industrial Machinery

    1.6     

Research & Consulting Services

    1.2     

Forest Products

    1.0     

Other (each representing less than 1%)

    4.9     

 

 

 

  (a) 

Excludes money market funds.

 

TEN LARGEST HOLDINGS

 

 

 

Security

   

Percent of   

Total Investments(a)

 

 

 

 

Equitrans Midstream Corp.

    0.8%  

Danimer Scientific Inc.

    0.8     

Sempra Energy

    0.8     

Constellation Energy Corp.

    0.8     

Evergy Inc.

    0.8     

U.S. Silica Holdings Inc.

    0.7     

PPL Corp.

    0.7     

Southern Co. (The)

    0.7     

FirstEnergy Corp.

    0.7     

Exelon Corp.

    0.7     

 

 

 

 

16  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Insurance ETF

 

Investment Objective

The iShares U.S. Insurance ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the insurance sector, as represented by the Dow Jones U.S. Select Insurance IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

    25.36      10.91      13.17       25.36      67.82      244.53

Fund Market

    25.31        10.93        13.17         25.31        67.97        244.67  

Index

    25.85        11.34        13.64               25.85        71.07        259.23  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      1,176.60          $       2.12                $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  17


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Insurance ETF

 

Portfolio Management Commentary

U.S. insurance stocks advanced strongly for the reporting period, continuing their recovery from the adverse effects of the coronavirus pandemic. Premiums and income grew as many insurers were able to increase insurance rates in response to an environment of higher inflation. Insurance stocks also rose as the Fed raised interest rates for the first time since 2018. Because insurance companies typically hold capital generated from premiums in relatively conservative, interest-bearing investments such as high-quality bonds, higher interest rates raise the prospect of greater investment income, a key component of the industry’s earnings.

The property and casualty insurance industry contributed the most to the Index’s return as companies expanded profit margins and exceeded earnings estimates. Insurers boosted premiums across global product lines to compensate for higher costs, particularly car insurance underwriting, as traffic approached pre-pandemic levels and accidents rose. As U.S. inflation grew, so too did the costs of car repairs, rentals, and replacements as supply chain issues affected the availability of auto parts and cars. An increase in catastrophic claims due to extreme weather events, including Hurricane Ida, deadly tornadoes in Kentucky, and wildfires in Colorado, likewise highlighted the rising costs of construction. After temporarily reducing premiums during the pandemic, many property and casualty insurance companies imposed policy rate increases to account for the inflationary environment.

The life and health insurance industry also strongly contributed to the Index’s return. Strong investment gains offset still-high payouts for COVID-19 deaths as life insurers’ income portfolios benefited from diversification in private-equity funds. Annuity lines also showed strong growth, and sales volume for pension risk-transfer transactions reached all-time highs, increasing profits for domestic life insurance companies.

Portfolio Information

 

ALLOCATION BY SECTOR

 

 

 
Sector    

Percent of    

Total Investments(a)

 

 

 

 

Property & Casualty Insurance

    53.6%  

Life & Health Insurance

    25.0     

Multi-line Insurance

    12.0     

Insurance Brokers

    7.0     

Reinsurance

    1.6     

Other Diversified Financial Services

    0.8     

 

 
TEN LARGEST HOLDINGS

 

 

 
Security    

Percent of    

Total Investments(a)

 

 

 

 

Chubb Ltd.

    12.0%  

Progressive Corp. (The)

    8.7     

American International Group Inc.

    6.8     

MetLife Inc.

    6.4     

Travelers Companies Inc. (The)

    5.7     

Prudential Financial Inc.

    5.1     

Allstate Corp. (The)

    4.7     

Arthur J Gallagher & Co.

    4.7     

Aflac Inc.

    4.4     

Hartford Financial Services Group Inc. (The)

    3.3     

 

 

 

  (a) 

Excludes money market funds.

 

 

 

18  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Medical Devices ETF

 

Investment Objective

The iShares U.S. Medical Devices ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the medical devices sector, as represented by the Dow Jones U.S. Select Medical Equipment IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
          1 Year      5 Years      10 Years              1 Year     5 Years      10 Years  

Fund NAV

      10.99      19.63      18.94       10.99     144.99      466.47

Fund Market

      11.01        19.64        18.94         11.01       145.17        466.58  

Index

        11.41        20.13        19.43           11.41       150.18        490.48  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $         971.40          $        1.92               $      1,000.00          $      1,023.00          $        1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  19


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Medical Devices ETF

 

Portfolio Management Commentary

Stocks of U.S. medical device makers advanced strongly for the reporting period amid distribution of COVID-19 vaccines and the resumption of elective medical procedures. The healthcare equipment industry contributed the most to the Index’s performance. Equipment manufacturers posted sharp gains as healthcare research spending increased and companies with larger, more diverse product lines gained market share. Diverse revenue drivers related to COVID-19, such as molecular, antibody, and antigen tests, vaccine production, and bioprocessing, boosted the industry, while higher sales of testing platforms also generated new customers for other tests. Makers of stents and valves for more serious conditions also gained, as these procedures were less affected by the pandemic due to their acute nature. Robotic tools makers for the surgical market experienced a similar boost in earnings amid economic recovery and increased capital spending. Hospitals and other healthcare facilities had more resources to mobilize as vaccination rates increased, which was also supportive for surgical device companies. Stocks of diabetes monitoring systems manufacturers also advanced, as easing restrictions allowed more sales force travel. The growing market for diabetes treatments also benefited the industry.

Life sciences tools and services companies also contributed to the Index’s performance amid a surge of COVID-19 Omicron variant cases. Government offices and other workplaces implemented weekly testing of their employees, which drove demand for testing supplies. As COVID-19 and its variants moved toward becoming endemic, testing became part of many employers’ regular routines. Beyond the COVID-19 related boost, the industry’s broad business base, including instruments, diagnostics, laboratory products, and biopharmaceutical solutions, fed strong organic revenue growth that supported gains.

Portfolio Information

 

ALLOCATION BY SECTOR

 

 

 
Sector    

Percent of    

Total Investments(a)

 

 

 

 

Health Care Equipment

    80.4%  

Life Sciences Tools & Services

    19.3     

Health Care Supplies

    0.3     

 

 
TEN LARGEST HOLDINGS

 

 

 
Security    

Percent of    

Total Investments(a)

 

 

 

 

Thermo Fisher Scientific Inc.

    16.1%  

Abbott Laboratories

    14.5     

Medtronic PLC

    10.3     

Edwards Lifesciences Corp.

    4.7     

Intuitive Surgical Inc.

    4.6     

Stryker Corp.

    4.6     

Boston Scientific Corp.

    4.5     

Becton Dickinson and Co.

    4.3     

Dexcom Inc.

    4.1     

IDEXX Laboratories Inc.

    3.8     

 

 

 

  (a) 

Excludes money market funds.

 

 

 

20  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Oil & Gas Exploration & Production ETF

 

Investment Objective

The iShares U.S. Oil & Gas Exploration & Production ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the oil and gas exploration and production sector, as represented by the Dow Jones U.S. Select Oil Exploration & Production IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
          1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

      78.44      9.12      4.30       78.44      54.73      52.33

Fund Market

      78.46        9.15        4.31         78.46        54.95        52.49  

Index

        79.20        9.56        4.71               79.20        57.87        58.52  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Certain sectors and markets performed exceptionally well based on market conditions during the one-year period. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such exceptional returns will be repeated.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual     Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $        1,473.20          $        2.40               $      1,000.00          $      1,023.00          $        1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  21


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Oil & Gas Exploration & Production ETF

 

Portfolio Management Commentary

U.S. oil and gas exploration and production stocks advanced sharply during the reporting period as oil prices soared on renewed demand and fears of supply constraints following Russia’s invasion of Ukraine. Oil prices began the reporting period at levels similar to those last seen prior to the beginning of the coronavirus pandemic, having recovered from a sharp decrease as the virus first began to spread. Oil prices rallied as vaccinations against COVID-19 rolled out and the global economy recovered. Prices continued to climb throughout 2021 as coronavirus-related restrictions eased, travel increased, and oil stockpiles dropped. Members of OPEC and other oil-producing countries gradually increased oil supply throughout 2021, but demand outstripped supply, sending prices higher. U.S. oil producers, which curtailed output in 2020 when prices slid, were slow to renew production in 2021 when economic activity and demand rebounded. Oil prices briefly faltered when the emergence of new coronavirus variants raised fears of renewed shutdowns and weakened global economic demand.

However, oil prices resumed their upward climb in the beginning of 2022 and by early March hit their highest levels in 14 years after the U.S. and its European allies began to consider banning oil imports from Russia following the invasion of Ukraine. Russia is the world’s top exporter of oil and oil products.

U.S. oil and gas exploration and production companies benefited significantly from the higher oil prices. Greater-than-expected earnings and stronger cash flow led to increased dividend payments to shareholders and plans to buy back stock. Despite the higher oil prices, producers generally kept their output at flat levels in a departure from previous boom periods.

Portfolio Information

 

ALLOCATION BY SECTOR

 

 

 
Sector    

Percent of    

Total Investments(a)

 

 

 

 

Oil & Gas Exploration & Production

    74.8%  

Oil & Gas Refining & Marketing

    18.4     

Oil & Gas Storage & Transportation

    6.8     

 

 
TEN LARGEST HOLDINGS

 

 

 
Security    

Percent of    

Total Investments(a)

 

 

 

 

ConocoPhillips

    17.7%  

EOG Resources Inc.

    9.5     

Pioneer Natural Resources Co.

    7.7     

Marathon Petroleum Corp.

    6.7     

Valero Energy Corp.

    4.9     

Phillips 66

    4.5     

Cheniere Energy Inc.

    4.3     

Hess Corp.

    4.3     

Devon Energy Corp.

    4.2     

Diamondback Energy Inc.

    3.4     

 

 

 

  (a) 

Excludes money market funds.

 

 

 

22  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Oil Equipment & Services ETF

 

Investment Objective

The iShares U.S. Oil Equipment & Services ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the oil equipment and services sector, as represented by the Dow Jones U.S. Select Oil Equipment & Services IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

    44.88      (12.52 )%       (8.15 )%        44.88      (48.75 )%       (57.25 )% 

Fund Market

    44.75        (12.53      (8.15       44.75        (48.79      (57.27

Index

    45.38        (12.23      (7.87             45.38        (47.92      (55.95

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Certain sectors and markets performed exceptionally well based on market conditions during the one-year period. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such exceptional returns will be repeated.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $     1,415.20          $        2.35               $      1,000.00          $      1,023.00          $         1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  23


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Oil Equipment & Services ETF

 

Portfolio Management Commentary

U.S. oil equipment and services stocks advanced sharply during the reporting period as oil prices soared on renewed demand and fears of supply constraints following Russia’s invasion of Ukraine. Oil prices began the reporting period at levels similar to those last seen prior to the beginning of the coronavirus pandemic. Oil prices rallied as vaccinations against COVID-19 rolled out and the global economy recovered. Prices continued to climb throughout 2021 as coronavirus-related restrictions eased, travel increased, and oil stockpiles dropped. Members of OPEC and other oil-producing countries gradually increased oil supply throughout 2021, but demand outstripped supply, sending prices higher. U.S. oil producers, which curtailed output in 2020 when prices slid, were slow to renew production in 2021 when economic activity and demand rebounded. Oil prices briefly faltered when the emergence of new coronavirus variants raised fears of renewed shutdowns and weakened global economic demand.

However, oil prices resumed their upward climb in the beginning of 2022 and by early March hit their highest levels in 14 years after the U.S. and its European allies began to consider banning oil imports from Russia following the invasion of Ukraine. Russia is the world’s top exporter of oil and oil products.

Stocks of companies in the oil and gas equipment and services industry, whose revenues depend on spending by oil producers and refiners, contributed the most to the Index’s return. Oilfield services providers posted higher-than-expected sales and earnings as oil prices soared. Looking ahead, spending on drilling services and equipment, such as oil rigs, is expected to rise amid increased investment in new production. However, the Russian invasion of Ukraine negatively impacted earnings, as the sale of some oil equipment to Russia was affected by sanctions.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector  

Percent of    

Total Investments(a)

Oil & Gas Equipment & Services

  82.9%

Oil & Gas Drilling

  17.1   

TEN LARGEST HOLDINGS

 

   
Security  

Percent of    

Total Investments(a)

Halliburton Co.

  23.3%

Schlumberger NV

  21.4   

Baker Hughes Co.

  4.8   

Helmerich & Payne Inc.

  4.6   

ChampionX Corp.

  4.4   

NOV Inc.

  4.1   

Valaris Ltd.

  4.0   

Cactus Inc., Class A

  3.9   

Patterson-UTI Energy Inc.

  3.9   

TechnipFMC PLC

  3.9   

 

  (a) 

Excludes money market funds.

 

 

 

24  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Pharmaceuticals ETF

 

Investment Objective

The iShares U.S. Pharmaceuticals ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector, as represented by the Dow Jones U.S. Select Pharmaceuticals IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

    11.29      6.69      10.43       11.29      38.24      169.73

Fund Market

    11.17        6.71        10.44         11.17        38.33        169.94  

Index

    11.59        6.98        10.76               11.59        40.12        177.81  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

           

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $     1,069.90          $         2.01               $     1,000.00          $      1,023.00          $        1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  25


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Pharmaceuticals ETF

 

Portfolio Management Commentary

Pharmaceuticals stocks advanced significantly during the reporting period, rebounding after a pause in both research and development and mergers and acquisitions during the most intense part of the coronavirus pandemic. Some pharmaceuticals companies focused their operations, divesting themselves of business units in order to emphasize new product development. For example, a large healthcare and pharmaceuticals company announced plans to spin off its legacy consumer products unit to focus on its core pharmaceuticals business. Other significant trends in the pharmaceuticals industry included the use of artificial intelligence to aid drug development and the move toward personalized medicine, allowing for more targeted and efficient research and development.

Vaccines developed by pharmaceuticals companies to protect against the COVID-19 virus were a crucial driver of revenues for the reporting period, generating billions of dollars in sales and boosting the Index’s return. Also beneficial for the industry was the development of antiviral medications. Once determined to be effective against COVID-19, these were purchased and distributed in large quantities by the U.S. government, then authorized for use in its new “test to treat” program. In addition, pharmaceuticals firms developed antibody therapies to fight COVID-19 that the U.S. government contracted to purchase, further bolstering revenues.

Outside of treatments and vaccines for COVID-19, the pharmaceuticals industry was helped by continued strong sales of previously approved drugs as global spending on medicine grew. Sales of treatments for conditions including plaque psoriasis, immune deficiencies, cancer, and schizophrenia bolstered revenues, generating significant revenue growth. Companies developing pharmaceuticals for animal and veterinary health also contributed to the Index’s return, as many new households adopted pets during the pandemic and spending on pets and pet care continued to rise.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector  

Percent of    

Total Investments(a)

Pharmaceuticals

  97.3%

Biotechnology

  2.7   

TEN LARGEST HOLDINGS

 

   
Security  

Percent of    

Total Investments(a)

Johnson & Johnson

  22.5%

Pfizer Inc.

  20.8   

Catalent Inc.

  4.8  

Eli Lilly & Co.

  4.7   

Bristol-Myers Squibb Co.

  4.6   

Merck & Co. Inc.

  4.5   

Royalty Pharma PLC, Class A

  4.4   

Viatris Inc.

  4.3   

Zoetis Inc.

  4.3   

Elanco Animal Health Inc.

  4.1   

 

  (a) 

Excludes money market funds.

 

 

 

26  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Real Estate ETF

 

Investment Objective

The iShares U.S. Real Estate ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the real estate sector, as represented by the Dow Jones U.S. Real Estate Capped IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns           Cumulative Total Returns  
     1 Year      5 Years      10 Years            1 Year      5 Years      10 Years  

Fund NAV

    20.27      9.83      9.39       20.27      59.79      145.24

Fund Market

    20.33        9.88        9.41         20.33        60.15        145.81  

Index

    20.72        10.18        9.85               20.72        62.34        155.90  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Index performance through January 24, 2021 reflects the performance of the Dow Jones U.S. Real Estate IndexTM. Index performance beginning on January 25, 2021 reflects the performance of the Dow Jones U.S. Real Estate Capped IndexTM.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual           Hypothetical 5% Return           
 

 

 

     

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      


Ending

Account Value
(03/31/22)

 


 

      

Expenses

Paid During

the Period 

 

 

(a) 

           

Beginning
Account Value

(10/01/21)

 
 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period 

 

 

(a) 

      

Annualized

Expense

Ratio

 

 

 

      $        1,000.00          $     1,069.80          $         2.01               $     1,000.00          $     1,023.00          $           1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  27


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Real Estate ETF

 

Portfolio Management Commentary

Real estate investment trusts (“REITs”) advanced significantly during the reporting period as their dividend payouts and growth potential attracted investors concerned about inflation and in search of an alternative to the low yields offered by bonds. As REITs own and operate properties that generate income from rents from tenants or businesses, the ability to raise rents can prove beneficial in an inflationary environment. In addition, they are required to pay out 90% of their earnings in dividends to shareholders each year in order to retain their tax-free status.

Specialized REITs, particularly those involved in self-storage, contributed the most to the Index. The COVID-19 pandemic encouraged Americans to declutter as they increasingly worked, studied, and exercised at home. To make room for home offices and gyms, people turned to self-storage rental units to stash excess items. Growing demand for storage space helped reduce the excess supply of rental units that existed prior to the pandemic, which led to significant price increases and record occupancy rates.

Residential REITs invested in apartment buildings also propelled the Index’s return. Apartment REITs revenues and lease rates grew sharply in 2021 as renters returned to urban areas as the impact of the pandemic eased. With housing prices climbing, many potential home buyers continued to rent instead of buy. Limited growth in new apartment buildings kept supply tight.

Industrial REITs that own and operate warehouses contributed significantly to the Index’s return. Demand for warehouse space grew throughout 2021 as supply chain disruptions due to the pandemic created a need for space to store a backlog of goods, supporting sharp rental price increases.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector   Percent of   
Total Investments(a)

Specialized REITs

  36.6%

Residential REITs

  15.5   

Industrial REITs

  12.6   

Retail REITs

  9.3   

Health Care REITs

  8.4   

Office REITs

  6.7   

Real Estate Services

  3.9   

Mortgage REITs

  2.3   

Research & Consulting Services

  1.8   

Diversified REITs

  1.7   

Other (each representing less than 1%)

  1.2   

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

Prologis Inc.

  8.0%

American Tower Corp.

  7.7   

Crown Castle International Corp.

  5.3   

Equinix Inc.

  4.5   

Public Storage

  4.0   

Simon Property Group Inc.

  2.9   

Welltower Inc.

  2.8   

Digital Realty Trust Inc.

  2.7   

Realty Income Corp.

  2.6   

SBA Communications Corp.

  2.5   

 

  (a) 

Excludes money market funds.

 

 

 

28  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Regional Banks ETF

 

Investment Objective

The iShares U.S. Regional Banks ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the regional banks sector, as represented by the Dow Jones U.S. Select Regional Banks IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year      5 Years      10 Years             1 Year      5 Years      10 Years  

Fund NAV

    6.11      8.27    11.40%       6.11      48.74      194.24

Fund Market

    6.11        8.29      11.41          6.11        48.91        194.61  

Index

    6.48        8.71      11.87                6.48        51.80        207.08  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      982.80          $       1.93                $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  29


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Regional Banks ETF

 

Portfolio Management Commentary

U.S. regional banks, which operate locally but may offer national services, advanced during the reporting period amid strong economic growth and robust consumer spending. Expectations of higher interest rates helped keep stocks in positive territory despite inflationary pressures, staffing shortages, and the persistence of COVID-19 variants. Regional bank stocks gained strongly as the Fed followed through on its plans to raise interest rates for the first time since 2018, then gave up some ground as investors became more cautious about the acceleration of interest rate hikes and the impact on commercial lending.

A rise in intermediate-term government bond yields in anticipation of tighter fiscal policy benefited the net interest margins of regional banks, which depend more on interest income from loans than larger banks. Because banks borrow at short-term interest rates and lend to customers at longer-term rates, the larger spread between shorter- and longer-term interest rates helped the industry.

Regional bank stocks advanced as average consumer loans increased, driven by high demand for residential mortgage loans despite rising mortgage rates. The recovering economy also increased demand for business loans and lowered the probability of loan defaults. Deferrals on small business loans made through the federal Paycheck Protection Program declined substantially, a positive indicator of the health of small businesses, which were disproportionately impacted by the pandemic.

Increased merger and acquisition activity also benefited regional banks. Consolidation in the industry and the resulting reduction in overhead costs elevated earnings. The industry also gained from acquisitions that helped expand banks’ digital capabilities and product offerings. Expansion into digital assets drove deposit growth, as user adoption of blockchain-based payment platforms increased.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector   Percent of   
Total Investments(a)

Regional Banks

  87.5%

Diversified Banks

  11.6   

Thrifts & Mortgage Finance

  0.9   

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

PNC Financial Services Group Inc. (The)

  12.5%

Truist Financial Corp.

  12.2   

U.S. Bancorp.

  11.6   

SVB Financial Group

  5.3   

First Republic Bank/CA

  4.5   

Fifth Third Bancorp.

  4.4   

M&T Bank Corp.

  3.6   

Huntington Bancshares Inc./OH

  3.4   

Regions Financial Corp.

  3.4   

KeyCorp

  3.4   

 

  (a) 

Excludes money market funds.

 

 

 

30  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Fund Summary as of March 31, 2022    iShares® U.S. Telecommunications ETF

 

Investment Objective

The iShares U.S. Telecommunications ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the telecommunications sector, as represented by the Russell 1000 Telecommunications RIC 22.5/45 Capped Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.

Performance

 

    Average Annual Total Returns         Cumulative Total Returns  
     1 Year      5 Years      10 Years             1 Year      5 Years      10 Years  

Fund NAV

    (5.63 )%       0.98    5.66%       (5.63 )%       4.99      73.48

Fund Market

    (5.42      1.01      5.68          (5.42      5.16        73.69  

Index(a)

    (5.26      1.18      5.87          (5.26      6.06        76.97  

Dow Jones U.S. Select Telecommunications Index

    4.18        3.13      6.88          4.18        16.63        94.61  

Russell 1000 Telecommunications RIC 22.5/45 Capped Index(b)

    N/A        N/A      N/A                N/A        N/A        N/A  

GROWTH OF $10,000 INVESTMENT

(AT NET ASSET VALUE)

 

LOGO

 

  (a) 

Index performance through September 19, 2021 reflects the performance of the Dow Jones U.S. Select Telecommunications Index. Index performance beginning on September 20, 2021 reflects the performance of the Russell 1000 Telecommunications RIC 22.5/45 Capped Index, which, effective as of September 20, 2021, replaced the Dow Jones U.S. Select Telecommunications Index as the underlying index of the fund.

 
  (b) 

The inception date of the Russell 1000 Telecommunications RIC 22.5/45 Capped Index was July 9, 2021. The cumulative total return for this index for the period July 9, 2021 through March 31, 2022 was -12.41%.

 

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 33 for more information.

Expense Example

 

    Actual            Hypothetical 5% Return           
 

 

 

      

 

 

      
     

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 

 (a) 

            

Beginning

Account Value

(10/01/21)

 

 

 

      

Ending

Account Value

(03/31/22)

 

 

 

      

Expenses

Paid During

the Period

 

 (a) 

      

Annualized

Expense

Ratio

 

 

 

      $       1,000.00          $      928.80          $       1.88                $     1,000.00          $      1,023.00          $       1.97          0.39

 

  (a) 

Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/365 (to reflect the one-half year period shown). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” for more information.

 

 

 

F U N D   S U M M A R Y

  31


Fund Summary as of March 31, 2022  (continued)    iShares® U.S. Telecommunications ETF

 

Portfolio Management Commentary

Telecommunications stocks declined during the reporting period amid investor concern surrounding the sustainability of growth in subscriptions to high-speed internet services. While use of these services grew sharply early in the pandemic due to increased distance learning and telecommuting, growth slowed as pandemic-related restrictions were lifted and many people returned to schools and offices. However, this impact was partially offset by continued migration to cloud computing, especially by large corporations, which benefited companies that provide networking infrastructure.

The communication services sector detracted the most from the Index’s return. In the cable and satellite industry, subscriptions to cable service were below analysts’ expectations as more people returned to pre-pandemic routines. Large expenditures on streaming video services and increased competition, especially from growing fiber optic networks and 5G wireless internet services, constrained returns. The entertainment industry was another detractor amid increasing competition in the market for both the software and the hardware supporting streaming video. Global supply chain disruptions also negatively affected the industry, leading to increased costs. Stocks in the telecommunications industry declined amid strong competition in the market for mobile data plans, leading to lower prices despite broad inflationary trends, and reducing revenues from users.

On the upside, the information technology sector contributed substantially to the Index’s return. In the communications equipment industry, migration to the cloud increased demand for the hardware used to construct data centers, bolstering returns. Revenues rose despite supply chain issues as constrained supply led to higher prices for hardware and equipment. Growth in applications for artificial intelligence, which require significant numbers of routers and switches to connect processors, drove rising sales. Increased development of virtual reality products and applications also drove substantial orders for communications equipment, bolstering revenues.

Portfolio Information

 

ALLOCATION BY SECTOR

 

   
Sector   Percent of   
Total Investments(a)

Communications Equipment

  41.3%

Media

  29.8   

Diversified Telecommunication Services

  21.8   

Wireless Telecommunication Services

  3.8   

Entertainment

  3.3   

TEN LARGEST HOLDINGS

 

   
Security   Percent of   
Total Investments(a)

Cisco Systems Inc.

  15.5%

Verizon Communications Inc.

  14.2   

Comcast Corp., Class A

  14.0   

AT&T Inc.

  4.5   

T-Mobile U.S. Inc.

  3.8   

Arista Networks Inc.

  3.7   

Motorola Solutions Inc.

  3.6   

Charter Communications Inc., Class A

  3.4   

Juniper Networks Inc.

  3.3   

Ubiquiti Inc.

  3.3   

 

  (a) 

Excludes money market funds.

 

 

 

32  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


About Fund Performance

 

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at iShares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.

Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. Beginning August 10, 2020, the price used to calculate market return (“Market Price”) is the closing price. Prior to August 10, 2020, Market Price was determined using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.

An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.

Shareholder Expenses

Shareholders of each Fund may incur the following charges: (1) transactional expenses, including brokerage commissions on purchases and sales of fund shares and (2) ongoing expenses, including management fees and other fund expenses. The expense examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each Fund and in comparing these expenses with similar costs of investing in other funds.

The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number under the heading entitled “Expenses Paid During Period.”

The expense examples also provide information about hypothetical account values and hypothetical expenses based on a Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in a Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect any transactional expenses, such as brokerage commissions and other fees paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

 

 

A B O U T   F U N D   P E R F O R M A N C E / S H A R E H O L D E R   E X P E N S E S

  33


Schedule of Investments

March 31, 2022

  

iShares® Focused Value Factor ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Apparel Retail — 1.1%

 

Foot Locker Inc.

    13,192     $ 391,275  
   

 

 

 

Asset Management & Custody Banks — 4.1%

 

Invesco Ltd.

    30,417       701,416  

Janus Henderson Group PLC

    20,949       733,634  
   

 

 

 
      1,435,050  
Automobile Manufacturers — 1.7%  

General Motors Co.(a)

    13,741       601,031  
   

 

 

 

Automotive Retail — 2.9%

 

Penske Automotive Group Inc.

    10,770       1,009,364  
   

 

 

 

Consumer Finance — 4.0%

 

Ally Financial Inc.

    16,313       709,290  

Capital One Financial Corp.

    5,256       690,060  
   

 

 

 
      1,399,350  
Food Retail — 3.5%  

Kroger Co. (The)

    21,223           1,217,564  
   

 

 

 

Health Care Services — 2.8%

 

CVS Health Corp.

    9,744       986,190  
   

 

 

 

Independent Power Producers & Energy Traders — 2.9%

 

Vistra Corp.

    43,830       1,019,048  
   

 

 

 

Investment Banking & Brokerage — 8.5%

 

Raymond James Financial Inc.

    9,388       1,031,835  

Stifel Financial Corp.

    12,535       851,126  

Virtu Financial Inc., Class A

    29,426       1,095,236  
   

 

 

 
      2,978,197  
Life & Health Insurance — 10.9%  

Aflac Inc.

    15,152       975,637  

MetLife Inc.

    13,585       954,754  

Principal Financial Group Inc.

    12,867       944,566  

Prudential Financial Inc.

    7,934       937,561  
   

 

 

 
      3,812,518  
Multi-line Insurance — 2.7%  

Hartford Financial Services Group Inc. (The)

    13,120       942,147  
   

 

 

 

Property & Casualty Insurance — 19.7%

 

Allstate Corp. (The)

    6,233       863,333  

Arch Capital Group Ltd.(a)

    20,879       1,010,961  

CNA Financial Corp.

    17,873       868,985  

Fidelity National Financial Inc.

    18,708       913,699  

First American Financial Corp.

    13,040       845,253  

Hanover Insurance Group Inc. (The)

    5,994       896,223  

Mercury General Corp.

    12,518       688,490  

Old Republic International Corp.

    32,639       844,371  
   

 

 

 
      6,931,315  
Security   Shares     Value  

 

 

Regional Banks — 16.3%

 

BOK Financial Corp.

    9,388     $ 882,003  

First Horizon Corp.

    47,051       1,105,228  

KeyCorp

    39,372       881,145  

People’s United Financial Inc.

    47,435       948,226  

Popular Inc.

    10,833       885,489  

Zions Bancorp. N.A.

    15,381       1,008,378  
   

 

 

 
      5,710,469  
Reinsurance — 2.8%  

Everest Re Group Ltd.

    3,226       972,252  
   

 

 

 

Specialty Stores — 2.3%

 

Dick’s Sporting Goods Inc.

    8,115       811,662  
   

 

 

 

Technology Distributors — 4.3%

 

Avnet Inc.

    20,285       823,368  

TD SYNNEX Corp.

    6,677       689,133  
   

 

 

 
      1,512,501  
Technology Hardware, Storage & Peripherals — 4.6%  

Hewlett Packard Enterprise Co.

    55,764       931,817  

Xerox Holdings Corp.

    34,612       698,124  
   

 

 

 
      1,629,941  
Thrifts & Mortgage Finance — 4.5%  

MGIC Investment Corp.

    59,782       810,046  

New York Community Bancorp. Inc.

    73,779       790,911  
   

 

 

 
      1,600,957  
   

 

 

 

Total Common Stocks — 99.6%
(Cost: $35,076,012)

 

    34,960,831  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.3%  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(b)(c)

    90,000       90,000  
   

 

 

 

Total Short -Term Investments — 0.3%
(Cost: $90,000)

 

    90,000  
   

 

 

 

Total Investments in Securities — 99.9%
(Cost: $35,166,012)

 

    35,050,831  

Other Assets, Less Liabilities — 0.1%

 

    45,050  
   

 

 

 

Net Assets — 100.0%

 

  $   35,095,881  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

 

 

34  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® Focused Value Factor ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares(a)

  $ 167,200     $       $ (167,318 )(b)    $ 118     $     $           $ 230 (c)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    50,000       40,000 (b)                        90,000       90,000       18        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 118     $     $ 90,000       $ 248     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

As of period end, the entity is no longer held.

 
  (b) 

Represents net amount purchased (sold).

 
  (c) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description  

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

   

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

       

E-Mini Financials Select Sector Index

    1       06/17/22     $ 118     $ 5,598  
       

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 5,598  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ (3,278
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 5,598  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 69,245      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  35


Schedule of Investments  (continued)

March 31, 2022

  

iShares® Focused Value Factor ETF

    

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                               

 

 
     Level 1      Level 2        Level 3        Total  

 

 

Investments

               

Assets

               

Common Stocks

   $ 34,960,831      $        $        $ 34,960,831  

Money Market Funds

     90,000                          90,000  
  

 

 

    

 

 

      

 

 

      

 

 

 
   $ 35,050,831      $         —        $         —        $ 35,050,831  
  

 

 

    

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

               

Assets

               

Futures Contracts

   $ 5,598      $        $        $ 5,598  
  

 

 

    

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

36  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Aerospace & Defense ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Aerospace & Defense — 97.6%

 

AAR Corp.(a)

    373,028     $ 18,065,746  

Aerojet Rocketdyne Holdings Inc.(a)

    838,511       32,995,408  

Aerovironment Inc.(a)(b)

    258,554       24,340,274  

Astra Space Inc., Class A(a)(b)

    1,401,680       5,410,485  

Axon Enterprise Inc.(a)(b)

    766,841       105,617,011  

Boeing Co. (The)(a)

    1,466,709       280,874,774  

BWX Technologies Inc.

    1,032,661       55,619,121  

Curtiss-Wright Corp.

    439,484       65,992,917  

General Dynamics Corp.

    682,480       164,600,526  

HEICO Corp.(b)

    448,490       68,861,155  

HEICO Corp., Class A

    790,361       100,241,486  

Hexcel Corp.

    939,588       55,877,298  

Howmet Aerospace Inc.

    4,250,566       152,765,342  

Huntington Ingalls Industries Inc.

    448,685       89,485,736  

Kaman Corp.

    311,582       13,547,585  

Kratos Defense & Security Solutions Inc.(a)

    1,388,931       28,445,307  

L3Harris Technologies Inc.

    632,498       157,156,778  

Lockheed Martin Corp.

    1,283,333       566,463,186  

Maxar Technologies Inc.(b)

    813,943       32,118,191  

Mercury Systems Inc.(a)(b)

    635,644       40,967,256  

Moog Inc., Class A

    325,457       28,575,125  

National Presto Industries Inc.

    56,730       4,365,374  

Northrop Grumman Corp.

    359,231       160,655,288  

Parsons Corp.(a)(b)

    297,467       11,511,973  

Raytheon Technologies Corp.

    7,901,672       782,818,645  

Rocket Lab USA Inc.(a)

    1,609,896       12,959,663  

Spirit AeroSystems Holdings Inc., Class A

    1,182,052       57,790,522  

Textron Inc.

    2,307,895       171,661,230  

TransDigm Group Inc.(a)

    254,971       166,123,805  

Triumph Group Inc.(a)

    724,287       18,309,975  

Virgin Galactic Holdings Inc.(a)(b)

    1,995,548       19,716,014  

Woodward Inc.

    706,368       88,232,427  
   

 

 

 
        3,582,165,623  
Security   Shares     Value  

 

 

Industrial Machinery — 1.7%

 

RBC Bearings Inc.(a)

    323,412     $ 62,703,119  
   

 

 

 

Leisure Products — 0.6%

 

Smith & Wesson Brands Inc.

    540,311       8,174,905  

Sturm Ruger & Co. Inc.

    196,874       13,706,368  
   

 

 

 
      21,881,273  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $3,255,459,788)

 

    3,666,750,015  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.9%

 

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    30,265,268       30,259,215  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    4,110,000       4,110,000  
   

 

 

 
      34,369,215  
   

 

 

 

Total Short -Term Investments — 0.9%
(Cost: $34,359,530)

 

    34,369,215  
   

 

 

 

Total Investments in Securities — 100.8%
(Cost: $3,289,819,318)

 

    3,701,119,230  

Other Assets, Less Liabilities — (0.8)%

 

    (31,104,157
   

 

 

 

Net Assets — 100.0%

 

  $   3,670,015,073  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 51,365,314     $     $ (21,055,561 )(a)    $ (5,306   $ (45,232   $ 30,259,215       30,265,268     $ 180,849 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    3,820,000       290,000 (a)                        4,110,000       4,110,000       1,061        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (5,306   $ (45,232   $ 34,369,215       $ 181,910     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  37


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Aerospace & Defense ETF

    

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

      

Expiration

Date

      

Notional

Amount

(000)

      

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

                 

XAI Industrial Index

     29          06/17/22        $ 3,006        $ 22,216  
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 22,216  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 359,812  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ (80,429
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 2,885,904      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1                    Level 2                    Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 3,666,750,015        $        $        $ 3,666,750,015  

Money Market Funds

     34,369,215                            34,369,215  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 3,701,119,230        $        $        $ 3,701,119,230  
  

 

 

      

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

                 

Assets

                 

Futures Contracts

   $ 22,216        $        $        $ 22,216  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

38  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Broker-Dealers & Securities Exchanges ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Asset Management & Custody Banks — 0.3%

 

Diamond Hill Investment Group Inc.

    9,683     $ 1,813,626  
   

 

 

 

Financial Exchanges & Data — 22.3%

   

Cboe Global Markets Inc.

    218,581       25,010,038  

CME Group Inc.

    109,270       25,990,962  

Intercontinental Exchange Inc.

    195,248       25,796,166  

MarketAxess Holdings Inc.

    71,981       24,487,936  

Nasdaq Inc.

    149,034       26,557,859  
   

 

 

 
      127,842,961  

Investment Banking & Brokerage — 77.3%

 

B. Riley Financial Inc.

    47,382       3,314,845  

BGC Partners Inc., Class A

    928,859       4,086,980  

Charles Schwab Corp. (The)

    1,319,269       111,227,569  

Cowen Inc., Class A

    78,590       2,129,789  

Evercore Inc., Class A

    112,257       12,496,449  

Goldman Sachs Group Inc. (The)

    108,698       35,881,210  

Houlihan Lokey Inc.

    148,113       13,004,321  

Interactive Brokers Group Inc., Class A

    254,347       16,764,011  

Jefferies Financial Group Inc.

    557,308       18,307,568  

Lazard Ltd., Class A

    324,430       11,192,835  

LPL Financial Holdings Inc.

    149,431       27,298,055  

Moelis & Co., Class A

    179,899       8,446,258  

Morgan Stanley

    1,244,092           108,733,641  

Piper Sandler Cos

    41,621       5,462,756  

PJT Partners Inc., Class A

    71,172       4,492,377  
Security   Shares     Value  

 

 

Investment Banking & Brokerage (continued)

 

Raymond James Financial Inc.

    250,975     $ 27,584,662  

Stifel Financial Corp.

    303,984       20,640,513  

StoneX Group Inc.(a)

    50,523       3,750,322  

Virtu Financial Inc., Class A

    239,645       8,919,587  
   

 

 

 
      443,733,748  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $598,290,677)

      573,390,335  
   

 

 

 

Short-Term Investments

   
Money Market Funds — 0.1%            

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(b)(c)

    720,000       720,000  
   

 

 

 

Total Short -Term Investments — 0.1%
(Cost: $720,000)

      720,000  
   

 

 

 

Total Investments in Securities — 100.0%
(Cost: $599,010,677)

      574,110,335  

Other Assets, Less Liabilities — (0.0)%

      (136,718
   

 

 

 

Net Assets — 100.0%

    $   573,973,617  
   

 

 

 

 

(a)

Non-income producing security.

(b) 

Affiliate of the Fund.

(c) 

Annualized 7-day yield as of period end.

    

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   

Value at

03/31/21

    

Purchases

at Cost

    

Proceeds

from Sales

    

Net Realized

Gain (Loss)

    

Change in

Unrealized

Appreciation

(Depreciation)

    

Value at

03/31/22

    

Shares

Held at

03/31/22

     Income     

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Treasury, SL Agency Shares

   $ 760,000      $      $ (40,000 )(a)     $      $      $ 720,000        720,000      $ 303      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

      

Expiration

Date

      

Notional

Amount

(000)

      

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

 

E-Mini Financials Select Sector Index

     3          06/17/22        $ 354        $ 9,693  

Russell 2000 E-Mini Index

     1          06/17/22          103          (315
                 

 

 

 
                  $ 9,378  
                 

 

 

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  39


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Broker-Dealers & Securities Exchanges ETF

    

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 9,693  
  

 

 

 

Liabilities — Derivative Financial Instruments

  

Futures contracts

  

Unrealized depreciation on futures contracts(a)

   $ 315  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 133,377  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 19,823  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 1,055,007      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1                Level 2                Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 573,390,335        $        $        $ 573,390,335  

Money Market Funds

     720,000                            720,000  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 574,110,335        $        $        $ 574,110,335  
  

 

 

      

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

                 

Assets

                 

Futures Contracts

   $ 9,693        $        $        $ 9,693  

Liabilities

                 

Futures Contracts

     (315                          (315
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 9,378        $        $        $ 9,378  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

40  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Healthcare Providers ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Health Care Facilities — 12.1%

   

Acadia Healthcare Co. Inc.(a)

    191,542     $ 12,551,747  

Brookdale Senior Living Inc.(a)

    395,638       2,789,248  

Cano Health Inc.(a)(b)

    385,069       2,445,188  

Community Health Systems Inc.(a)(b)

    263,874       3,132,184  

Encompass Health Corp.

    211,906       15,068,636  

Ensign Group Inc. (The)

    111,387       10,025,944  

Hanger Inc.(a)(b)

    78,490       1,438,722  

HCA Healthcare Inc.

    220,255       55,200,308  

Joint Corp. (The)(a)

    30,763       1,088,703  

National HealthCare Corp.

    28,968       2,034,423  

Pennant Group Inc. (The)(a)

    57,742       1,075,734  

Select Medical Holdings Corp.

    225,663       5,413,655  

Surgery Partners Inc.(a)(b)

    75,288       4,144,604  

Tenet Healthcare Corp.(a)

    228,165       19,613,063  

U.S. Physical Therapy Inc.

    27,549       2,739,748  

Universal Health Services Inc., Class B

    155,738       22,574,223  
   

 

 

 
      161,336,130  
Health Care Services — 36.4%            

1Life Healthcare Inc.(a)(b)

    361,338       4,003,625  

Accolade Inc.(a)(b)

    124,337       2,183,358  

Addus HomeCare Corp.(a)

    33,995       3,171,394  

Agiliti Inc.(a)

    58,562       1,235,658  

agilon health Inc.(a)(b)

    100,827       2,555,964  

Amedisys Inc.(a)(b)

    69,424       11,961,061  

Apollo Medical Holdings Inc.(a)(b)

    80,352       3,894,661  

Castle Biosciences Inc.(a)(b)

    50,377       2,259,912  

Chemed Corp.

    32,790       16,609,775  

Cigna Corp.

    251,783       60,329,725  

CorVel Corp.(a)

    19,965       3,362,905  

CVS Health Corp.

    1,840,273       186,254,030  

DaVita Inc.(a)

    131,268       14,847,723  

DocGo Inc.(a)

    162,327       1,501,525  

Fulgent Genetics Inc.(a)

    41,386       2,582,900  

Guardant Health Inc.(a)(b)

    216,514       14,341,887  

Hims & Hers Health Inc.(a)

    264,408       1,409,295  

Invitae Corp.(a)

    442,938       3,530,216  

Laboratory Corp. of America Holdings(a)

    198,291       52,281,405  

LHC Group Inc.(a)(b)

    67,421       11,367,181  

MEDNAX Inc.(a)

    181,381       4,258,826  

ModivCare Inc.(a)

    26,175       3,020,333  

Oak Street Health Inc.(a)(b)

    297,711       8,002,472  

Option Care Health Inc.(a)(b)

    295,120       8,428,627  

Premier Inc., Class A

    253,426       9,019,431  

Privia Health Group Inc.(a)

    56,829       1,519,039  

Quest Diagnostics Inc.

    253,456       34,687,988  

R1 RCM Inc.(a)

    284,520       7,613,755  

RadNet Inc.(a)

    99,506       2,225,949  

Sema4 Holdings Corp.(a)

    269,236       826,555  

Signify Health Inc., Class A(a)(b)

    51,132       928,046  

Tivity Health Inc.(a)

    94,507       3,040,290  
   

 

 

 
          483,255,511  
Health Care Technology — 6.5%            

American Well Corp., Class A(a)(b)

    417,577       1,757,999  
Security   Shares     Value  

 

 
Health Care Technology (continued)            

Certara Inc.(a)(b)

    220,898     $ 4,744,889  

Change Healthcare Inc.(a)

    537,301       11,713,162  

Definitive Healthcare Corp.(a)

    57,205       1,410,103  

Doximity Inc., Class A(a)(b)

    197,256       10,275,065  

GoodRx Holdings Inc., Class A(a)(b)

    146,407       2,830,047  

Health Catalyst Inc.(a)(b)

    110,576       2,889,351  

HealthStream Inc.(a)

    53,892       1,073,529  

Inspire Medical Systems Inc.(a)(b)

    58,269       14,957,070  

Multiplan Corp.(a)(b)

    517,688       2,422,780  

Phreesia Inc.(a)(b)

    108,903       2,870,683  

Schrodinger Inc.(a)

    99,751       3,403,504  

Sharecare Inc.(a)(b)

    615,092       1,519,277  

Teladoc Health Inc.(a)(b)

    340,967       24,593,950  
   

 

 

 
      86,461,409  
Life Sciences Tools & Services — 0.2%            

NeoGenomics Inc.(a)(b)

    262,045       3,183,847  
   

 

 

 
Managed Health Care — 44.7%            

Anthem Inc.

    215,920       106,064,222  

Centene Corp.(a)

    702,800       59,168,732  

Clover Health Investments Corp.(a)(b)

    578,415       2,053,373  

HealthEquity Inc.(a)

    177,977       12,002,769  

Humana Inc.

    135,672       59,040,384  

Molina Healthcare Inc.(a)

    124,384       41,493,259  

Progyny Inc.(a)(b)

    148,347       7,625,036  

UnitedHealth Group Inc.

    599,572       305,763,733  
   

 

 

 
      593,211,508  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $1,144,421,766)

      1,327,448,405  
   

 

 

 

Short-Term Investments

   

Money Market Funds — 3.8%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    49,222,629       49,212,785  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    1,470,000       1,470,000  
   

 

 

 
      50,682,785  
   

 

 

 

Total Short -Term Investments — 3.8%
(Cost: $50,673,112)

      50,682,785  
   

 

 

 

Total Investments in Securities — 103.7%
(Cost: $1,195,094,878)

 

    1,378,131,190  

Other Assets, Less Liabilities — (3.7)%

      (49,389,272
   

 

 

 

Net Assets — 100.0%

    $  1,328,741,918  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  41


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Healthcare Providers ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 

   
       Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

   

    

 

 

   
 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 59,045,877     $     $ (9,796,350 )(a)    $ (27,859   $ (8,883   $ 49,212,785       49,222,629     $ 130,484 (b)    $    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

    1,150,000       320,000 (a)                        1,470,000       1,470,000       307          
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   
          $ (27,859   $ (8,883   $ 50,682,785       $ 130,791     $    
         

 

 

   

 

 

   

 

 

     

 

 

   

 

 

   

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

      

Expiration

Date

      

Notional

Amount

(000)

      

Value/
Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

                 

E-Mini Health Care Sector Index

     8          06/17/22        $ 1,105        $ 57,343  
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 57,343  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 239,245  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 59,065  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 952,406      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

 

 

42  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Healthcare Providers ETF

    

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 1,327,448,405      $                 —      $                 —      $ 1,327,448,405  

Money Market Funds

     50,682,785                      50,682,785  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 1,378,131,190      $      $      $ 1,378,131,190  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 57,343      $      $      $ 57,343  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  43


Schedule of Investments

March 31, 2022

  

iShares® U.S. Home Construction ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   
Building Products — 14.0%  

American Woodmark Corp.(a)(b)

    53,917     $ 2,639,237  

AZEK Co. Inc. (The)(a)(b)

    338,516       8,408,737  

Builders FirstSource Inc.(a)

    580,396       37,458,758  

Fortune Brands Home & Security Inc.

    426,443       31,676,186  

Hayward Holdings Inc.(a)

    127,206       2,114,164  

JELD-WEN Holding Inc.(a)(b)

    274,069       5,558,119  

Lennox International Inc.

    110,017       28,368,984  

Masco Corp.

    758,802       38,698,902  

Masonite International Corp.(a)(b)

    74,404       6,617,492  

Owens Corning

    301,480       27,585,420  

PGT Innovations Inc.(a)

    195,424       3,513,723  

Quanex Building Products Corp.

    109,145       2,290,954  

Simpson Manufacturing Co. Inc.

    138,524       15,104,657  

Trex Co. Inc.(a)(b)

    344,781       22,524,543  

UFP Industries Inc.

    198,127       15,287,479  
   

 

 

 
          247,847,355  
Construction Materials — 0.9%  

Eagle Materials Inc.

    121,919       15,649,523  
   

 

 

 
Forest Products — 1.0%            

Louisiana-Pacific Corp.

    286,259       17,782,409  
   

 

 

 
Home Furnishings — 2.1%            

Ethan Allen Interiors Inc.

    70,102       1,827,559  

Leggett & Platt Inc.

    425,496       14,807,261  

Mohawk Industries Inc.(a)

    163,496       20,306,203  
   

 

 

 
      36,941,023  
Home Improvement Retail — 10.7%  

Floor & Decor Holdings Inc., Class A(a)(b)

    331,328       26,837,568  

Home Depot Inc. (The)

    274,463       82,155,010  

LL Flooring Holdings Inc.(a)(b)

    92,803       1,301,098  

Lowe’s Companies Inc.

    385,407       77,925,441  
   

 

 

 
      188,219,117  
Homebuilding — 63.6%  

Beazer Homes USA Inc.(a)(b)

    297,963       4,534,997  

Cavco Industries Inc.(a)

    86,339       20,794,748  

Century Communities Inc.

    306,908       16,441,062  

DR Horton Inc.

    3,335,618       248,536,897  

Green Brick Partners Inc.(a)

    497,747       9,835,481  

Installed Building Products Inc.

    239,701       20,252,337  

KB Home

    889,924       28,815,739  

Lennar Corp., Class A

    2,654,890       215,497,421  

Lennar Corp., Class B

    156,459       10,693,973  

LGI Homes Inc.(a)(b)

    222,462       21,730,088  
Security   Shares     Value  

 

 
Homebuilding (continued)  

M/I Homes Inc.(a)

    300,397     $ 13,322,607  

MDC Holdings Inc.

    587,003       22,212,194  

Meritage Homes Corp.(a)

    382,477       30,303,653  

NVR Inc.(a)(b)

    34,172       152,655,550  

PulteGroup Inc.

    2,576,326       107,948,059  

Skyline Champion Corp.(a)(b)

    525,803       28,856,069  

Taylor Morrison Home Corp.(a)(b)

    1,283,753       34,943,757  

Toll Brothers Inc.

    1,140,250       53,614,555  

TopBuild Corp.(a)(b)

    322,973       58,584,072  

Tri Pointe Homes Inc.(a)(b)

    1,171,758       23,528,901  
   

 

 

 
      1,123,102,160  
Specialty Chemicals — 5.1%  

Sherwin-Williams Co. (The)

    360,181       89,908,381  
   

 

 

 
Trading Companies & Distributors — 2.5%  

Beacon Roofing Supply Inc.(a)(b)

    173,435       10,281,227  

Watsco Inc.

    108,017       32,906,299  
   

 

 

 
      43,187,526  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $2,294,376,871)

 

    1,762,637,494  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 1.8%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    30,174,717       30,168,682  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    2,040,000       2,040,000  
   

 

 

 
      32,208,682  
   

 

 

 

Total Short -Term Investments — 1.8%
(Cost: $32,202,087)

 

    32,208,682  
   

 

 

 

Total Investments in Securities — 101.7%
(Cost: $2,326,578,958)

 

    1,794,846,176  

Other Assets, Less Liabilities — (1.7)%

 

    (29,870,634
   

 

 

 

Net Assets — 100.0%

 

  $  1,764,975,542  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

44  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Home Construction ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

    Purchases
at Cost
    Proceeds
from Sales
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
03/31/22
    Shares
Held at
03/31/22
    Income    

Capital

Gain
Distributions

from
Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 31,310,054     $     $ (1,100,641 )(a)    $  (40,527   $ (204   $ 30,168,682       30,174,717     $ 83,563(b )    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    1,583,000       457,000(a )                        2,040,000       2,040,000       619        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (40,527   $ (204   $ 32,208,682       $ 84,182     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description  

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

    Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

       

S&P Mid 400 E-Mini Index

    8       06/17/22     $ 2,151     $ 92,708  
       

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
     Equity
Contracts
 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 92,708  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ (142,894
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 92,708  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 1,585,296      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  45


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Home Construction ETF

    

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 1,762,637,494      $                 —      $                 —      $ 1,762,637,494  

Money Market Funds

     32,208,682                      32,208,682  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 1,794,846,176      $      $      $ 1,794,846,176  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 92,708      $      $      $ 92,708  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

46  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Infrastructure ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   
Aluminum — 1.6%            

Arconic Corp.(a)

    185,822     $ 4,760,760  

Century Aluminum Co.(a)

    170,918       4,496,852  

Kaiser Aluminum Corp.

    52,949       4,985,678  
   

 

 

 
          14,243,290  
Auto Parts & Equipment — 0.5%            

XPEL Inc.(a)

    88,221       4,641,307  
   

 

 

 
Building Products — 6.6%            

Advanced Drainage Systems Inc.

    41,655       4,949,031  

Apogee Enterprises Inc.

    111,869       5,309,303  

Armstrong World Industries Inc.

    56,425       5,078,814  

AZEK Co. Inc. (The)(a)

    187,655       4,661,350  

Builders FirstSource Inc.(a)

    67,874       4,380,588  

Carlisle Companies Inc.

    21,778       5,355,646  

Cornerstone Building Brands Inc.(a)

    235,975       5,738,912  

Gibraltar Industries Inc.(a)

    104,918       4,506,228  

Insteel Industries Inc.

    133,130       4,924,479  

Owens Corning

    57,381       5,250,361  

Simpson Manufacturing Co. Inc.

    43,029       4,691,882  

Trex Co. Inc.(a)

    67,528       4,411,604  
   

 

 

 
      59,258,198  
Commodity Chemicals — 3.6%            

AdvanSix Inc.

    117,658       6,011,147  

Hawkins Inc.

    108,911       4,999,015  

LyondellBasell Industries NV, Class A

    51,270       5,271,581  

Olin Corp.

    105,379       5,509,214  

Tredegar Corp.

    424,606       5,091,026  

Westlake Chemical Corp.

    44,616       5,505,615  
   

 

 

 
      32,387,598  
Construction & Engineering — 12.3%  

AECOM

    71,300       5,476,553  

API Group Corp.(a)

    255,971       5,383,070  

Argan Inc.

    124,879       5,068,839  

Comfort Systems USA Inc.

    59,319       5,279,984  

Construction Partners Inc., Class A(a)(b)

    195,340       5,114,001  

EMCOR Group Inc.

    43,321       4,879,244  

Fluor Corp.(a)

    214,169       6,144,509  

Granite Construction Inc.

    170,268       5,584,790  

Great Lakes Dredge & Dock Corp.(a)

    344,298       4,830,501  

IES Holdings Inc.(a)(b)

    123,239       4,954,208  

Infrastructure and Energy Alternatives Inc.(a)

    476,536       5,646,952  

MasTec Inc.(a)

    66,989       5,834,742  

MDU Resources Group Inc.

    189,833       5,059,049  

MYR Group Inc.(a)

    55,171       5,188,281  

Northwest Pipe Co.(a)

    173,839       4,424,202  

NV5 Global Inc.(a)(b)

    40,448       5,391,718  

Primoris Services Corp.

    203,209       4,840,438  

Quanta Services Inc.

    46,033       6,058,403  

Sterling Construction Co. Inc.(a)

    178,032       4,771,258  

Tutor Perini Corp.(a)

    514,837       5,560,240  

Valmont Industries Inc.

    23,256       5,548,882  
   

 

 

 
      111,039,864  
Construction Machinery & Heavy Trucks — 2.3%  

Astec Industries Inc.

    106,378       4,574,254  

Greenbrier Companies Inc. (The)

    103,987       5,356,370  

Terex Corp.

    130,898       4,667,823  
Security   Shares     Value  
Construction Machinery & Heavy Trucks (continued)  

Trinity Industries Inc.

    164,779     $ 5,661,806  
   

 

 

 
          20,260,253  
Construction Materials — 1.8%            

Martin Marietta Materials Inc.

    13,485       5,190,242  

Summit Materials Inc., Class A(a)(b)

    172,775       5,366,391  

Vulcan Materials Co.

    28,518       5,238,757  
   

 

 

 
      15,795,390  
Copper — 0.6%            

Taseko Mines Ltd.(a)

    2,378,428       5,446,600  
   

 

 

 
Distributors — 0.5%            

Pool Corp.

    10,867       4,595,111  
   

 

 

 
Diversified Metals & Mining — 0.6%  

Compass Minerals International Inc.

    82,949       5,208,368  
   

 

 

 
Electric Utilities — 19.4%            

ALLETE Inc.

    94,991       6,362,497  

Alliant Energy Corp.

    102,279       6,390,392  

American Electric Power Co. Inc.

    64,547       6,439,854  

Avangrid Inc.

    136,572       6,383,375  

Constellation Energy Corp.

    120,036       6,752,025  

Duke Energy Corp.

    58,474       6,529,207  

Edison International

    93,531       6,556,523  

Entergy Corp.

    54,768       6,394,164  

Evergy Inc.

    97,295       6,649,140  

Eversource Energy

    72,357       6,381,164  

Exelon Corp.

    138,893       6,615,474  

FirstEnergy Corp.

    144,281       6,616,727  

Fortis Inc./Canada

    130,009       6,435,445  

Hawaiian Electric Industries Inc.

    147,379       6,235,605  

IDACORP Inc.

    55,957       6,455,200  

MGE Energy Inc.

    81,700       6,518,843  

NextEra Energy Inc

    77,260       6,544,695  

NRG Energy Inc.

    163,787       6,282,869  

OGE Energy Corp.

    156,192       6,369,510  

Otter Tail Corp.

    98,147       6,134,188  

PG&E Corp.(a)

    549,216       6,557,639  

Pinnacle West Capital Corp.

    82,501       6,443,328  

PNM Resources Inc.

    134,779       6,424,915  

Portland General Electric Co.

    115,143       6,350,136  

PPL Corp.

    232,482       6,639,686  

Southern Co. (The)

    91,545       6,637,928  

Xcel Energy Inc.

    86,965       6,276,264  
   

 

 

 
      174,376,793  
Environmental & Facilities Services — 0.6%  

Tetra Tech Inc.

    31,588       5,210,125  
   

 

 

 
Forest Products — 1.0%            

Louisiana-Pacific Corp.

    72,372       4,495,748  

West Fraser Timber Co. Ltd.

    51,730       4,264,104  
   

 

 

 
      8,759,852  
Gas Utilities — 5.3%            

Atmos Energy Corp.

    53,348       6,374,553  

Chesapeake Utilities Corp.

    39,604       5,455,847  

New Jersey Resources Corp.

    136,711       6,269,566  

Northwest Natural Holding Co.

    110,715       5,726,180  

ONE Gas Inc.

    71,032       6,267,864  

South Jersey Industries Inc.

    178,122       6,154,115  

Southwest Gas Holdings Inc.

    68,258       5,343,919  

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  47


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Infrastructure ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Gas Utilities (continued)

   

Spire Inc.

    87,123     $ 6,251,946  
   

 

 

 
      47,843,990  
Independent Power Producers & Energy Traders — 0.7%  

Vistra Corp.

    274,547       6,383,218  
   

 

 

 
Industrial Machinery — 1.6%            

Luxfer Holdings PLC

    292,696       4,917,293  

Mueller Industries Inc.

    90,537       4,904,389  

Omega Flex Inc.

    33,835       4,394,151  
   

 

 

 
      14,215,833  
Multi-Utilities — 10.6%            

Algonquin Power & Utilities Corp.

    421,457       6,541,013  

Ameren Corp.

    69,232       6,491,192  

Avista Corp.

    128,246       5,790,307  

Black Hills Corp.

    85,289       6,568,959  

CenterPoint Energy Inc.

    213,744       6,549,116  

CMS Energy Corp.

    92,493       6,468,960  

Consolidated Edison Inc.

    69,093       6,541,725  

Dominion Energy Inc.

    75,184       6,388,385  

DTE Energy Co.

    48,521       6,414,961  

NiSource Inc.

    203,326       6,465,767  

NorthWestern Corp.

    100,340       6,069,567  

Public Service Enterprise Group Inc.

    91,670       6,416,900  

Sempra Energy

    40,680       6,839,122  

Unitil Corp.

    113,042       5,638,535  

WEC Energy Group Inc.

    65,509       6,538,453  
   

 

 

 
          95,722,962  
Oil & Gas Equipment & Services — 0.7%            

U.S. Silica Holdings Inc.(a)(b)

    355,936       6,641,766  
   

 

 

 
Oil & Gas Storage & Transportation — 6.9%            

Antero Midstream Corp.

    604,539       6,571,339  

DTE Midstream LLC(a)

    110,770       6,010,380  

Enbridge Inc.

    136,884       6,308,984  

EnLink Midstream LLC

    616,157       5,945,915  

Equitrans Midstream Corp.

    877,035       7,402,175  

Kinder Morgan Inc.

    324,148       6,129,639  

Kinetik Holdings Inc.

    82,824       5,384,388  

ONEOK Inc.

    90,179       6,369,343  

TC Energy Corp.

    108,986       6,148,990  

Williams Companies Inc. (The)

    184,756       6,172,698  
   

 

 

 
      62,443,851  
Railroads — 2.1%            

CSX Corp.

    164,806       6,171,985  

Norfolk Southern Corp.

    21,714       6,193,267  

Union Pacific Corp.

    23,322       6,371,803  
   

 

 

 
      18,737,055  
Research & Consulting Services — 1.2%            

Jacobs Engineering Group Inc.

    38,964       5,369,629  

Stantec Inc.

    103,745       5,201,774  
   

 

 

 
      10,571,403  
Semiconductors — 0.7%            

SunPower Corp.(a)

    299,104       6,424,754  
   

 

 

 
Specialty Chemicals — 3.0%            

Avient Corp.

    99,805       4,790,640  

Danimer Scientific Inc.(a)(b)

    1,209,295       7,086,469  

Eastman Chemical Co.

    43,632       4,889,402  

Ecovyst Inc.

    471,996       5,456,274  
Security   Shares     Value  

 

 
Specialty Chemicals (continued)            

Ingevity Corp.(a)

    79,822     $ 5,114,195  
   

 

 

 
      27,336,980  
Steel — 7.9%            

Allegheny Technologies Inc.(a)

    193,458       5,192,413  

Carpenter Technology Corp.

    137,714       5,781,234  

Cleveland-Cliffs Inc.(a)

    193,452       6,231,089  

Commercial Metals Co.

    126,510       5,265,346  

Haynes International Inc.

    126,750       5,399,550  

Nucor Corp.

    36,323       5,399,414  

Olympic Steel Inc.

    149,466       5,748,462  

Reliance Steel & Aluminum Co.

    26,519       4,862,259  

Ryerson Holding Corp.

    158,169       5,539,078  

Steel Dynamics Inc.

    64,359       5,369,471  

TimkenSteel Corp.(a)

    258,807       5,662,697  

United States Steel Corp.

    159,478       6,018,700  

Worthington Industries Inc.

    83,561       4,295,871  
   

 

 

 
      70,765,584  
Trading Companies & Distributors — 2.2%            

BlueLinx Holdings Inc.(a)

    56,622       4,069,990  

Boise Cascade Co.

    64,658       4,491,791  

H&E Equipment Services Inc.

    127,085       5,530,739  

United Rentals Inc.(a)

    15,896       5,646,418  
   

 

 

 
      19,738,938  
Water Utilities — 5.4%            

American States Water Co.

    70,327       6,260,509  

American Water Works Co. Inc.

    38,478       6,369,263  

Artesian Resources Corp., Class A, NVS

    125,663       6,100,939  

California Water Service Group

    106,056       6,287,000  

Essential Utilities Inc.

    126,999       6,493,459  

Middlesex Water Co.

    45,999       4,837,715  

SJW Group

    91,070       6,336,651  

York Water Co. (The)

    132,759       5,970,172  
   

 

 

 
      48,655,708  
   

 

 

 

Total Common Stocks — 99.7%
(Cost: $829,748,159)

      896,704,791  
   

 

 

 

Short-Term Investments

   

Money Market Funds — 0.9%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    6,923,529       6,922,144  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    1,310,000       1,310,000  
   

 

 

 
      8,232,144  
   

 

 

 

Total Short -Term Investments — 0.9%
(Cost: $8,231,188)

      8,232,144  
   

 

 

 

Total Investments in Securities — 100.6%
(Cost: $837,979,347)

      904,936,935  

Other Assets, Less Liabilities — (0.6)%

      (5,822,454
   

 

 

 

Net Assets — 100.0%

    $  899,114,481  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

48  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Infrastructure ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                                                                                                                                                                 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 1,775,064     $ 5,149,016 (a)    $     $ (2,889   $ 953     $ 6,922,144       6,923,529     $ 21,066 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    510,000       800,000 (a)                        1,310,000       1,310,000       318        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (2,889   $ 953     $ 8,232,144       $ 21,384     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

   

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

        

E-Mini Energy Select Sector Index

     2       06/17/22     $ 159     $ 1,856  

E-Mini Utilities Select Sector Index

     9       06/17/22       676       25,463  

S&P Mid 400 E-Mini Index

     5       06/17/22       1,345       (7,951
        

 

 

 
         $ 19,368  
        

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 27,319  
  

 

 

 

Liabilities — Derivative Financial Instruments

  

Futures contracts

  

Unrealized depreciation on futures contracts(a)

   $ 7,951  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 96,015  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 19,368  
  

 

 

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  49


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Infrastructure ETF

    

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 1,137,364      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                       

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 896,704,791      $      $      $ 896,704,791  

Money Market Funds

     8,232,144                      8,232,144  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 904,936,935      $      $      $ 904,936,935  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 27,319      $      $      $ 27,319  

Liabilities

           

Futures Contracts

     (7,951                    (7,951
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 19,368      $      $      $ 19,368  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

50  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Insurance ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Insurance Brokers — 7.0%

   

Arthur J Gallagher & Co.

    49,758     $ 8,687,747  

Brown & Brown Inc.

    59,947       4,332,369  

eHealth Inc.(a)(b)

    8,763       108,749  
   

 

 

 
      13,128,865  
Life & Health Insurance — 24.9%            

Aflac Inc.

    128,417       8,268,771  

American Equity Investment Life Holding Co.

    21,846       871,874  

Brighthouse Financial Inc.(a)

    20,459       1,056,912  

CNO Financial Group Inc.

    32,007       803,056  

Genworth Financial Inc., Class A(a)

    63,891       241,508  

Globe Life Inc.

    23,906       2,404,943  

Lincoln National Corp.

    42,781       2,796,166  

MetLife Inc.

    170,527       11,984,637  

National Western Life Group Inc., Class A

    736       154,854  

Oscar Health Inc., Class A(a)(b)

    13,112       130,727  

Primerica Inc.

    10,251       1,402,542  

Principal Financial Group Inc.

    62,081       4,557,366  

Prudential Financial Inc.

    79,814       9,431,620  

Trupanion Inc.(a)

    8,730       778,018  

Unum Group

    52,935       1,667,982  
   

 

 

 
      46,550,976  
Multi-line Insurance — 12.0%            

American International Group Inc.

    201,952       12,676,527  

American National Group Inc.

    3,471       656,331  

Assurant Inc.

    14,648       2,663,446  

Hartford Financial Services Group Inc. (The)

    85,395       6,132,215  

Horace Mann Educators Corp.

    5,224       218,520  
   

 

 

 
          22,347,039  
Other Diversified Financial Services — 0.8%            

Voya Financial Inc.

    21,447       1,423,009  
   

 

 

 
Property & Casualty Insurance — 53.5%            

Allstate Corp. (The)

    63,374       8,777,933  

Ambac Financial Group Inc.(a)

    15,327       159,401  

American Financial Group Inc./OH

    17,040       2,481,365  

AMERISAFE Inc.

    5,592       277,755  

Arch Capital Group Ltd.(a)

    98,647       4,776,488  

Argo Group International Holdings Ltd.

    9,676       399,425  

Assured Guaranty Ltd.

    18,259       1,162,368  

Axis Capital Holdings Ltd.

    20,124       1,216,898  

Chubb Ltd.

    104,595       22,372,870  

Cincinnati Financial Corp.

    38,256       5,201,286  

CNA Financial Corp.

    7,584       368,734  

Employers Holdings Inc.

    3,521       144,431  

Erie Indemnity Co., Class A, NVS

    6,525       1,149,248  

First American Financial Corp.

    28,324       1,835,962  

Hanover Insurance Group Inc. (The)

    9,267       1,385,602  
Security   Shares     Value  

 

 
Property & Casualty Insurance (continued)            

James River Group Holdings Ltd.

    4,696     $ 116,179  

Kemper Corp.

    15,812       894,010  

Kinsale Capital Group Inc.

    5,584       1,273,264  

Lemonade Inc.(a)(b)

    10,918       287,908  

Loews Corp.

    50,273       3,258,696  

Markel Corp.(a)

    3,480       5,133,835  

MBIA Inc.(a)

    14,212       218,723  

Mercury General Corp.

    7,363       404,965  

Old Republic International Corp.

    73,704       1,906,722  

Palomar Holdings Inc.(a)

    6,678       427,325  

ProAssurance Corp.

    6,798       182,730  

Progressive Corp. (The)

    141,956       16,181,564  

RLI Corp.

    10,420       1,152,765  

Safety Insurance Group Inc.

    1,792       162,803  

Selective Insurance Group Inc.

    15,629       1,396,607  

Travelers Companies Inc. (The)

    58,672       10,721,135  

United Fire Group Inc.

    5,495       170,730  

W R Berkley Corp.

    53,658       3,573,086  

White Mountains Insurance Group Ltd.(b)

    790       897,630  
   

 

 

 
          100,070,443  
Reinsurance — 1.6%            

Alleghany Corp.(a)

    3,517       2,978,899  
   

 

 

 

Total Common Stocks — 99.8%
(Cost: $171,924,694)

      186,499,231  
   

 

 

 

Short-Term Investments

   

Money Market Funds — 0.8%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    1,050,196       1,049,986  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    510,000       510,000  
   

 

 

 
          1,559,986  
   

 

 

 

Total Short -Term Investments — 0.8%
(Cost: $1,559,794)

      1,559,986  
   

 

 

 

Total Investments in Securities — 100.6%
(Cost: $173,484,488)

      188,059,217  

Other Assets, Less Liabilities — (0.6)%

      (1,199,087
   

 

 

 

Net Assets — 100.0%

    $   186,860,130  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  51


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Insurance ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at
03/31/22

    Income    

Capital

Gain
Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 207,497     $ 842,601 (a)    $     $ (298   $ 186     $ 1,049,986       1,050,196     $ 3,845 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    180,000       330,000 (a)                        510,000       510,000       61        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (298   $ 186     $ 1,559,986       $ 3,906     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

    Expiration
Date
    Notional
Amount
(000)
    Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

        

E-Mini Financials Select Sector Index

     3       06/17/22     $ 354     $ 1,012  
        

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 1,012  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ (16,788
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 2,367  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 251,060      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

52  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Insurance ETF

    

 

Fair Value Hierarchy as of Period End (continued)

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                       

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 186,499,231      $      $      $ 186,499,231  

Money Market Funds

     1,559,986                      1,559,986  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 188,059,217      $      $      $ 188,059,217  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 1,012      $      $      $ 1,012  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  53


Schedule of Investments

March 31, 2022

  

iShares® U.S. Medical Devices ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   
Health Care Equipment — 80.3%            

Abbott Laboratories

    9,873,232     $   1,168,595,740  

ABIOMED Inc.(a)(b)

    300,893       99,667,797  

AngioDynamics Inc.(a)(b)

    255,943       5,513,012  

Artivion Inc.(a)(b)

    259,999       5,558,779  

AtriCure Inc.(a)(b)

    303,639       19,939,973  

Axogen Inc.(a)(b)

    274,758       2,181,579  

Axonics Inc.(a)(b)

    306,059       19,159,293  

Baxter International Inc.

    3,309,929       256,651,895  

Becton Dickinson and Co.

    1,297,569       345,153,354  

Boston Scientific Corp.(a)

    8,168,163       361,767,939  

Butterfly Network Inc.(a)(b)

    880,855       4,192,870  

Cardiovascular Systems Inc.(a)(b)

    268,257       6,062,608  

CONMED Corp.

    193,343       28,721,103  

CryoPort Inc.(a)(b)

    326,350       11,392,879  

Dexcom Inc.(a)(b)

    640,720       327,792,352  

Edwards Lifesciences Corp.(a)(b)

    3,244,452       381,936,889  

Envista Holdings Corp.(a)(b)

    1,066,758       51,961,782  

Glaukos Corp.(a)(b)

    309,976       17,922,812  

Globus Medical Inc., Class A(a)(b)

    522,444       38,545,918  

Heska Corp.(a)(b)

    70,805       9,790,915  

Hologic Inc.(a)

    1,652,581       126,951,272  

IDEXX Laboratories Inc.(a)

    560,551       306,655,030  

Inari Medical Inc.(a)(b)

    212,411       19,252,933  

Inogen Inc.(a)

    135,199       4,383,152  

Insulet Corp.(a)(b)

    455,920       121,452,529  

Integer Holdings Corp.(a)(b)

    218,281       17,586,900  

Integra LifeSciences Holdings Corp.(a)

    481,533       30,943,311  

Intersect ENT Inc.(a)

    221,210       6,196,092  

Intuitive Surgical Inc.(a)(b)

    1,232,372       371,781,985  

iRhythm Technologies Inc.(a)(b)

    194,530       30,632,639  

LeMaitre Vascular Inc.

    127,040       5,903,549  

LivaNova PLC(a)(b)

    351,852       28,792,049  

Masimo Corp.(a)(b)

    335,850       48,879,609  

Medtronic PLC

    7,507,341       832,939,484  

Mesa Laboratories Inc.(b)

    34,681       8,839,493  

Natus Medical Inc.(a)

    225,769       5,933,209  

Nevro Corp.(a)(b)

    230,740       16,689,424  

Novocure Ltd.(a)(b)

    590,229       48,900,473  

NuVasive Inc.(a)(b)

    342,011       19,392,024  

Ortho Clinical Diagnostics
Holdings PLC(a)(b)

    752,585       14,043,236  

Orthofix Medical Inc.(a)

    130,530       4,268,331  

Outset Medical Inc.(a)(b)

    270,853       12,296,726  

Penumbra Inc.(a)(b)

    232,148       51,567,035  

ResMed Inc.

    966,706       234,435,872  

SeaSpine Holdings Corp.(a)(b)

    216,815       2,636,470  

Senseonics Holdings Inc.(a)(b)

    2,712,401       5,343,430  

Shockwave Medical Inc.(a)(b)

    233,385       48,394,714  

SI-BONE Inc.(a)(b)

    181,545       4,102,917  
Security   Shares     Value  

 

 
Health Care Equipment (continued)  

STERIS PLC

    661,907     $ 160,029,255  

Stryker Corp.

    1,376,228       367,934,556  

Surmodics Inc.(a)

    92,390       4,188,039  

Tactile Systems Technology Inc.(a)(b)

    131,047       2,641,908  

Tandem Diabetes Care Inc.(a)

    420,000       48,841,800  

Teleflex Inc.

    309,677       109,882,690  

TransMedics Group Inc.(a)(b)

    183,568       4,945,322  

Vapotherm Inc.(a)(b)

    151,679       2,108,338  

Varex Imaging Corp.(a)(b)

    261,782       5,573,339  

ViewRay Inc.(a)

    1,016,244       3,983,677  

Zimmer Biomet Holdings Inc.

    1,381,029       176,633,609  

Zimvie Inc.(a)

    138,032       3,152,651  
   

 

 

 
      6,481,618,561  
Health Care Supplies — 0.3%  

STAAR Surgical Co.(a)(b)

    314,667       25,145,040  
   

 

 

 
Life Sciences Tools & Services — 19.3%  

Bio-Rad Laboratories Inc., Class A(a)

    142,839       80,451,210  

Bruker Corp.(b)

    671,709       43,190,888  

NanoString Technologies Inc.(a)(b)

    301,784       10,486,994  

Thermo Fisher Scientific Inc.

    2,200,166       1,299,528,048  

Waters Corp.(a)

    403,492       125,239,882  
   

 

 

 
      1,558,897,022  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $6,989,482,210)

 

    8,065,660,623  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 1.9%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    149,943,051       149,913,062  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    5,130,000       5,130,000  
   

 

 

 
      155,043,062  
   

 

 

 

Total Short -Term Investments — 1.9%
(Cost: $154,994,881)

 

    155,043,062  
   

 

 

 

Total Investments in Securities — 101.8%
(Cost: $7,144,477,091)

 

    8,220,703,685  

Other Assets, Less Liabilities — (1.8)%

 

    (144,446,404
   

 

 

 

Net Assets — 100.0%

    $  8,076,257,281  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

54  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Medical Devices ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
03/31/21
   

Purchases

at Cost

    Proceeds
from Sales
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
03/31/22
   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 217,217,031     $     $ (67,203,364 )(a)    $ (10,989   $ (89,616   $ 149,913,062       149,943,051     $ 368,925 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    8,910,000             (3,780,000 )(a)                  5,130,000       5,130,000       2,409        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (10,989   $ (89,616   $ 155,043,062       $ 371,334     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description    Number of
Contracts
    Expiration
Date
    Notional
Amount
(000)
    Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

        

E-Mini Health Care Sector Index

     46       06/17/22     $ 6,354     $ 235,723  

E-Mini Technology Select Sector Index

     17       06/17/22       2,725       153,440  
        

 

 

 
         $ 389,163  
        

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
     Equity
Contracts
 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 389,163  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 1,774,807  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 88,335  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

Futures contracts:

  

Average notional value of contracts — long

   $11,369,164    

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  55


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Medical Devices ETF

    

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1      Level 2        Level 3        Total  

 

 

Investments

               

Assets

               

Common Stocks

   $ 8,065,660,623      $        $        $ 8,065,660,623  

Money Market Funds

     155,043,062                          155,043,062  
  

 

 

    

 

 

      

 

 

      

 

 

 
   $ 8,220,703,685      $        $        $ 8,220,703,685  
  

 

 

    

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

               

Assets

               

Futures Contracts

   $ 389,163      $                 —        $                 —        $ 389,163  
  

 

 

    

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

56  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Oil & Gas Exploration & Production ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Oil & Gas Exploration & Production — 74.7%  

Antero Resources Corp.(a)

    332,900     $ 10,163,437  

APA Corp.

    423,327       17,496,105  

Brigham Minerals Inc., Class A

    55,416       1,415,879  

California Resources Corp.

    93,761       4,193,930  

Callon Petroleum Co.(a)(b)

    55,008       3,249,873  

Centennial Resource Development Inc./DE, Class A(a)

    214,979       1,734,881  

Chesapeake Energy Corp.

    121,454       10,566,498  

Civitas Resources Inc.

    84,033       5,017,610  

CNX Resources Corp.(a)

    236,118       4,892,365  

Comstock Resources Inc.(a)(b)

    105,765       1,380,233  

ConocoPhillips

    1,413,157       141,315,700  

Continental Resources Inc./OK

    68,222       4,184,055  

Coterra Energy Inc.

    948,070       25,569,448  

Denbury Inc.(a)

    58,448       4,592,259  

Devon Energy Corp.

    565,054       33,411,643  

Diamondback Energy Inc.

    198,459       27,204,760  

EOG Resources Inc.

    634,924       75,701,988  

EQT Corp.

    350,546       12,062,288  

Gulfport Energy Corp.(a)

    13,422       1,205,564  

Hess Corp.

    321,226       34,384,031  

Kosmos Energy Ltd.(a)

    526,090       3,782,587  

Laredo Petroleum Inc.(a)(b)

    16,692       1,321,005  

Magnolia Oil & Gas Corp., Class A

    171,756       4,062,029  

Marathon Oil Corp.

    907,235       22,780,671  

Matador Resources Co.

    128,551       6,810,632  

Murphy Oil Corp.

    169,223       6,834,917  

Northern Oil and Gas Inc.

    76,392       2,153,490  

Oasis Petroleum Inc.

    21,611       3,161,689  

Ovintiv Inc.

    304,244       16,450,473  

PDC Energy Inc.

    113,480       8,247,726  

Pioneer Natural Resources Co.

    246,384       61,603,392  

Range Resources Corp.(a)

    291,086       8,843,193  

SM Energy Co.

    141,609       5,515,671  

Southwestern Energy Co.(a)

    1,298,530       9,310,460  

Talos Energy Inc.(a)

    47,487       749,820  

Tellurian Inc.(a)

    457,277       2,423,568  

Texas Pacific Land Corp.

    7,221       9,763,586  

Whiting Petroleum Corp.

    45,558       3,713,433  
   

 

 

 
        597,270,889  
Oil & Gas Refining & Marketing — 18.3%  

Archaea Energy Inc.(a)

    47,509       1,041,872  
Security   Shares     Value  

 

 
Oil & Gas Refining & Marketing (continued)  

Clean Energy Fuels Corp.(a)

    197,390     $ 1,567,277  

CVR Energy Inc.

    34,029       869,101  

Delek U.S. Holdings Inc.(a)

    86,294       1,831,159  

HF Sinclair Corp.

    174,250       6,943,862  

Marathon Petroleum Corp.

    628,314       53,720,847  

Par Pacific Holdings Inc.(a)

    53,263       693,484  

PBF Energy Inc., Class A(a)

    110,593       2,695,151  

Phillips 66

    419,713       36,259,006  

Valero Energy Corp.

    382,081       38,796,505  

World Fuel Services Corp.

    73,545       1,988,657  
   

 

 

 
      146,406,921  
Oil & Gas Storage & Transportation — 6.8%  

Cheniere Energy Inc.

    248,503       34,454,941  

Targa Resources Corp.

    266,823       20,137,132  
   

 

 

 
      54,592,073  
   

 

 

 

Total Common Stocks — 99.8%
(Cost: $648,704,826)

 

    798,269,883  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.5%            

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    2,984,981       2,984,384  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    1,490,000       1,490,000  
   

 

 

 
      4,474,384  
   

 

 

 

Total Short -Term Investments — 0.5%
(Cost: $4,473,787)

 

    4,474,384  
   

 

 

 

Total Investments in Securities — 100.3%
(Cost: $653,178,613)

 

    802,744,267  

Other Assets, Less Liabilities — (0.3)%

 

    (2,604,246
   

 

 

 

Net Assets — 100.0%

    $  800,140,021  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  57


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Oil & Gas Exploration & Production ETF

    

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
03/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net Realized
Gain (Loss)
   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 2,451,170     $ 535,546 (a)    $      $ (2,080    $ (252   $ 2,984,384       2,984,981     $ 7,687 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    470,000       1,020,000 (a)                        1,490,000       1,490,000       311        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
         $ (2,080    $ (252   $ 4,474,384       $ 7,998     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description    Number of
Contracts
    

Expiration

Date

    

Notional

Amount

(000)

     Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

           

E-Mini Energy Select Sector Index

     22        06/17/22      $ 1,754      $ 22,444  
           

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 22,444  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
   
Equity
Contracts
 
 

 

 

Net Realized Gain (Loss) from:

 

Futures contracts

  $ 489,950  
 

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

 

Futures contracts

  $ 46,536  
 

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 745,426      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

 

 

58  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Oil & Gas Exploration & Production ETF

    

 

Fair Value Hierarchy as of Period End (continued)

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

         
      Level 1      Level 2        Level 3        Total  

Investments

               

Assets

               

Common Stocks

   $ 798,269,883      $        $        $ 798,269,883  

Money Market Funds

     4,474,384                          4,474,384  
  

 

 

    

 

 

      

 

 

      

 

 

 
   $ 802,744,267      $                 —        $                 —        $ 802,744,267  
  

 

 

    

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

               

Assets

               

Futures Contracts

   $ 22,444      $        $        $ 22,444  
  

 

 

    

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  59


Schedule of Investments

March 31, 2022

  

iShares® U.S. Oil Equipment & Services ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Oil & Gas Drilling — 17.1%

 

Helmerich & Payne Inc.

    301,501     $ 12,898,213  

Nabors Industries Ltd.(a)

    25,849       3,947,659  

Patterson-UTI Energy Inc.

    717,763       11,110,971  

Transocean Ltd.(a)(b)

    2,012,249       9,195,978  

Valaris Ltd.(a)

    217,724       11,315,117  
   

 

 

 
      48,467,938  
Oil & Gas Equipment & Services — 82.8%  

Archrock Inc.

    447,197       4,127,629  

Baker Hughes Co.

    370,160       13,477,526  

Bristow Group Inc.(a)

    77,335       2,867,582  

Cactus Inc., Class A

    196,696       11,160,531  

ChampionX Corp.(a)

    508,123       12,438,851  

Core Laboratories NV(b)

    154,412       4,884,052  

DMC Global Inc.(a)

    64,321       1,961,790  

Dril-Quip Inc.(a)(b)

    118,076       4,410,139  

Expro Group Holdings NV(a)(b)

    98,293       1,747,649  

Halliburton Co.

    1,745,603       66,105,986  

Helix Energy Solutions Group Inc.(a)(b)

    473,267       2,262,216  

Liberty Oilfield Services Inc., Class A(a)(b)

    351,033       5,202,309  

NexTier Oilfield Solutions Inc.(a)

    532,868       4,923,700  

NOV Inc.

    592,015       11,609,414  

Oceaneering International Inc.(a)

    333,004       5,048,341  

ProPetro Holding Corp.(a)

    282,834       3,939,878  

RPC Inc.(a)

    235,040       2,507,877  

Schlumberger NV

    1,470,294       60,737,845  

TechnipFMC PLC(a)

    1,413,623       10,955,578  

U.S. Silica Holdings Inc.(a)

    248,819       4,642,962  
   

 

 

 
      235,011,855  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $245,760,335)

 

    283,479,793  
   

 

 

 
Security   Shares     Value  

 

 

Short-Term Investments

 

Money Market Funds — 3.7%

 

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    10,307,601     $ 10,305,539  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    160,000       160,000  
   

 

 

 
      10,465,539  
   

 

 

 

Total Short -Term Investments — 3.7%
(Cost: $10,462,887)

 

    10,465,539  
   

 

 

 

Total Investments in Securities — 103.6%
(Cost: $256,223,222)

 

    293,945,332  

Other Assets, Less Liabilities — (3.6)%

      (10,267,899
   

 

 

 

Net Assets — 100.0%

    $  283,677,433  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

    Proceeds
from Sales
   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

    Value at
03/31/22
    Shares
Held at
03/31/22
    Income    

Capital

Gain
Distributions

from

Underlying

Funds

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 8,721,767     $ 1,589,818 (a)    $     $ (6,310   $ 264     $ 10,305,539       10,307,601     $ 15,631 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    630,000             (470,000 )(a)                  160,000       160,000       68        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (6,310   $ 264     $ 10,465,539       $ 15,699     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

60  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

   iShares® U.S. Oil Equipment & Services ETF

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description   

Number of

Contracts

    

Expiration

Date

    

Notional

Amount

(000)

    

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

           

E-Mini Energy Select Sector Index

     2        06/17/22      $ 159      $ 212  
           

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 212  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 85,920  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 7,591  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 315,340      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1        Level 2      Level 3        Total  

 

 

Investments

               

Assets

               

Common Stocks

   $ 283,479,793        $      $        $ 283,479,793  

Money Market Funds

     10,465,539                          10,465,539  
  

 

 

      

 

 

    

 

 

      

 

 

 
   $ 293,945,332        $      $        $ 293,945,332  
  

 

 

      

 

 

    

 

 

      

 

 

 

Derivative financial instruments(a)

               

Assets

               

Futures Contracts

   $ 212        $                 —      $                 —        $ 212  
  

 

 

      

 

 

    

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  61


Schedule of Investments

March 31, 2022

  

iShares® U.S. Pharmaceuticals ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

   

Biotechnology — 2.7%

   

Amicus Therapeutics Inc.(a)(b)

    336,086     $ 3,182,734  

Catalyst Pharmaceuticals Inc.(a)

    128,524       1,065,464  

ChemoCentryx Inc.(a)

    65,698       1,647,049  

Ironwood Pharmaceuticals Inc.(a)

    219,322       2,759,071  

Madrigal Pharmaceuticals Inc.(a)(b)

    16,498       1,618,784  

Vanda Pharmaceuticals Inc.(a)

    74,652       844,314  
   

 

 

 
          11,117,416  

Pharmaceuticals — 97.1%

   

Aerie Pharmaceuticals Inc.(a)

    63,296       575,994  

Amneal Pharmaceuticals Inc.(a)

    132,718       553,434  

Amphastar Pharmaceuticals Inc.(a)(b)

    49,378       1,772,670  

Antares Pharma Inc.(a)

    227,878       934,300  

Arvinas Inc.(a)

    58,104       3,910,399  

Atea Pharmaceuticals Inc.(a)

    71,601       516,959  

Axsome Therapeutics Inc.(a)

    39,906       1,651,709  

Bristol-Myers Squibb Co.

    257,452       18,801,720  

Cara Therapeutics Inc.(a)(b)

    56,037       680,850  

Cassava Sciences Inc.(a)(b)

    50,413       1,872,339  

Catalent Inc.(a)(b)

    177,730       19,710,257  

Collegium Pharmaceutical Inc.(a)(b)

    46,326       943,197  

Corcept Therapeutics Inc.(a)(b)

    127,774       2,877,470  

Elanco Animal Health Inc.(a)(b)

    634,042       16,542,156  

Eli Lilly & Co.

    66,746       19,114,052  

Endo International PLC(a)

    312,887       722,769  

Harmony Biosciences Holdings Inc.(a)

    30,562       1,486,841  

Innoviva Inc.(a)(b)

    83,819       1,621,898  

Intra-Cellular Therapies Inc.(a)

    113,946       6,972,356  

Jazz Pharmaceuticals PLC(a)

    82,381       12,824,250  

Johnson & Johnson

    517,837       91,776,252  

Merck & Co. Inc.

    225,481       18,500,716  

NGM Biopharmaceuticals Inc.(a)

    49,963       761,936  

Nuvation Bio Inc.(a)(b)

    154,637       813,391  

Omeros Corp.(a)(b)

    84,196       506,018  

Organon & Co.

    339,805       11,869,389  

Pacira BioSciences Inc.(a)(b)

    59,697       4,556,075  

Perrigo Co. PLC

    179,282       6,889,807  

Pfizer Inc.

    1,637,180       84,756,809  
Security   Shares     Value  

 

 
Pharmaceuticals (continued)            

Phathom Pharmaceuticals Inc.(a)

    20,854     $ 283,823  

Phibro Animal Health Corp., Class A

    27,380       546,231  

Prestige Consumer Healthcare Inc.(a)

    67,276       3,561,591  

Reata Pharmaceuticals Inc., Class A(a)(b)

    36,696       1,202,161  

Revance Therapeutics Inc.(a)(b)

    88,521       1,726,160  

Roivant Sciences Ltd.(a)(b)

    129,677       640,604  

Royalty Pharma PLC, Class A

    457,014       17,805,265  

Theravance Biopharma Inc.(a)

    70,027       669,458  

Viatris Inc.

    1,620,815       17,634,467  

Zoetis Inc.

    92,521       17,448,535  
   

 

 

 
      396,034,308  
   

 

 

 

Total Common Stocks — 99.8%
(Cost: $360,993,918)

 

    407,151,724  
   

 

 

 

Short-Term Investments

 

 

Money Market Funds — 3.0%

   

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    11,798,410       11,796,050  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    400,000       400,000  
   

 

 

 
      12,196,050  
   

 

 

 

Total Short -Term Investments — 3.0%
(Cost: $12,191,576)

 

    12,196,050  
   

 

 

 

Total Investments in Securities — 102.8%
(Cost: $373,185,494)

 

    419,347,774  

Other Assets, Less Liabilities — (2.8)%

 

    (11,574,609
   

 

 

 

Net Assets — 100.0%

 

  $  407,773,165  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

                   
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

    Proceeds
from Sales
   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

    Value at
03/31/22
   

Shares

Held at

03/31/22

    Income    

Capital

Gain
Distributions

from

Underlying

Funds

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 15,774,536     $     $ (3,970,369 )(a)    $ (4,733   $ (3,384   $ 11,796,050       11,798,410     $ 128,173 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    440,000             (40,000 )(a)                  400,000       400,000       119        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (4,733   $ (3,384   $ 12,196,050       $ 128,292     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

62  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

   iShares® U.S. Pharmaceuticals ETF

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description  

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

   

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

       

E-Mini Health Care Sector Index

    4       06/17/22     $ 553     $ 13,771  
       

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 13,771  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 114,595  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 4,012  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 603,258      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1      Level 2        Level 3        Total  

 

 

Investments

               

Assets

               

Common Stocks

   $ 407,151,724      $        $        $ 407,151,724  

Money Market Funds

     12,196,050                          12,196,050  
  

 

 

    

 

 

      

 

 

      

 

 

 
   $ 419,347,774      $        $        $ 419,347,774  
  

 

 

    

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

               

Assets

               

Futures Contracts

   $ 13,771      $                 —        $                 —        $ 13,771  
  

 

 

    

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  63


Schedule of Investments

March 31, 2022

  

iShares® U.S. Real Estate ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Diversified REITs — 1.7%  

PS Business Parks Inc.

    72,322     $ 12,155,882  

STORE Capital Corp.

    879,731       25,714,537  

WP Carey Inc.

    683,266       55,235,223  
   

 

 

 
      93,105,642  
Health Care REITs — 8.4%  

Healthcare Realty Trust Inc.

    529,318       14,545,659  

Healthcare Trust of America Inc., Class A

    791,647       24,810,217  

Healthpeak Properties Inc.

    1,933,250       66,368,473  

Medical Properties Trust Inc.

    2,139,408       45,227,085  

National Health Investors Inc.

    163,409       9,642,765  

Omega Healthcare Investors Inc.

    856,671       26,693,868  

Physicians Realty Trust

    791,047       13,874,964  

Sabra Health Care REIT Inc.

    822,300       12,244,047  

Ventas Inc.

    1,430,934       88,374,484  

Welltower Inc.

    1,560,334       150,010,511  
   

 

 

 
      451,792,073  
Hotel & Resort REITs — 0.9%  

Host Hotels & Resorts Inc.

    2,559,626       49,733,533  
   

 

 

 
Industrial REITs — 12.6%  

Americold Realty Trust

    956,311       26,661,951  

Duke Realty Corp.

    1,365,236       79,265,602  

EastGroup Properties Inc.

    145,844       29,647,168  

First Industrial Realty Trust Inc.

    467,061       28,915,747  

LXP Industrial Trust

    1,015,013       15,935,704  

Prologis Inc.

    2,652,700       428,357,996  

Rexford Industrial Realty Inc.

    574,495       42,851,582  

STAG Industrial Inc.

    631,709       26,121,167  
   

 

 

 
      677,756,917  
Mortgage REITs — 2.3%  

AGNC Investment Corp.

    1,871,956       24,522,625  

Annaly Capital Management Inc.

    5,232,780       36,838,771  

Blackstone Mortgage Trust Inc., Class A

    604,413       19,214,289  

New Residential Investment Corp.

    1,673,220       18,371,956  

Starwood Property Trust Inc.

    1,091,973       26,392,987  
   

 

 

 
      125,340,628  
Office REITs — 6.6%  

Alexandria Real Estate Equities Inc.

    521,747       105,001,584  

Boston Properties Inc.

    509,556       65,630,813  

Corporate Office Properties Trust

    400,264       11,423,535  

Cousins Properties Inc.

    533,024       21,475,537  

Douglas Emmett Inc.

    629,076       21,023,720  

Equity Commonwealth(a)

    403,650       11,386,966  

Highwoods Properties Inc.

    376,024       17,199,338  

Hudson Pacific Properties Inc.

    547,455       15,191,876  

JBG SMITH Properties

    406,869       11,888,712  

Kilroy Realty Corp.

    376,563       28,776,944  

Orion Office REIT Inc.

    201,625       2,822,750  

SL Green Realty Corp.

    229,987       18,670,345  

Vornado Realty Trust

    569,954       25,830,315  
   

 

 

 
        356,322,435  
Real Estate Development — 0.3%  

Howard Hughes Corp. (The)(a)(b)

    148,438       15,379,661  
   

 

 

 
Real Estate Services — 3.9%  

CBRE Group Inc., Class A(a)(b)

    1,199,680       109,794,713  

Compass Inc., Class A(a)(b)

    101,488       797,696  

Jones Lang LaSalle Inc.(a)(b)

    180,910       43,320,709  
Security   Shares     Value  

 

 
Real Estate Services (continued)  

Opendoor Technologies Inc.(a)(b)

    1,398,345     $ 12,095,684  

Redfin Corp.(a)(b)

    375,985       6,782,769  

Zillow Group Inc., Class A(a)(b)

    132,443       6,387,726  

Zillow Group Inc., Class C, NVS(a)(b)

    596,754       29,414,005  
   

 

 

 
      208,593,302  
Research & Consulting Services — 1.8%  

CoStar Group Inc.(a)

    1,415,739       94,302,375  
   

 

 

 
Residential REITs — 15.5%  

American Campus Communities Inc.

    498,840       27,920,075  

American Homes 4 Rent, Class A

    1,058,508       42,372,075  

Apartment Income REIT Corp.

    562,742       30,084,187  

AvalonBay Communities Inc.

    501,001       124,433,618  

Camden Property Trust

    366,352       60,887,702  

Equity LifeStyle Properties Inc.

    618,896       47,333,166  

Equity Residential

    1,225,010       110,152,899  

Essex Property Trust Inc.

    233,889       80,803,972  

Invitation Homes Inc.

    2,139,259       85,955,427  

Mid-America Apartment Communities Inc.

    413,455       86,598,150  

Sun Communities Inc.

    415,719       72,871,384  

UDR Inc.

    1,072,056       61,503,853  
   

 

 

 
      830,916,508  
Retail REITs — 9.3%  

Brixmor Property Group Inc.

    1,067,685       27,556,950  

Federal Realty Investment Trust

    253,640       30,961,835  

Kimco Realty Corp.

    2,210,561       54,600,857  

National Retail Properties Inc.

    629,606       28,294,493  

Realty Income Corp.

    2,028,087       140,546,429  

Regency Centers Corp.

    552,379       39,406,718  

Simon Property Group Inc.

    1,177,989       154,976,233  

Spirit Realty Capital Inc.

    457,783       21,067,174  
   

 

 

 
      497,410,689  
Specialized REITs — 36.4%  

American Tower Corp.

    1,632,527       410,123,433  

Crown Castle International Corp.

    1,549,322       286,004,841  

CubeSmart

    784,375       40,811,031  

Digital Realty Trust Inc.

    1,017,296       144,252,573  

Equinix Inc.

    322,773       239,374,912  

Extra Space Storage Inc.

    479,970       98,681,832  

Gaming and Leisure Properties Inc.

    841,862       39,508,584  

Iron Mountain Inc.

    1,037,962       57,513,475  

Lamar Advertising Co., Class A

    311,218       36,157,307  

Life Storage Inc.

    294,031       41,290,773  

National Storage Affiliates Trust

    293,804       18,439,139  

PotlatchDeltic Corp.

    248,042       13,079,255  

Public Storage

    546,880       213,436,327  

Rayonier Inc.

    521,144       21,429,441  

SBA Communications Corp.

    389,943       134,179,386  

VICI Properties Inc.

    2,254,598       64,165,859  

Weyerhaeuser Co.

    2,678,867       101,529,059  
   

 

 

 
        1,959,977,227  
   

 

 

 

Total Common Stocks — 99.7%
(Cost: $5,873,866,346)

 

    5,360,630,990  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 1.2%  

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    60,312,538       60,300,476  

 

 

64  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Real Estate ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 
Money Market Funds (continued)  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    5,660,000     $ 5,660,000  
   

 

 

 
      65,960,476  
   

 

 

 

Total Short -Term Investments — 1.2%
(Cost: $65,965,695)

 

    65,960,476  
   

 

 

 

Total Investments in Securities — 100.9%
(Cost: $5,939,832,041)

 

    5,426,591,466  

Other Assets, Less Liabilities — (0.9)%

 

    (47,724,883
   

 

 

 

Net Assets — 100.0%

 

  $   5,378,866,583  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 1,932,786     $ 58,415,065 (a)    $     $ (39,065   $ (8,310   $ 60,300,476       60,312,538     $ 64,287 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    4,890,000       770,000 (a)                        5,660,000       5,660,000       2,682        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (39,065   $ (8,310   $ 65,960,476       $ 66,969     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description  

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

   

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

       

Dow Jones U.S. Real Estate Index

    423       06/17/22     $ 17,749     $ 419,767  
       

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 419,767  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  65


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Real Estate ETF

    

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 1,185,756  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 203,898  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 25,523,268      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                                   

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 5,360,630,990      $      $      $ 5,360,630,990  

Money Market Funds

     65,960,476                      65,960,476  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 5,426,591,466      $      $      $ 5,426,591,466  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 419,767      $      $      $ 419,767  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

66  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments

March 31, 2022

  

iShares® U.S. Regional Banks ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

 

Diversified Banks — 11.5%  

U.S. Bancorp.

    3,013,681     $ 160,177,145  
   

 

 

 
Regional Banks — 87.3%            

Bank OZK

    272,987           11,656,545  

BOK Financial Corp.

    67,890       6,378,266  

Citizens Financial Group Inc.

    961,522       43,585,792  

Comerica Inc.

    294,837       26,662,110  

Commerce Bancshares Inc.

    249,308       17,847,960  

Cullen/Frost Bankers Inc.

    128,551       17,792,744  

East West Bancorp. Inc.

    320,147       25,298,016  

Fifth Third Bancorp.

    1,415,540       60,924,842  

First Citizens BancShares Inc./NC, Class A

    30,037       19,992,627  

First Financial Bankshares Inc.

    289,402       12,768,416  

First Horizon Corp.

    1,204,721       28,298,896  

First Republic Bank/CA

    384,292       62,293,733  

FNB Corp.

    766,827       9,546,996  

Glacier Bancorp. Inc.

    244,726       12,304,823  

Home BancShares Inc./AR

    339,391       7,670,237  

Huntington Bancshares Inc./OH

    3,243,593       47,421,330  

KeyCorp.

    2,095,516       46,897,648  

M&T Bank Corp.

    290,362       49,216,359  

People’s United Financial Inc.

    965,403       19,298,406  

Pinnacle Financial Partners Inc.

    171,766       15,816,213  

PNC Financial Services Group Inc. (The)

    937,283       172,881,849  

Popular Inc.

    180,147       14,725,216  

Prosperity Bancshares Inc.

    207,938       14,426,738  

Regions Financial Corp.

    2,125,183       47,306,574  

Signature Bank/New York NY

    141,526       41,536,466  

SVB Financial Group(a)(b)

    131,104       73,346,133  

Synovus Financial Corp.

    327,147       16,030,203  

Truist Financial Corp.

    2,978,982       168,908,279  

UMB Financial Corp.

    97,281       9,451,822  

Umpqua Holdings Corp.

    488,178       9,207,037  

United Bankshares Inc./WV

    307,774       10,735,157  

Valley National Bancorp.

    950,805       12,379,481  
Security   Shares     Value  

 

 
Regional Banks (continued)  

Webster Financial Corp.

    405,658     $ 22,765,527  

Western Alliance Bancorp

    240,493       19,917,630  

Wintrust Financial Corp.

    128,621       11,952,750  

Zions Bancorp. N.A.

    342,072       22,426,240  
   

 

 

 
      1,209,669,061  
Thrifts & Mortgage Finance — 0.9%  

New York Community Bancorp. Inc.

    1,049,257       11,248,035  

TFS Financial Corp.

    108,036       1,793,398  
   

 

 

 
      13,041,433  
   

 

 

 

Total Common Stocks — 99.7%
(Cost: $1,389,422,281)

 

    1,382,887,639  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 0.6%

 

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    5,958,843       5,957,651  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    1,697,000       1,697,000  
   

 

 

 
      7,654,651  
   

 

 

 

Total Short -Term Investments — 0.6%
(Cost: $7,654,651)

 

    7,654,651  
   

 

 

 

Total Investments in Securities — 100.3%
(Cost: $1,397,076,932)

 

    1,390,542,290  

Other Assets, Less Liabilities — (0.3)%

 

    (4,198,033
   

 

 

 

Net Assets — 100.0%

 

  $   1,386,344,257  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer  

Value at

03/31/21

   

Purchases

at Cost

   

Proceeds

from Sales

   

Net Realized

Gain (Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Value at

03/31/22

   

Shares

Held at

03/31/22

    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 6,598     $ 5,956,759 (a)    $     $ (5,706   $     $ 5,957,651       5,958,843     $ 12,720 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    1,127,000       570,000 (a)                        1,697,000       1,697,000       475        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (5,706   $     $ 7,654,651       $ 13,195     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  67


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Regional Banks ETF

    

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description  

Number of

Contracts

   

Expiration

Date

   

Notional

Amount

(000)

   

Value/

Unrealized

Appreciation

(Depreciation)

 

 

 

Long Contracts

       

E-Mini Financials Select Sector Index

    26       06/17/22     $ 3,067     $ 113,437  
       

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
    

Equity

Contracts

 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 113,437  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
    

Equity

Contracts

 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ 152,258  
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 123,416  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 2,540,125      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                                   

 

 
     Level 1      Level 2      Level 3      Total  

 

 

Investments

           

Assets

           

Common Stocks

   $ 1,382,887,639      $      $      $ 1,382,887,639  

Money Market Funds

     7,654,651                      7,654,651  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 1,390,542,290      $      $      $ 1,390,542,290  
  

 

 

    

 

 

    

 

 

    

 

 

 

Derivative financial instruments(a)

           

Assets

           

Futures Contracts

   $ 113,437      $      $      $ 113,437  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

68  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  

March 31, 2022

  

iShares® U.S. Telecommunications ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

 

 

Common Stocks

   

Alternative Carriers — 3.2%

   

Lumen Technologies Inc.

    1,431,079     $ 16,128,260  
   

 

 

 
Cable & Satellite — 29.8%            

Altice USA Inc., Class A(a)

    1,303,268       16,264,785  

Cable One Inc.

    10,299       15,080,208  

Charter Communications Inc., Class A(a)(b)

    31,791       17,342,626  

Comcast Corp., Class A

    1,507,091       70,562,000  

DISH Network Corp., Class A(a)

    486,635       15,401,998  

Liberty Broadband Corp., Class A(a)

    16,385       2,147,418  

Liberty Broadband Corp., Class C, NVS(a)

    98,425       13,318,871  
   

 

 

 
          150,117,906  

Communications Equipment — 41.3%

 

Arista Networks Inc.(a)(b)

    132,805       18,457,239  

Ciena Corp.(a)(b)

    254,716       15,443,431  

Cisco Systems Inc.

    1,398,676       77,990,174  

CommScope Holding Co. Inc.(a)

    1,883,038       14,838,339  

Juniper Networks Inc.

    451,023       16,760,015  

Lumentum Holdings Inc.(a)(b)

    158,673       15,486,485  

Motorola Solutions Inc.

    73,832       17,882,110  

Ubiquiti Inc.

    57,263       16,672,695  

Viasat Inc.(a)

    292,525       14,275,220  
   

 

 

 
      207,805,708  

Integrated Telecommunication Services — 18.6%

 

AT&T Inc.

    954,063       22,544,509  

Verizon Communications Inc.

    1,397,774       71,202,607  
   

 

 

 
      93,747,116  

Movies & Entertainment — 3.2%

   

Roku Inc.(a)

    130,443       16,340,595  
   

 

 

 
Security   Shares     Value  

 

 

Wireless Telecommunication Services — 3.8%

 

T-Mobile U.S. Inc.(a)

    147,144     $ 18,885,933  
   

 

 

 

Total Common Stocks — 99.9%
(Cost: $559,386,404)

       503,025,518  
   

 

 

 

Short-Term Investments

 

Money Market Funds — 1.2%

 

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.34%(c)(d)(e)

    5,514,747       5,513,644  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.25%(c)(d)

    490,000       490,000  
   

 

 

 
      6,003,644  
   

 

 

 

Total Short -Term Investments — 1.2%
(Cost: $6,003,082)

 

    6,003,644  
   

 

 

 

Total Investments in Securities — 101.1%
(Cost: $565,389,486)

 

    509,029,162  

Other Assets, Less Liabilities — (1.1)%

 

    (5,589,199
   

 

 

 

Net Assets — 100.0%

    $ 503,439,963  
   

 

 

 

 

(a) 

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d) 

Annualized 7-day yield as of period end.

(e) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the year ended March 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

 

 
Affiliated Issuer   Value at
03/31/21
    Purchases
at Cost
    Proceeds
from Sales
    Net Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
03/31/22
    Shares
Held at
03/31/22
    Income    

Capital

Gain

Distributions

from

Underlying

Funds

 

 

 

BlackRock Cash Funds: Institutional, SL Agency Shares

  $ 13,810,207     $     $ (8,292,240 )(a)    $ 76     $ (4,399   $ 5,513,644       5,514,747     $ 14,564 (b)    $  

BlackRock Cash Funds: Treasury, SL Agency Shares

    550,000             (60,000 )(a)                  490,000       490,000       157        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 76     $ (4,399   $ 6,003,644       $ 14,721     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  69


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Telecommunications ETF

    

 

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

 

 

 
Description    Number of
Contracts
       Expiration
Date
       Notional
Amount
(000)
       Value/
Unrealized
Appreciation
(Depreciation)
 

 

 

Long Contracts

                 

E-Mini S&P Communication Services Select Sector Index

     1          06/17/22        $ 90        $ 1,448  

S&P Mid 400 E-Mini Index

     1          06/17/22          269          (1,523
                 

 

 

 
                  $ (75
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

 

 
     Equity
Contracts
 

 

 

Assets — Derivative Financial Instruments

  

Futures contracts

  

Unrealized appreciation on futures contracts(a)

   $ 1,448  
  

 

 

 

Liabilities — Derivative Financial Instruments

  

Futures contracts

  

Unrealized depreciation on futures contracts(a)

   $ 1,523  
  

 

 

 

 

  (a) 

Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss).

 

For the period ended March 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

 

 
     Equity
Contracts
 

 

 

Net Realized Gain (Loss) from:

  

Futures contracts

   $ (28,476
  

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on:

  

Futures contracts

   $ 4,520  
  

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

 

 

Futures contracts:

  

Average notional value of contracts — long

   $ 436,486      

 

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

 

 

70  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Schedule of Investments  (continued)

March 31, 2022

  

iShares® U.S. Telecommunications ETF

    

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

 

 
     Level 1                Level 2                Level 3        Total  

 

 

Investments

                 

Assets

                 

Common Stocks

   $ 503,025,518        $        $        $ 503,025,518  

Money Market Funds

     6,003,644                            6,003,644  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 509,029,162        $        $        $ 509,029,162  
  

 

 

      

 

 

      

 

 

      

 

 

 

Derivative financial instruments(a)

                 

Assets

                 

Futures Contracts

   $ 1,448        $        $        $ 1,448  

Liabilities

                 

Futures Contracts

     (1,523                          (1,523
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ (75      $        $        $ (75
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

S C H E D U L E   O F   I N V E S T M E N T S

  71


Statements of Assets and Liabilities  

March 31, 2022

 

   

iShares

Focused Value
Factor ETF

    

iShares

U.S. Aerospace

& Defense ETF

   

iShares

U.S. Broker-Dealers
& Securities
Exchanges

ETF

   

iShares

U.S. Healthcare
Providers ETF

 

 

 

ASSETS

              

Investments in securities, at value (including securities on loan)(a):

              

Unaffiliated(b)

           $ 34,960,831      $ 3,666,750,015          $ 573,390,335       $ 1,327,448,405  

Affiliated(c)

      90,000        34,369,215         720,000         50,682,785  

Cash

      8,080        7,329         558         11,474  

Cash pledged:

              

Futures contracts

      8,000        147,000         27,000         58,000  

Receivables:

              

Investments sold

                     3,094,790          

Securities lending income — Affiliated

             20,204                 10,123  

Capital shares sold

             4,395                 28,025  

Dividends

      39,153        187,901         204         195,440  
   

 

 

    

 

 

     

 

 

     

 

 

 

Total assets

      35,106,064        3,701,486,059         577,232,887                1,378,434,252  
   

 

 

    

 

 

     

 

 

     

 

 

 

LIABILITIES

              

Collateral on securities loaned, at value

             30,328,850                 49,252,657  

Payables:

              

Investments purchased

                     3,039,736          

Variation margin on futures contracts

      2,709        45,249         9,312         12,449  

Investment advisory fees

      7,474        1,096,887         210,222         427,228  
   

 

 

    

 

 

     

 

 

     

 

 

 

Total liabilities

      10,183        31,470,986         3,259,270         49,692,334  
   

 

 

    

 

 

     

 

 

     

 

 

 

NET ASSETS

    $ 35,095,881      $ 3,670,015,073       $ 573,973,617       $ 1,328,741,918  
   

 

 

    

 

 

     

 

 

     

 

 

 

NET ASSETS CONSIST OF:

              

Paid-in capital

    $ 35,856,114      $ 4,176,001,160       $ 652,586,096       $ 1,263,400,891  

Accumulated earnings (loss)

      (760,233      (505,986,087       (78,612,479       65,341,027  
   

 

 

    

 

 

     

 

 

     

 

 

 

NET ASSETS

    $ 35,095,881      $ 3,670,015,073       $ 573,973,617       $ 1,328,741,918  
   

 

 

    

 

 

     

 

 

     

 

 

 

Shares outstanding

      600,000        33,150,000         5,750,000         4,700,000  
   

 

 

    

 

 

     

 

 

     

 

 

 

Net asset value

    $ 58.49      $ 110.71       $ 99.82       $ 282.71  
   

 

 

    

 

 

     

 

 

     

 

 

 

Shares authorized

      Unlimited        Unlimited         Unlimited         Unlimited  
   

 

 

    

 

 

     

 

 

     

 

 

 

Par value

      None        None         None         None  
   

 

 

    

 

 

     

 

 

     

 

 

 

(a)   Securities loaned, at value

    $      $ 27,759,656       $       $ 47,405,618  

(b)   Investments, at cost — Unaffiliated

    $ 35,076,012      $ 3,255,459,788       $ 598,290,677       $ 1,144,421,766  

(c)   Investments, at cost — Affiliated

    $ 90,000      $ 34,359,530       $ 720,000       $ 50,673,112  

See notes to financial statements.

 

 

72  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Assets and Liabilities   (continued)

March 31, 2022

 

   

iShares

U.S. Home
Construction

ETF

   

iShares

U.S. Infrastructure

ETF

    

iShares

U.S. Insurance

ETF

    

iShares

U.S. Medical

Devices ETF

 

 

 

ASSETS

           

Investments in securities, at value (including securities on loan)(a):

           

Unaffiliated(b)

  $ 1,762,637,494       $ 896,704,791      $ 186,499,231      $ 8,065,660,623  

Affiliated(c)

    32,208,682         8,232,144        1,559,986        155,043,062  

Cash

    233,930         9,607        3,018        4,079  

Cash pledged:

              

Futures contracts

    135,000         116,000        21,000        474,000  

Receivables:

           

Securities lending income — Affiliated

    6,835         10,540        1,434        70,648  

Capital shares sold

    31,069         40,309        248,273         

Dividends

    849,329         1,164,866        166,234        7,601,729  
 

 

 

     

 

 

    

 

 

    

 

 

 

Total assets

    1,796,102,339         906,278,257        188,499,176        8,228,854,141  
 

 

 

     

 

 

    

 

 

    

 

 

 

LIABILITIES

           

Collateral on securities loaned, at value

    30,252,528         6,924,196        1,050,031        149,873,086  

Payables:

           

Investments purchased

                   533,319         

Variation margin on futures contracts

    31,663         21,881        8,200        107,861  

Capital shares redeemed

    180,005                       3,811  

Investment advisory fees

    662,601         217,699        47,496        2,612,102  
 

 

 

     

 

 

    

 

 

    

 

 

 

Total liabilities

    31,126,797         7,163,776        1,639,046        152,596,860  
 

 

 

     

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 1,764,975,542       $ 899,114,481      $ 186,860,130      $ 8,076,257,281  
 

 

 

     

 

 

    

 

 

    

 

 

 

NET ASSETS CONSIST OF:

           

Paid-in capital

  $ 2,458,724,190       $ 853,771,812      $ 176,135,309      $ 7,093,497,710  

Accumulated earnings (loss)

    (693,748,648       45,342,669        10,724,821        982,759,571  
 

 

 

     

 

 

    

 

 

    

 

 

 

NET ASSETS

  $ 1,764,975,542       $ 899,114,481      $ 186,860,130      $ 8,076,257,281  
 

 

 

     

 

 

    

 

 

    

 

 

 

Shares outstanding

    29,800,000         23,100,000        2,050,000        132,550,000 (d) 
 

 

 

     

 

 

    

 

 

    

 

 

 

Net asset value

  $ 59.23       $ 38.92      $ 91.15      $ 60.93 (d) 
 

 

 

     

 

 

    

 

 

    

 

 

 

Shares authorized

    Unlimited         Unlimited        Unlimited        Unlimited  
 

 

 

     

 

 

    

 

 

    

 

 

 

Par value

    None         None        None        None  
 

 

 

     

 

 

    

 

 

    

 

 

 

(a)   Securities loaned, at value

  $ 28,594,627       $ 6,584,668      $ 1,029,718      $ 146,507,708  

(b)   Investments, at cost — Unaffiliated

  $ 2,294,376,871       $ 829,748,159      $ 171,924,694      $ 6,989,482,210  

(c)   Investments, at cost — Affiliated

  $ 32,202,087       $ 8,231,188      $ 1,559,794      $ 154,994,881  

(d)   Shares outstanding and net asset value per share reflect a six-for-one stock split effective after the close of trading on July 16, 2021.

    

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  73


Statements of Assets and Liabilities  (continued)

March 31, 2022

 

   

iShares

U.S. Oil & Gas
Exploration &
Production ETF

   

iShares

U.S. Oil

Equipment &
Services ETF

   

iShares

U.S. Pharmaceuticals
ETF

   

iShares

U.S. Real

Estate ETF

 

 

 

ASSETS

         

Investments in securities, at value (including securities on loan)(a):

         

Unaffiliated(b)

  $ 798,269,883     $ 283,479,793       $ 407,151,724     $ 5,360,630,990  

Affiliated(c)

    4,474,384       10,465,539              12,196,050       65,960,476  

Cash

    78,066       11,560         6,685        

Cash pledged:

         

Futures contracts

    135,000       13,000         22,000       911,000  

Receivables:

         

Securities lending income — Affiliated

    457       1,599         32,208       9,561  

Capital shares sold

    211,830                     247,259  

Dividends

    441,224       103,658         303,108       13,898,916  
 

 

 

   

 

 

     

 

 

   

 

 

 

Total assets

    803,610,844       294,075,149         419,711,775       5,441,658,202  
 

 

 

   

 

 

     

 

 

   

 

 

 

LIABILITIES

         

Bank overdraft

                        11,424  

Collateral on securities loaned, at value

    2,983,382       10,305,360         11,801,041       60,347,839  

Payables:

         

Investments purchased

    223,535                      

Variation margin on futures contracts

    23,551       2,137         6,541       232,698  

Capital shares redeemed

          667               361,098  

Investment advisory fees

    240,355       89,552         131,028       1,838,560  
 

 

 

   

 

 

     

 

 

   

 

 

 

Total liabilities

    3,470,823       10,397,716         11,938,610       62,791,619  
 

 

 

   

 

 

     

 

 

   

 

 

 

NET ASSETS

  $ 800,140,021     $ 283,677,433       $ 407,773,165     $ 5,378,866,583  
 

 

 

   

 

 

     

 

 

   

 

 

 

NET ASSETS CONSIST OF:

         

Paid-in capital

  $ 869,530,852     $ 537,586,179       $ 552,830,178     $ 6,230,273,923  

Accumulated loss

    (69,390,831     (253,908,746       (145,057,013     (851,407,340
 

 

 

   

 

 

     

 

 

   

 

 

 

NET ASSETS

  $ 800,140,021     $ 283,677,433       $ 407,773,165     $ 5,378,866,583  
 

 

 

   

 

 

     

 

 

   

 

 

 

Shares outstanding

    9,500,000       14,700,000         2,100,000       49,800,000  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net asset value

  $ 84.23     $ 19.30       $ 194.18     $ 108.01  
 

 

 

   

 

 

     

 

 

   

 

 

 

Shares authorized

    Unlimited       Unlimited         Unlimited       Unlimited  
 

 

 

   

 

 

     

 

 

   

 

 

 

Par value

    None       None         None       None  
 

 

 

   

 

 

     

 

 

   

 

 

 

(a) Securities loaned, at value

  $ 2,831,162     $ 10,108,804       $ 11,364,829     $ 56,124,661  

(b) Investments, at cost — Unaffiliated

  $ 648,704,826     $ 245,760,335       $ 360,993,918     $ 5,873,866,346  

(c)  Investments, at cost — Affiliated

  $ 4,473,787     $ 10,462,887       $ 12,191,576     $ 65,965,695  

See notes to financial statements.

 

 

74  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Assets and Liabilities  (continued)

March 31, 2022

 

   

iShares

U.S. Regional

Banks ETF

   

iShares

U.S. Telecommunications
ETF

 

 

 

ASSETS

     

Investments in securities, at value (including securities on loan)(a):

     

Unaffiliated(b)

  $ 1,382,887,639                     $ 503,025,518  

Affiliated(c)

    7,654,651         6,003,644  

Cash

    348         3,469  

Cash pledged:

     

Futures contracts

    176,000         22,000  

Receivables:

     

Securities lending income — Affiliated

    160         1,348  

Capital shares sold

            5,555  

Dividends

    3,712,453         50,394  
 

 

 

     

 

 

 

Total assets

    1,394,431,251         509,111,928  
 

 

 

     

 

 

 

LIABILITIES

     

Collateral on securities loaned, at value

    5,957,651         5,516,577  

Payables:

     

Investments purchased

    1,549,093          

Variation margin on futures contracts

    70,858         5,519  

Capital shares redeemed

    32,017          

Investment advisory fees

    477,375         149,869  
 

 

 

     

 

 

 

Total liabilities

    8,086,994         5,671,965  
 

 

 

     

 

 

 

NET ASSETS

  $ 1,386,344,257       $ 503,439,963  
 

 

 

     

 

 

 

NET ASSETS CONSIST OF:

     

Paid-in capital

  $ 1,424,235,461       $ 806,312,196  

Accumulated loss

    (37,891,204       (302,872,233
 

 

 

     

 

 

 

NET ASSETS

  $ 1,386,344,257       $ 503,439,963  
 

 

 

     

 

 

 

Shares outstanding

    23,550,000         16,850,000  
 

 

 

     

 

 

 

Net asset value

  $ 58.87       $ 29.88  
 

 

 

     

 

 

 

Shares authorized

    Unlimited         Unlimited  
 

 

 

     

 

 

 

Par value

    None         None  
 

 

 

     

 

 

 

(a) Securities loaned, at value

  $ 5,762,335       $ 5,187,173  

(b) Investments, at cost — Unaffiliated

  $ 1,389,422,281       $ 559,386,404  

(c)  Investments, at cost — Affiliated

  $ 7,654,651       $ 6,003,082  

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  75


Statements of Operations

Year Ended March 31, 2022

 

    iShares
Focused Value
Factor ETF
   

iShares

U.S. Aerospace
& Defense ETF

   

iShares

U.S. Broker-Dealers
& Securities
Exchanges

ETF

   

iShares

U.S. Healthcare
Providers ETF

 

 

 

INVESTMENT INCOME

           

Dividends — Unaffiliated

  $ 1,248,918     $ 29,673,588       $ 17,487,299       $ 12,214,875  

Dividends — Affiliated

    18       4,485         303         3,203  

Securities lending income — Affiliated — net

    230       177,425                          127,588  

Foreign taxes withheld

    (2,296                      
 

 

 

   

 

 

     

 

 

     

 

 

 

Total investment income

    1,246,870       29,855,498         17,487,602         12,345,666  
 

 

 

   

 

 

     

 

 

     

 

 

 

EXPENSES

           

Investment advisory fees

    95,718       10,931,883         3,261,343         4,802,016  

Professional fees

          217         217         217  
 

 

 

   

 

 

     

 

 

     

 

 

 

Total expenses

    95,718       10,932,100         3,261,560         4,802,233  
 

 

 

   

 

 

     

 

 

     

 

 

 

Net investment income

    1,151,152       18,923,398         14,226,042         7,543,433  
 

 

 

   

 

 

     

 

 

     

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

           

Net realized gain (loss) from:

           

Investments — Unaffiliated

    8,997,380       (154,720,016       (17,270,373       11,339,401  

Investments — Affiliated

    118       (5,306               (27,859

In-kind redemptions — Unaffiliated

    5,312,294       145,557,548         115,257,912         157,925,414  

Futures contracts

    (3,278     359,812         133,377         239,245  
 

 

 

   

 

 

     

 

 

     

 

 

 

Net realized gain (loss)

    14,306,514       (8,807,962       98,120,916         169,476,201  
 

 

 

   

 

 

     

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation) on:

           

Investments — Unaffiliated

    (10,810,763     181,407,819         (62,495,618       (28,184,986

Investments — Affiliated

          (45,232               (8,883

Futures contracts

    5,598       (80,429       19,823         59,065  
 

 

 

   

 

 

     

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation)

    (10,805,165     181,282,158         (62,475,795       (28,134,804
 

 

 

   

 

 

     

 

 

     

 

 

 

Net realized and unrealized gain

    3,501,349       172,474,196         35,645,121         141,341,397  
 

 

 

   

 

 

     

 

 

     

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 4,652,501     $ 191,397,594       $ 49,871,163       $ 148,884,830  
 

 

 

   

 

 

     

 

 

     

 

 

 

See notes to financial statements.

 

 

76  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Operations  (continued)

Year Ended March 31, 2022

 

   

iShares

U.S. Home
Construction

ETF

   

iShares

U.S. Infrastructure
ETF

   

iShares

U.S. Insurance
ETF

   

iShares

U.S. Medical

Devices ETF

 

 

 

INVESTMENT INCOME

          

Dividends — Unaffiliated

  $ 22,677,480        $ 15,123,096     $ 2,583,207     $ 53,890,274  

Dividends — Affiliated

    5,713          856       83       9,439  

Securities lending income — Affiliated — net

    78,469                 20,528       3,823       361,895  

Foreign taxes withheld

             (24,799            
 

 

 

      

 

 

   

 

 

   

 

 

 

Total investment income

    22,761,662          15,119,681       2,587,113       54,261,608  
 

 

 

      

 

 

   

 

 

   

 

 

 

EXPENSES

          

Investment advisory fees

    10,020,736          2,397,182       415,047       32,526,290  

Professional fees

    217          217       217       217  
 

 

 

      

 

 

   

 

 

   

 

 

 

Total expenses

    10,020,953          2,397,399       415,264       32,526,507  
 

 

 

      

 

 

   

 

 

   

 

 

 

Net investment income

    12,740,709          12,722,282       2,171,849       21,735,101  
 

 

 

      

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

          

Net realized gain (loss) from:

          

Investments — Unaffiliated

    (17,606,722        (18,642,870     (261,431     34,460,720  

Investments — Affiliated

    (40,527        (2,889     (298     (10,989

In-kind redemptions — Unaffiliated

    539,746,529          52,295,953       16,346,678       1,188,506,572  

Futures contracts

    (142,894        96,015       (16,788     1,774,807  
 

 

 

      

 

 

   

 

 

   

 

 

 

Net realized gain

    521,956,386          33,746,209       16,068,161       1,224,731,110  
 

 

 

      

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

          

Investments — Unaffiliated

    (841,156,042        44,232,142       6,016,820       (480,418,173

Investments — Affiliated

    (204        953       186       (89,616

Futures contracts

    92,708          19,368       2,367       88,335  

Foreign currency translations

             (331            
 

 

 

      

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    (841,063,538        44,252,132       6,019,373       (480,419,454
 

 

 

      

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

    (319,107,152        77,998,341       22,087,534       744,311,656  
 

 

 

      

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $ (306,366,443      $ 90,720,623     $ 24,259,383     $ 766,046,757  
 

 

 

      

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  77


Statements of Operations  (continued)

Year Ended March 31, 2022

 

   

iShares

U.S. Oil & Gas
Exploration &
Production
ETF

   

iShares

U.S. Oil
Equipment &
Services ETF

   

iShares

U.S. Pharmaceuticals
ETF

   

iShares

U.S. Real

Estate ETF

 

 

 

INVESTMENT INCOME

         

Dividends — Unaffiliated

  $ 14,247,401     $ 1,294,678                $ 7,574,209     $ 124,742,811  

Dividends — Affiliated

    655       636         849       8,070  

Securities lending income — Affiliated — net

    7,343       15,063         127,443       58,899  

Foreign taxes withheld

          (612              
 

 

 

   

 

 

     

 

 

   

 

 

 

Total investment income

    14,255,399       1,309,765         7,702,501       124,809,780  
 

 

 

   

 

 

     

 

 

   

 

 

 

EXPENSES

         

Investment advisory fees

    1,523,527       584,682         1,491,817       25,003,003  

Professional fees

    217       217         217       217  
 

 

 

   

 

 

     

 

 

   

 

 

 

Total expenses

    1,523,744       584,899         1,492,034       25,003,220  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net investment income

    12,731,655       724,866         6,210,467       99,806,560  
 

 

 

   

 

 

     

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

         

Net realized gain (loss) from:

         

Investments — Unaffiliated

    (31,549,738     (2,251,436       2,135,033       (20,886,911

Investments — Affiliated

    (2,080     (6,310       (4,733     (39,065

In-kind redemptions — Unaffiliated

    61,874,846       11,412,878         13,167,620       873,562,235  

Futures contracts

    489,950       85,920         114,595       1,185,756  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net realized gain

    30,812,978       9,241,052         15,412,515       853,822,015  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

         

Investments — Unaffiliated

    191,239,162       47,961,930         18,112,025       (111,678,396

Investments — Affiliated

    (252     264         (3,384     (8,310

Futures contracts

    46,536       7,591         4,012       203,898  
 

 

 

   

 

 

     

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

    191,285,446       47,969,785         18,112,653       (111,482,808
 

 

 

   

 

 

     

 

 

   

 

 

 

Net realized and unrealized gain

    222,098,424       57,210,837         33,525,168       742,339,207  
 

 

 

   

 

 

     

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 234,830,079     $ 57,935,703       $ 39,735,635     $ 842,145,767  
 

 

 

   

 

 

     

 

 

   

 

 

 

See notes to financial statements.

 

 

78  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Operations   (continued)

Year Ended March 31, 2022

 

   

iShares

U.S. Regional

Banks ETF

   

iShares
U.S. Telecommunications
ETF

 

 

 

INVESTMENT INCOME

     

Dividends — Unaffiliated

  $ 30,273,332                     $ 12,535,377  

Dividends — Affiliated

    1,046         989  

Securities lending income — Affiliated — net

    12,149         13,732  

Foreign taxes withheld

    (29,728        
 

 

 

     

 

 

 

Total investment income

    30,256,799         12,550,098  
 

 

 

     

 

 

 

EXPENSES

     

Investment advisory fees

    4,575,432         1,773,147  

Professional fees

    217         217  
 

 

 

     

 

 

 

Total expenses

    4,575,649         1,773,364  
 

 

 

     

 

 

 

Net investment income

    25,681,150         10,776,734  
 

 

 

     

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain (loss) from:

     

Investments — Unaffiliated

    (12,916,632       (14,242,242

Investments — Affiliated

    (5,706       76  

In-kind redemptions — Unaffiliated

    65,176,957         47,507,367  

Futures contracts

    152,258         (28,476
 

 

 

     

 

 

 

Net realized gain

    52,406,877         33,236,725  
 

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation) on:

     

Investments — Unaffiliated

    (37,256,576       (61,914,753

Investments — Affiliated

            (4,399

Futures contracts

    123,416         4,520  
 

 

 

     

 

 

 

Net change in unrealized appreciation (depreciation)

    (37,133,160       (61,914,632
 

 

 

     

 

 

 

Net realized and unrealized gain (loss)

    15,273,717         (28,677,907
 

 

 

     

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $ 40,954,867       $ (17,901,173
 

 

 

     

 

 

 

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  79


Statements of Changes in Net Assets

 

   

iShares

      Focused Value Factor ETF       

        

iShares

        U.S. Aerospace & Defense  ETF        

 
   
Year Ended
03/31/22
 
 
   
Year Ended
03/31/21
 
 
      
Year Ended
03/31/22
 
 
   

Year Ended

03/31/21

(a) 

 

 

 

INCREASE (DECREASE) IN NET ASSETS

            

OPERATIONS

            

Net investment income

    $ 1,151,152     $ 771,653        $ 18,923,398     $ 29,845,339  

Net realized gain (loss)

      14,306,514       (7,763,351        (8,807,962     (289,293,750

Net change in unrealized appreciation (depreciation)

      (10,805,165     21,884,168          181,282,158       1,323,199,745  
   

 

 

   

 

 

      

 

 

   

 

 

 

Net increase in net assets resulting from operations

      4,652,501       14,892,470          191,397,594       1,063,751,334  
   

 

 

   

 

 

      

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)

            

Decrease in net assets resulting from distributions to shareholders

      (1,163,130     (787,521        (18,744,404     (30,040,535
   

 

 

   

 

 

      

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

            

Net increase (decrease) in net assets derived from capital share transactions

      (8,396,139     7,756,785          534,748,916       (905,501,184
   

 

 

   

 

 

      

 

 

   

 

 

 

NET ASSETS

            

Total increase (decrease) in net assets

      (4,906,768     21,861,734          707,402,106       128,209,615  

Beginning of year

      40,002,649       18,140,915          2,962,612,967       2,834,403,352  
   

 

 

   

 

 

      

 

 

   

 

 

 

End of year

    $ 35,095,881     $ 40,002,649        $ 3,670,015,073     $ 2,962,612,967  
   

 

 

   

 

 

      

 

 

   

 

 

 

 

(a) 

Share transactions reflect a two-for-one stock split effective after the close of trading on December 4, 2020.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

80  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Broker-Dealers & Securities

Exchanges ETF

         

iShares

U.S. Healthcare Providers ETF

 

 

 

     

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
           Year Ended
03/31/22
   

Year Ended

03/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

              

OPERATIONS

              

Net investment income

  $ 14,226,042       $ 2,321,910       $ 7,543,433        $ 6,096,993  

Net realized gain

    98,120,916         3,038,924         169,476,201          61,949,559  

Net change in unrealized appreciation (depreciation)

    (62,475,795       80,308,220         (28,134,804        326,549,848  
 

 

 

     

 

 

     

 

 

      

 

 

 

Net increase in net assets resulting from operations

    49,871,163         85,669,054         148,884,830          394,596,400  
 

 

 

     

 

 

     

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

              

Decrease in net assets resulting from distributions to shareholders

    (14,480,571       (2,538,244       (7,445,339        (6,386,427
 

 

 

     

 

 

     

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

              

Net increase (decrease) in net assets derived from capital share transactions

    128,635,346         185,731,316         43,579,447          (28,687,694
 

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

              

Total increase in net assets

    164,025,938         268,862,126         185,018,938          359,522,279  

Beginning of year

    409,947,679         141,085,553         1,143,722,980          784,200,701  
 

 

 

     

 

 

     

 

 

      

 

 

 

End of year

  $ 573,973,617       $ 409,947,679       $ 1,328,741,918        $ 1,143,722,980  
 

 

 

     

 

 

     

 

 

      

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  81


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Home Construction ETF

         

iShares

U.S. Infrastructure ETF

 
 

 

 

     

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
           Year Ended
03/31/22
    Year Ended
03/31/21
 

 

 

INCREASE (DECREASE) IN NET ASSETS

              

OPERATIONS

              

Net investment income

  $ 12,740,709       $ 9,435,630       $ 12,722,282        $ 1,859,166  

Net realized gain

    521,956,386         409,554,555         33,746,209          14,962,382  

Net change in unrealized appreciation (depreciation)

    (841,063,538       784,776,170         44,252,132          23,853,728  
 

 

 

     

 

 

     

 

 

      

 

 

 

Net increase (decrease) in net assets resulting from operations

    (306,366,443       1,203,766,355         90,720,623          40,675,276  
 

 

 

     

 

 

     

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

              

Decrease in net assets resulting from distributions to shareholders

    (12,816,171       (9,561,991       (13,909,010        (1,833,932
 

 

 

     

 

 

     

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

              

Net increase (decrease) in net assets derived from capital share transactions

    (561,414,419       743,728,526         452,497,643          325,895,791  
 

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

              

Total increase (decrease) in net assets

    (880,597,033       1,937,932,890         529,309,256          364,737,135  

Beginning of year

    2,645,572,575         707,639,685         369,805,225          5,068,090  
 

 

 

     

 

 

     

 

 

      

 

 

 

End of year

  $ 1,764,975,542       $ 2,645,572,575       $ 899,114,481        $ 369,805,225  
 

 

 

     

 

 

     

 

 

      

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

 

82  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Insurance ETF

         

iShares

U.S. Medical Devices ETF

 
 

 

 

     

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
          Year Ended
03/31/22
   

Year Ended

03/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

              

OPERATIONS

              

Net investment income

  $ 2,171,849       $ 1,636,658              $ 21,735,101        $ 23,384,672  

Net realized gain

    16,068,161         2,807,695         1,224,731,110          772,771,841  

Net change in unrealized appreciation (depreciation)

    6,019,373         22,558,140         (480,419,454        1,810,213,646  
 

 

 

     

 

 

     

 

 

      

 

 

 

Net increase in net assets resulting from operations

    24,259,383         27,002,493         766,046,757          2,606,370,159  
 

 

 

     

 

 

     

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

              

Decrease in net assets resulting from distributions to shareholders

    (2,177,905       (1,644,120       (21,981,981        (21,882,239
 

 

 

     

 

 

     

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

              

Net increase (decrease) in net assets derived from capital share transactions

    79,477,725         (2,263,174       (874,728,044        1,477,573,504  
 

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

              

Total increase (decrease) in net assets

    101,559,203         23,095,199         (130,663,268        4,062,061,424  

Beginning of year

    85,300,927         62,205,728         8,206,920,549          4,144,859,125  
 

 

 

     

 

 

     

 

 

      

 

 

 

End of year

  $ 186,860,130       $ 85,300,927       $ 8,076,257,281        $ 8,206,920,549  
 

 

 

     

 

 

     

 

 

      

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  83


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Oil & Gas Exploration & Production
ETF

         

iShares

U.S. Oil Equipment & Services ETF

 

 

 

     

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
          Year Ended
03/31/22
    Year Ended
03/31/21
 

 

 

INCREASE (DECREASE) IN NET ASSETS

              

OPERATIONS

              

Net investment income

  $ 12,731,655                $ 5,266,848       $ 724,866        $ 1,665,364  

Net realized gain (loss)

    30,812,978         (64,686,478              9,241,052          (44,753,323

Net change in unrealized appreciation (depreciation)

    191,285,446         166,816,570         47,969,785          78,366,002  
 

 

 

     

 

 

     

 

 

      

 

 

 

Net increase in net assets resulting from operations

    234,830,079         107,396,940         57,935,703          35,278,043  
 

 

 

     

 

 

     

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

              

Decrease in net assets resulting from distributions to shareholders

    (12,422,061       (5,431,832       (935,137        (3,559,832
 

 

 

     

 

 

     

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

              

Net increase (decrease) in net assets derived from capital share transactions

    334,558,987         51,039,147         (144,838,846        314,128,775  
 

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

              

Total increase (decrease) in net assets

    556,967,005         153,004,255         (87,838,280        345,846,986  

Beginning of year

    243,173,016         90,168,761         371,515,713          25,668,727  
 

 

 

     

 

 

     

 

 

      

 

 

 

End of year

  $ 800,140,021       $ 243,173,016       $ 283,677,433        $ 371,515,713  
 

 

 

     

 

 

     

 

 

      

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

84  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Pharmaceuticals ETF

         

iShares

U.S. Real Estate ETF

 
 

 

 

     

 

 

 
    Year Ended
03/31/22
   

Year Ended

03/31/21

          Year Ended
03/31/22
   

Year Ended

03/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

              

OPERATIONS

              

Net investment income

  $ 6,210,467       $ 4,693,351       $ 99,806,560        $ 79,978,949  

Net realized gain (loss)

    15,412,515         8,153,078                853,822,015          (66,849,504

Net change in unrealized appreciation (depreciation)

    18,112,653         83,541,789         (111,482,808        1,034,179,845  
 

 

 

     

 

 

     

 

 

      

 

 

 

Net increase in net assets resulting from operations

    39,735,635         96,388,218         842,145,767          1,047,309,290  
 

 

 

     

 

 

     

 

 

      

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

              

Decrease in net assets resulting from distributions to shareholders

    (6,432,724       (4,525,848       (140,375,492        (102,538,797
 

 

 

     

 

 

     

 

 

      

 

 

 

CAPITAL SHARE TRANSACTIONS

              

Net increase (decrease) in net assets derived from capital share transactions

    19,708,210         (13,503,900       (9,950,229        675,178,259  
 

 

 

     

 

 

     

 

 

      

 

 

 

NET ASSETS

              

Total increase in net assets

    53,011,121         78,358,470         691,820,046          1,619,948,752  

Beginning of year

    354,762,044         276,403,574         4,687,046,537          3,067,097,785  
 

 

 

     

 

 

     

 

 

      

 

 

 

End of year

  $ 407,773,165       $ 354,762,044       $ 5,378,866,583        $ 4,687,046,537  
 

 

 

     

 

 

     

 

 

      

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

F I N A N C I A L   S T A T E M E N T S

  85


Statements of Changes in Net Assets (continued)

 

   

iShares

U.S. Regional Banks ETF

   

iShares

U.S. Telecommunications ETF

 
 

 

 

   

 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

   

Year Ended

03/31/22

   

Year Ended

03/31/21

 

 

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment income

  $ 25,681,150     $ 9,303,626     $ 10,776,734     $ 10,604,477  

Net realized gain

    52,406,877       6,986,488       33,236,725       9,326,372  

Net change in unrealized appreciation (depreciation)

    (37,133,160     174,236,220       (61,914,632     82,965,567  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

    40,954,867       190,526,334       (17,901,173     102,896,416  
 

 

 

   

 

 

   

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

       

Decrease in net assets resulting from distributions to shareholders

    (24,749,500     (9,060,857     (10,823,757     (10,690,881
 

 

 

   

 

 

   

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net increase in net assets derived from capital share transactions

    696,331,202       295,159,904       106,283,084       41,297,341  
 

 

 

   

 

 

   

 

 

   

 

 

 

NET ASSETS

       

Total increase in net assets

    712,536,569       476,625,381       77,558,154       133,502,876  

Beginning of year

    673,807,688       197,182,307       425,881,809       292,378,933  
 

 

 

   

 

 

   

 

 

   

 

 

 

End of year

  $ 1,386,344,257         $ 673,807,688         $ 503,439,963         $ 425,881,809  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

86  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights

(For a share outstanding throughout each period)

 

   

iShares Focused Value Factor ETF

 
                                     

 

Period From

 
  Year Ended

 

    Year Ended       Year Ended         03/19/19 (a) 
  03/31/22

 

    03/31/21       03/31/20       to 03/31/19  

 

 

Net asset value, beginning of period

    $ 53.34              $ 30.23              $ 48.63               $ 49.43  
   

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

      1.71         1.23         1.33         0.04  

Net realized and unrealized gain (loss)(c)

      5.25         23.04         (18.31       (0.84
   

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      6.96         24.27         (16.98       (0.80
   

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

 

 

             

From net investment income

      (1.81       (1.16       (1.42        
   

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.81       (1.16       (1.42        
   

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 58.49       $ 53.34       $ 30.23       $ 48.63  
   

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

               

Based on net asset value

      13.20       81.85       (35.71 )%        (1.62 )%(f) 
   

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(g)

               

Total expenses

      0.25       0.25       0.25       0.25 %(h) 
   

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      3.01       3.20       2.76       2.36 %(h) 
   

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

               

Net assets, end of period (000)

    $ 35,096       $ 40,003       $ 18,141       $ 31,607  
   

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(i)

      138       70       149       0 %(f) 
   

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Commencement of operations.

 

(b) 

Based on average shares outstanding.

 

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

 

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

 

(e) 

Where applicable, assumes the reinvestment of distributions.

 

(f) 

Not annualized.

 

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

 

(h) 

Annualized.

 

(i) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  87


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Aerospace & Defense ETF  
 

 

 

 
    Year Ended     Year Ended     Year Ended     Year Ended     Year Ended  
    03/31/22         03/31/21 (a)        03/31/20 (a)        03/31/19 (a)        03/31/18 (a) 

 

 

Net asset value, beginning of year

  $ 104.13       $ 71.94       $ 99.80       $ 98.97       $ 74.40  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(b)

    0.72         0.89         1.69         0.89         0.78  

Net realized and unrealized gain (loss)(c)

    6.55         32.23         (27.74       1.01         24.70  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

    7.27         33.12         (26.05       1.90         25.48  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(d)

                                      

From net investment income

    (0.69              (0.93       (1.81       (0.92       (0.91

From net realized gain

                            (0.15        
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

    (0.69       (0.93       (1.81       (1.07       (0.91
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of year

  $ 110.71       $ 104.13       $ 71.94       $ 99.80       $ 98.97  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

                 

Based on net asset value

    7.00       46.23       (26.58 )%        1.91       34.40
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(f)

                 

Total expenses

    0.39       0.42       0.42       0.42       0.43
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

    0.68       1.04       1.57       0.90       0.87
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                 

Net assets, end of year (000)

  $ 3,670,015       $ 2,962,613       $ 2,834,403       $ 5,019,632       $ 5,749,730  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(g)

    27       49       20       38       14
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Per share amounts reflect a two-for-one stock split effective after the close of trading on December 4, 2020.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

88  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Broker-Dealers & Securities Exchanges ETF  
 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

    Year Ended
03/31/20
   

Year Ended

03/31/19

    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

    $ 92.12       $ 51.30       $ 58.82       $ 65.50       $ 51.31  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(a)

      1.80         1.07         1.03         0.88         0.83  

Net realized and unrealized gain (loss)(b)

      7.84         40.82         (7.46       (6.51       14.15  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      9.64                41.89                (6.43              (5.63            14.98  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(c)

                   

From net investment income

      (1.94       (1.07       (1.09       (1.05       (0.79
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.94       (1.07       (1.09       (1.05       (0.79
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of year

    $ 99.82       $ 92.12       $ 51.30       $ 58.82       $ 65.50  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

                   

Based on net asset value

      10.38       82.40       (11.15 )%        (8.63 )%        29.39
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(e)

                   

Total expenses

      0.39       0.41       0.42       0.42       0.43
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      1.70       1.48       1.60       1.38       1.44
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of year (000)

    $ 573,974       $ 409,948       $ 141,086       $ 217,641       $ 347,155  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(f)

      24       37       15       27       13
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  89


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Healthcare Providers ETF  
 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
   

Year Ended

03/31/20

    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

    $ 251.37       $ 166.85              $ 167.98       $ 157.08       $ 134.12  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(a)

      1.65         1.30         1.25         0.54         0.35  

Net realized and unrealized gain (loss)(b)

      31.33         84.59         (1.04       16.99         22.97  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase from investment operations

      32.98                85.89         0.21                17.53         23.32  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(c)

                   

From net investment income

      (1.64       (1.37       (1.34       (6.63              (0.36
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.64       (1.37       (1.34       (6.63       (0.36
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of year

    $ 282.71       $ 251.37       $ 166.85       $ 167.98       $ 157.08  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

                   

Based on net asset value

      13.15       51.63       0.10       11.25       17.40
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(e)

                   

Total expenses

      0.39       0.42       0.42       0.43       0.43
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      0.61       0.61       0.70       0.29       0.24
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of year (000)

    $ 1,328,742       $ 1,143,723       $ 784,201       $ 797,909       $ 471,251  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(f)

      24       27       30       48       20
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

90  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Home Construction ETF  
 

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
    Year Ended
03/31/20
    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

  $ 67.84     $ 28.94        $ 35.26     $ 39.24     $ 31.97  
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Net investment income(a)

    0.36       0.27          0.23       0.19       0.13  

Net realized and unrealized gain (loss)(b)

    (8.59     38.89          (6.31     (3.97     7.28  
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (8.23     39.16          (6.08     (3.78     7.41  
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Distributions(c)

            

From net investment income

    (0.38     (0.26        (0.24     (0.20     (0.14
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Total distributions

    (0.38     (0.26        (0.24     (0.20     (0.14
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Net asset value, end of year

  $ 59.23     $ 67.84        $ 28.94     $ 35.26     $ 39.24  
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Total Return(d)

            

Based on net asset value

    (12.21 )%      135.53        (17.40 )%      (9.60 )%      23.19
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(e)

            

Total expenses

    0.39     0.41        0.42     0.42     0.43
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Net investment income

    0.50     0.50        0.55     0.53     0.34
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Supplemental Data

            

Net assets, end of year (000)

  $ 1,764,976     $ 2,645,573        $ 707,640     $ 1,147,657     $ 1,618,817  
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

Portfolio turnover rate(f)

    5     14        15     17     18
 

 

 

   

 

 

      

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  91


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Infrastructure ETF  
 

 

 
            Period From  
 

Year Ended

      Year Ended       Year Ended          04/03/18 (a) 
 

03/31/22

      03/31/21       03/31/20       to 03/31/19  

 

 

Net asset value, beginning of period

    $ 34.56               $ 20.27                $ 26.31                $ 25.31  
   

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(b)

      0.67          0.77          0.49          0.43  

Net realized and unrealized gain (loss)(c)

      4.38          14.10          (6.00        1.24  
   

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

      5.05          14.87          (5.51        1.67  
   

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(d)

                  

From net investment income

      (0.69        (0.58        (0.47        (0.34

From net realized gain

                                 (0.33

Return of capital

                        (0.06        (0.00 )(e) 
   

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

      (0.69        (0.58        (0.53        (0.67
   

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of period

    $ 38.92        $ 34.56        $ 20.27        $ 26.31  
   

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(f)

                  

Based on net asset value

      14.78        74.11        (21.26 )%         6.78 %(g) 
   

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(h)

                  

Total expenses

      0.35        0.40        0.40        0.40 %(i) 
   

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

      1.85        2.54        1.84        1.67 %(i) 
   

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                  

Net assets, end of period (000)

    $ 899,114        $ 369,805        $ 5,068        $ 5,262  
   

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(j)

      33        65        23        43 %(g) 
   

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Rounds to less than $0.01.

(f) 

Where applicable, assumes the reinvestment of distributions.

(g) 

Not annualized.

(h) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(i) 

Annualized.

(j) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

92  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Insurance ETF
 

 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
    Year Ended
03/31/20
    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

  $ 74.17        $ 49.76        $ 63.64        $ 64.54              $ 60.46  
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(a)

    1.67          1.51          1.35          1.23          1.18  

Net realized and unrealized gain (loss)(b)

    16.94                24.37                (13.77              (0.89        4.20  
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

    18.61          25.88          (12.42        0.34          5.38  
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(c)

                     

From net investment income

    (1.63        (1.47        (1.46        (1.24        (1.30
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

    (1.63        (1.47        (1.46        (1.24        (1.30
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of year

  $ 91.15        $ 74.17        $ 49.76        $ 63.64        $ 64.54  
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(d)

                     

Based on net asset value

    25.36        52.54        (19.92 )%         0.60        8.93
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(e)

                     

Total expenses

    0.39        0.42        0.42        0.43        0.43
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

    2.04        2.50        1.95        1.94        1.85
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                     

Net assets, end of year (000)

  $ 186,860        $ 85,301        $ 62,206        $ 98,637        $ 132,302  
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(f)

    11        10        8        17        12
 

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  93


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Medical Devices ETF  
 

 

 

 
   
Year Ended
03/31/22
 
(a) 
    
Year Ended
03/31/21
 
(a) 
    
Year Ended
03/31/20
 
(a) 
   
Year Ended
03/31/19
 
(a) 
    
Year Ended
03/31/18
 
(a) 

 

 

Net asset value, beginning of year

  $ 55.04      $ 37.54      $ 38.57     $ 30.81      $ 25.24  
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Net investment income(b)

    0.16        0.15        0.16       0.12        0.11  

Net realized and unrealized gain (loss)(c)

    5.89        17.49        (1.04     7.73        5.55  
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Net increase (decrease) from investment operations

    6.05        17.64        (0.88     7.85        5.66  
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Distributions(d)

            

From net investment income

    (0.16      (0.14      (0.15     (0.09      (0.09
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Total distributions

    (0.16      (0.14      (0.15     (0.09      (0.09
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Net asset value, end of year

  $ 60.93      $ 55.04      $ 37.54     $ 38.57      $ 30.81  
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Total Return(e)

            

Based on net asset value

    10.99      47.02      (2.32 )%      25.50      22.48
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Ratios to Average Net Assets(f)

            

Total expenses

    0.39      0.41      0.42     0.43      0.43
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Net investment income

    0.26      0.30      0.39     0.33      0.38
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Supplemental Data

            

Net assets, end of year (000)

  $ 8,076,257      $ 8,206,921      $ 4,144,859     $ 3,656,734      $ 1,719,373  
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Portfolio turnover rate(g)

    11      9      9     36      15
 

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

(a) 

Per share amounts reflect a six-for-one stock split effective after the close of trading on July 16, 2021.

(b) 

Based on average shares outstanding.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

94  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Oil & Gas Exploration & Production ETF  
 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
    Year Ended
03/31/20
    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

    $ 48.63              $ 22.83              $ 58.20              $ 63.55              $ 61.16  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(a)

      2.00          0.98          0.95          0.67          0.56  

Net realized and unrealized gain (loss)(b)

      35.51          25.92          (35.22        (5.11        2.49  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

      37.51          26.90          (34.27        (4.44        3.05  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(c)

                       

From net investment income

      (1.91        (1.10        (1.10        (0.91        (0.66
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

      (1.91        (1.10        (1.10        (0.91        (0.66
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of year

    $ 84.23        $ 48.63        $ 22.83        $ 58.20        $ 63.55  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(d)

                       

Based on net asset value

      78.44        120.05        (59.65 )%         (7.06 )%         5.09
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(e)

                       

Total expenses

      0.39        0.42        0.42        0.42        0.43
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

      3.27        2.81        1.87        1.00        0.96
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                       

Net assets, end of year (000)

    $ 800,140        $ 243,173        $ 90,169        $ 276,450        $ 365,406  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(f)

      17        21        25        12        17
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  95


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Oil Equipment & Services ETF  
 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

   

Year Ended

03/31/20

   

Year Ended

03/31/19

   

Year Ended

03/31/18

 

 

 

Net asset value, beginning of year

      $ 13.41              $ 5.97               $ 25.24               $ 32.41               $ 42.09  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(a)

      0.07          0.14          0.47          0.34          1.18 (b) 

Net realized and unrealized gain (loss)(c)

      5.92          7.50          (19.27        (7.14        (9.61
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

      5.99          7.64          (18.80        (6.80        (8.43
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(d)

                       

From net investment income

      (0.10        (0.20        (0.47        (0.37        (1.25
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

      (0.10        (0.20        (0.47        (0.37        (1.25
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of year

    $ 19.30        $ 13.41        $ 5.97        $ 25.24        $ 32.41  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(e)

                       

Based on net asset value

      44.88        129.06        (75.48 )%         (21.10 )%         (20.19 )%(f) 
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(g)

                       

Total expenses

      0.39        0.41        0.42        0.42        0.43
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

      0.49        1.37        2.44        1.09        3.37 %(b) 
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                       

Net assets, end of year (000)

    $ 283,677        $ 371,516        $ 25,669        $ 155,238        $ 204,188  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(h)

      55        71        23        35        25
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Includes a one-time special distribution from Baker Hughes Inc. Excluding such special distribution, the net investment income would have been $0.37 per share and 1.05% of average net assets.

(c) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Includes proceeds received from a class action litigation, which impacted the Fund’s total return. Not including these proceeds, the Fund’s total return would have been (20.37)% for the year ended March 31, 2018.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

96  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Pharmaceuticals ETF  
 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
    Year Ended
03/31/20
    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

       $ 177.38        $ 134.83        $ 154.05        $ 147.20        $ 150.97  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(a)

      3.06          2.20          2.14          1.73          2.25  

Net realized and unrealized gain (loss)(b)

      16.88          42.53          (19.09        6.91          (3.75
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

      19.94          44.73          (16.95        8.64          (1.50
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(c)

                       

From net investment income

      (3.14        (2.18        (2.27        (1.79        (2.27
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

      (3.14        (2.18        (2.27        (1.79        (2.27
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of year

    $ 194.18        $ 177.38        $ 134.83        $ 154.05        $ 147.20  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(d)

                       

Based on net asset value

      11.29        33.30        (11.06 )%         5.88        (1.05 )% 
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(e)

                       

Total expenses

      0.39        0.42        0.42        0.42        0.43
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

      1.63        1.33        1.45        1.12        1.47
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                       

Net assets, end of year (000)

    $ 407,773        $ 354,762        $ 276,404        $ 385,114        $ 390,088  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(f)

      20        52        40        51        23
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  97


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Real Estate ETF  
 

 

 
    Year Ended
03/31/22
    Year Ended
03/31/21
    Year Ended
03/31/20
    Year Ended
03/31/19
    Year Ended
03/31/18
 

 

 

Net asset value, beginning of year

       $ 91.81        $ 69.71        $ 86.99        $ 75.48        $ 78.51  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income(a)

      1.64          1.67          2.16          2.28          2.22  

Net realized and unrealized gain (loss)(b)

      16.94          22.49          (16.61        11.86          (2.36
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net increase (decrease) from investment operations

      18.58          24.16          (14.45        14.14          (0.14
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Distributions(c)

                       

From net investment income

      (2.38        (2.06        (2.83        (2.63        (2.89
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total distributions

      (2.38        (2.06        (2.83        (2.63        (2.89
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net asset value, end of year

    $ 108.01        $ 91.81        $ 69.71        $ 86.99        $ 75.48  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Total Return(d)

                       

Based on net asset value

      20.27        35.02        (17.14 )%         19.09        (0.29 )% 
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Ratios to Average Net Assets(e)

                       

Total expenses

      0.39        0.41        0.42        0.42        0.43
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net investment income

      1.56        2.03        2.39        2.85        2.80
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Supplemental Data

                       

Net assets, end of year (000)

    $ 5,378,867        $ 4,687,047        $ 3,067,098        $ 4,597,605        $ 3,596,742  
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Portfolio turnover rate(f)

      9        14        8        11        13
   

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

98  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

    iShares U.S. Regional Banks ETF  
 

 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

   

Year Ended

03/31/20

   

Year Ended

03/31/19

   

Year Ended

03/31/18

 

 

Net asset value, beginning of year

  $ 56.62              $ 29.00              $ 43.44              $ 50.39              $ 44.79  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(a)

    1.34         1.32         1.20         1.01         0.80  

Net realized and unrealized gain (loss)(b)

    2.14         27.52         (14.32       (6.91       5.60  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

    3.48         28.84         (13.12       (5.90       6.40  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(c)

                 

From net investment income

    (1.23       (1.22       (1.32       (1.05       (0.80
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

    (1.23       (1.22       (1.32       (1.05       (0.80
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of year

  $ 58.87       $ 56.62       $ 29.00       $ 43.44       $ 50.39  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

                 

Based on net asset value

    6.11       101.55       (31.09 )%        (11.79 )%        14.42
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(e)

                 

Total expenses

    0.39       0.41       0.42       0.42       0.43
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

    2.19       3.26       2.60       2.08       1.68
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                 

Net assets, end of year (000)

  $ 1,386,344       $ 673,808       $ 197,182       $ 519,088       $ 902,061  
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(f)

    14       6       5       10       4
 

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

F I N A N C I A L   H I G H L I G H T S

  99


Financial Highlights (continued)

(For a share outstanding throughout each period)

 

   

iShares U.S. Telecommunications ETF

 
 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

   

Year Ended

03/31/20

   

Year Ended

03/31/19

   

Year Ended

03/31/18

 

 

 

Net asset value, beginning of year

    $ 32.39              $ 24.88              $ 29.73              $ 27.06              $ 32.38  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income(a)

      0.77         0.82         0.71         0.49         0.74  

Net realized and unrealized gain (loss)(b)

      (2.54       7.50         (4.80       2.71         (5.08
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net increase (decrease) from investment operations

      (1.77       8.32         (4.09       3.20         (4.34
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Distributions(c)

                   

From net investment income

      (0.74       (0.81       (0.76       (0.53       (0.98
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.74       (0.81       (0.76       (0.53       (0.98
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of year

    $ 29.88       $ 32.39       $ 24.88       $ 29.73       $ 27.06  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

                   

Based on net asset value

      (5.63 )%        33.82       (13.99 )%        11.91       (13.63 )% 
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Ratios to Average Net Assets(e)

                   

Total expenses

      0.39       0.42       0.42       0.42       0.43
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net investment income

      2.37       2.82       2.40       1.73       2.41
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Supplemental Data

                   

Net assets, end of year (000)

    $ 503,440       $ 425,882       $ 292,379       $ 463,756       $ 316,596  
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Portfolio turnover rate(f)

      75       40       41       35       86
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

The amounts reported for a share outstanding may not accord with the change in aggregate gains and losses in securities for the fiscal period due to the timing of capital share transactions in relation to the fluctuating market values of the Fund’s underlying securities.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Portfolio turnover rate excludes in-kind transactions.

See notes to financial statements.

 

 

100  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements

 

1.

ORGANIZATION

iShares Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust and is authorized to have multiple series or portfolios.

These financial statements relate only to the following funds (each, a “Fund” and collectively, the “Funds”):

 

   
iShares ETF   Diversification  
Classification  

Focused Value Factor(a)

    Diversified    

U.S. Aerospace & Defense

    Non-diversified    

U.S. Broker-Dealers & Securities Exchanges

    Non-diversified    

U.S. Healthcare Providers

    Non-diversified  

U.S. Home Construction

    Non-diversified    

U.S. Infrastructure(a)

    Diversified  

U.S. Insurance

    Non-diversified  

U.S. Medical Devices

    Non-diversified    

U.S. Oil & Gas Exploration & Production

    Non-diversified    

U.S. Oil Equipment & Services

    Non-diversified    

U.S. Pharmaceuticals

    Non-diversified    

U.S. Real Estate

    Diversified    

U.S. Regional Banks

    Non-diversified    

U.S. Telecommunications

    Non-diversified    

 

  (a)

The Fund’s classification changed from non-diversified to diversified during the reporting period.

 

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend date. Non-cash dividends, if any, are recorded on the ex-dividend date at fair value. Dividends from foreign securities where the ex-dividend date may have passed are subsequently recorded when the Funds are informed of the ex-dividend date. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers or as estimated by management, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain.

Foreign Taxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its Statements of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Other foreign taxes”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of March 31, 2022, if any, are disclosed in the Statements of Assets and Liabilities.

The Funds file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Funds may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statements of Operations includes tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.

Segregation and Collateralization: In cases where a Fund enters into certain investments (e.g., futures contracts) that would be treated as “senior securities” for 1940 Act purposes, a Fund may segregate or designate on its books and record cash or liquid assets having a market value at least equal to the amount of its future obligations under such investments. Doing so allows the investment to be excluded from treatment as a “senior security.” Furthermore, if required by an exchange or counterparty agreement, the Funds may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments or obligations.

In-kind Redemptions: For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the Funds. Because such gains or losses are not taxable to the Funds and are not distributed to existing Fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the Funds’ tax year. These reclassifications have no effect on net assets or net asset value (“NAV”) per share.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  101


Notes to Financial Statements  (continued)

 

Distributions: Dividends and distributions paid by each Fund are recorded on the ex-dividend dates. Distributions are determined on a tax basis and may differ from net investment income and net realized capital gains for financial reporting purposes. Dividends and distributions are paid in U.S. dollars and cannot be automatically reinvested in additional shares of the Funds. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

Indemnifications: In the normal course of business, each Fund enters into contracts that contain a variety of representations that provide general indemnification. The Funds’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Funds, which cannot be predicted with any certainty.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund’s listing exchange is open and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with a policy approved by the Board as reflecting fair value. The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

   

Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day are valued at the last traded price.

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published NAV.

   

Futures contracts are valued based on that day’s last reported settlement or trade price on the exchange where the contract is traded.

Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the New York Stock Exchange (“NYSE”). Each business day, the Funds use current market factors supplied by independent pricing services to value certain foreign instruments (“Systematic Fair Value Price”). The Systematic Fair Value Price is designed to value such foreign securities at fair value as of the close of trading on the NYSE, which follows the close of the local markets.

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, in accordance with a policy approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Global Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Global Valuation Committee, or its delegate, seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Global Valuation Committee, or its delegate, deems relevant and consistent with the principles of fair value measurement. The pricing of all Fair Valued Investments is subsequently reported to the Board or a committee thereof on a quarterly basis.

Fair value pricing could result in a difference between the prices used to calculate a fund’s NAV and the prices used by the fund’s underlying index, which in turn could result in a difference between the fund’s performance and the performance of the fund’s underlying index.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, (including the Global Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

 

 

102  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

4.

SECURITIES AND OTHER INVESTMENTS

Securities Lending: Each Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by an approved bank, or securities issued or guaranteed by the U.S. government. The initial collateral received by each Fund is required to have a value of at least 102% of the current market value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund or excess collateral is returned by the Fund, on the next business day. During the term of the loan, each Fund is entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested in money market funds managed by BlackRock Fund Advisors (“BFA”), the Funds’ investment adviser, or its affiliates is disclosed in the Schedule of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are also disclosed in each Fund’s Schedule of Investments. The market value of any securities on loan and the value of any related cash collateral are disclosed in the Statements of Assets and Liabilities.

Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Funds, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the Funds can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

As of period end, the following table is a summary of the securities on loan by counterparty which are subject to offset under an MSLA:

 

 

 

iShares ETF and Counterparty

    

Market Value of

Securities on Loan

 

 

    

Cash Collateral

Received

 

(a) 

    

Non-Cash Collateral

Received

 

 

     Net Amount  

 

 

U.S. Aerospace & Defense

           

Barclays Bank PLC

   $ 1,301,783      $ 1,301,783      $      $  

BNP Paribas SA

     5,152,264        5,152,264                

BofA Securities, Inc.

     4,299,332        4,299,332                

Citigroup Global Markets, Inc.

     5,527        5,527                

Goldman Sachs & Co. LLC

     6,107,135        6,107,135                

J.P. Morgan Securities LLC

     4,771,536        4,771,536                

Morgan Stanley

     1,020,893        1,020,893                 

National Financial Services LLC

     2,442,655        2,442,655                

State Street Bank & Trust Co.

     1,772,898        1,772,898                

Toronto-Dominion Bank

     286,550        286,550                

UBS AG

     231,689        231,689                

UBS Securities LLC

     150,123        150,123                

Wells Fargo Securities LLC

     217,271        217,271                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $     27,759,656      $     27,759,656      $             —      $             —  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  103


Notes to Financial Statements  (continued)

 

 

 

iShares ETF and Counterparty

    

Market Value of

Securities on Loan

 

 

    

Cash Collateral

Received

 

(a) 

    

Non-Cash Collateral

Received

 

 

     Net Amount  

 

 

U.S. Healthcare Providers

           

Barclays Bank PLC

   $ 1,001,113      $ 1,001,113      $      $  

BNP Paribas SA

     12,222,110        12,222,110                

Citigroup Global Markets, Inc.

     28,340        28,340                

Deutsche Bank Securities, Inc.

     102,060        102,060                

Goldman Sachs & Co. LLC

     2,286,920        2,286,920                

ING Financial Markets LLC

     842,000        842,000                

J.P. Morgan Securities LLC

     22,827,325        22,827,325                

Jefferies LLC

     7,810        7,810                

Morgan Stanley

     2,798,037        2,798,037                

National Financial Services LLC

     116,233        116,233                

Scotia Capital (USA), Inc.

     1,231,638        1,231,638                

SG Americas Securities LLC

     437,310        437,310                

State Street Bank & Trust Co.

     199,595        199,595                 

Toronto-Dominion Bank

     795,739        795,739                

UBS Securities LLC

     1,486,076        1,486,076                

Virtu Americas LLC

     58,163        58,163                

Wells Fargo Bank N.A

     135,252        135,252                

Wells Fargo Securities LLC

     829,897        829,897                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 47,405,618      $ 47,405,618      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Home Construction

           

Barclays Bank PLC

   $ 261,375      $ 261,375      $      $  

BNP Paribas SA

     6,227,271        6,227,271                

Citigroup Global Markets, Inc.

     178,788        178,788                

Goldman Sachs & Co. LLC

     264,978        264,978                

J.P. Morgan Securities LLC

     264,859        264,859                

Morgan Stanley

     6,233,614        6,233,614                

Scotia Capital (USA), Inc.

     770,640        770,640                

SG Americas Securities LLC

     446,727        446,727                

Toronto-Dominion Bank

     9,340,155        9,340,155                

UBS AG

     3,854,182        3,854,182                

UBS Securities LLC

     734,250        734,250                

Wells Fargo Securities LLC

     17,788        17,788                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 28,594,627      $ 28,594,627      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Infrastructure

           

Barclays Capital, Inc.

   $ 16,080      $ 16,080      $      $   

BMO Capital Markets Corp.

     74,422        74,422                

BofA Securities, Inc.

     1,974,636        1,974,636                

Jefferies LLC

     11,196        11,196                

Morgan Stanley

     4,489,236        4,489,236                

UBS Securities LLC

     19,098        19,098                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 6,584,668      $ 6,584,668      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Insurance

           

Barclays Bank PLC

   $ 73,778      $ 73,778      $      $  

BofA Securities, Inc.

     770,014        770,014                

J.P. Morgan Securities LLC

     47,492        47,492                

Morgan Stanley

     124,783        124,783                

Wells Fargo Securities LLC

     13,651        13,651                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 1,029,718      $ 1,029,718      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

 

104  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

 

 

iShares ETF and Counterparty

    

Market Value of

Securities on Loan

 

 

    

Cash Collateral

Received

 

(a) 

    

Non-Cash Collateral

Received

 

 

     Net Amount  

 

 

U.S. Medical Devices

           

Barclays Bank PLC

   $ 1,562,625      $ 1,562,625      $      $  

Barclays Capital, Inc.

     1,303,364        1,303,364                

BMO Capital Markets Corp.

     36,555        36,555                

BNP Paribas SA

     36,568,164        36,568,164                

BofA Securities, Inc.

     7,332,330        7,332,330                

Citigroup Global Markets, Inc.

     3,347,102        3,347,102                

Credit Suisse Securities (USA) LLC

     303,658        303,658                

Goldman Sachs & Co. LLC

     9,918,713        9,918,713                

HSBC Bank PLC

     2,470,759        2,470,759                

J.P. Morgan Securities LLC

     18,411,883        18,411,883                

Jefferies LLC

     2,971,197        2,971,197                

Morgan Stanley

     25,519,024        25,519,024                

National Financial Services LLC

     1,094,341        1,094,341                

Pershing LLC

     246,250        246,250                

RBC Capital Markets LLC

     306,072        306,072                

Scotia Capital (USA), Inc.

     1,753,958        1,753,958                

SG Americas Securities LLC

     3,651,550        3,651,550                

Toronto-Dominion Bank

     19,156,580        19,156,580                

UBS AG

     6,977,869        6,977,869                

UBS Securities LLC

     1,986,551        1,986,551                

Wells Fargo Securities LLC

     1,589,163        1,589,163                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 146,507,708      $ 146,507,708      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Oil & Gas Exploration & Production

           

Goldman Sachs & Co. LLC

   $ 997,451      $ 997,451      $      $  

J.P. Morgan Securities LLC

     638,064        638,064                

Wells Fargo Bank N.A

     1,195,647        1,195,647                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 2,831,162      $ 2,831,162      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Oil Equipment & Services

           

BNP Paribas SA

   $ 1,038,672      $ 1,038,672      $      $  

Citigroup Global Markets, Inc.

     3,662,754        3,662,754                

Goldman Sachs & Co. LLC

     201,388        201,388                

J.P. Morgan Securities LLC

     1,199,736        1,199,736                

Morgan Stanley

     3,843,256        3,812,342               (30,914 )(b) 

UBS Securities LLC

     162,998        162,998                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 10,108,804      $ 10,077,890      $      $ (30,914
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Pharmaceuticals

           

Barclays Bank PLC

   $ 844,654      $ 844,654      $      $  

Barclays Capital, Inc

     1,329,478        1,329,478                

BNP Paribas SA

     1,462,586        1,462,586                

BofA Securities, Inc

     2,129,017        2,129,017                

Citadel Clearing LLC

     38,284        38,284                

Citigroup Global Markets, Inc.

     1,212,858        1,212,858                

J.P. Morgan Securities LLC

     427,630        427,630                

Jefferies LLC

     539,660        539,660                

Morgan Stanley

     917,952        917,952                

National Financial Services LLC

     1,842,390        1,842,390                

SG Americas Securities LLC

     111,150        111,150                

Toronto-Dominion Bank

     120,852        116,154               (4,698 )(b) 

UBS AG

     156,104        154,774               (1,330 )(b) 

Wells Fargo Securities LLC

     232,214        232,214                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 11,364,829      $ 11,358,801      $      $ (6,028
  

 

 

    

 

 

    

 

 

    

 

 

 

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  105


Notes to Financial Statements  (continued)

 

 

 

iShares ETF and Counterparty

    
Market Value of
Securities on Loan
 
 
    
Cash Collateral
Received
 
(a) 
    

Non-Cash Collateral

Received

 

 

     Net Amount  

 

 

U.S. Real Estate

           

Barclays Bank PLC

   $ 2,994,329      $ 2,994,329      $      $  

BNP Paribas SA

     15,685,785        15,685,785                

BofA Securities, Inc.

     138,187        138,187                

Credit Suisse Securities (USA) LLC

     12,628        12,628                

Deutsche Bank Securities, Inc.

     290,444        290,444                

J.P. Morgan Securities LLC

     8,888,061        8,888,061                

Jefferies LLC

     10,919,376        10,919,376                

National Financial Services LLC

     94,320        94,320                

SG Americas Securities LLC

     6,132        6,132                

State Street Bank & Trust Co.

     8,099,974        8,099,974                

Wells Fargo Bank N.A

     1,178,031        1,178,031                

Wells Fargo Securities LLC

     7,817,394        7,817,394                 
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 56,124,661      $ 56,124,661      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Regional Banks

           

Goldman Sachs & Co. LLC

   $ 5,594,500      $ 5,594,500      $      $  

Wells Fargo Securities LLC

     167,835        167,835                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 5,762,335      $ 5,762,335      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

U.S. Telecommunications

           

BNP Paribas SA

   $ 10,150      $ 10,150      $      $  

J.P. Morgan Securities LLC

     2,618,496        2,618,496                

UBS Securities LLC

     2,558,527        2,558,527                
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 5,187,173      $ 5,187,173      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Fund’s statement of assets and liabilities.

 
  (b) 

The market value of the loaned securities is determined as of March 31, 2022. Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by a counterparty.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BlackRock, Inc. (“BlackRock”). BlackRock’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value of the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by each Fund.

 

5.

DERIVATIVE FINANCIAL INSTRUMENTS

Futures Contracts: Futures contracts are purchased or sold to gain exposure to, or manage exposure to, changes in interest rates (interest rate risk) and changes in the value of equity securities (equity risk) or foreign currencies (foreign currency exchange rate risk).

Futures contracts are exchange-traded agreements between the Funds and a counterparty to buy or sell a specific quantity of an underlying instrument at a specified price and on a specified date. Depending on the terms of a contract, it is settled either through physical delivery of the underlying instrument on the settlement date or by payment of a cash amount on the settlement date. Upon entering into a futures contract, the Funds are required to deposit initial margin with the broker in the form of cash or securities in an amount that varies depending on a contract’s size and risk profile. The initial margin deposit must then be maintained at an established level over the life of the contract. Amounts pledged, which are considered restricted, are included in cash pledged for futures contracts in the Statements of Assets and Liabilities.

Securities deposited as initial margin are designated in the Schedule of Investments and cash deposited, if any, are shown as cash pledged for futures contracts in the Statements of Assets and Liabilities. Pursuant to the contract, the Funds agree to receive from or pay to the broker an amount of cash equal to the daily fluctuation in market value of the contract (“variation margin”). Variation margin is recorded as unrealized appreciation (depreciation) and, if any, shown as variation margin receivable (or payable) on futures contracts in the Statements of Assets and Liabilities. When the contract is closed, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the notional amount of the contract at the time it was opened and the notional amount at the time it was closed. The use of futures contracts involves the risk of an imperfect correlation in the movements in the price of futures contracts and interest rates, foreign currency exchange rates or underlying assets.

 

 

106  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

6.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory Fees: Pursuant to an Investment Advisory Agreement with the Trust, BFA manages the investment of each Fund’s assets. BFA is a California corporation indirectly owned by BlackRock. Under the Investment Advisory Agreement, BFA is responsible for substantially all expenses of the Funds, except (i) interest and taxes; (ii) brokerage commissions and other expenses connected with the execution of portfolio transactions; (iii) distribution fees; (iv) the advisory fee payable to BFA; and (v) litigation expenses and any extraordinary expenses (in each case as determined by a majority of the independent trustees).

For its investment advisory services to each of the following Funds, BFA is entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on the average daily net assets of each Fund as follows:

 

   
iShares ETF   Investment Advisory Fee  

Focused Value Factor

    0.25

U.S. Infrastructure

    0.30  

Prior to October 20, 2021, for its investment advisory services to the iShares U.S. Infrastructure ETF, BFA was entitled to an annual investment advisory fee of 0.40%, accrued daily and paid monthly by the Fund, based on the average daily net assets of the Fund.

For its investment advisory services to each Fund, except for the iShares Focused Value Factor ETF and iShares U.S. Infrastructure ETF, BFA is entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on each Fund’s allocable portion of the aggregate of the average daily net assets of the Fund and certain other iShares funds, as follows:

 

   
Aggregate Average Daily Net Assets   Investment Advisory Fee  

First $10 billion

    0.4800

Over $10 billion, up to and including $20 billion

    0.4300  

Over $20 billion, up to and including $30 billion

    0.3800  

Over $30 billion, up to and including $40 billion

    0.3400  

Over $40 billion, up to and including $50 billion

    0.3300  

Over $50 billion, up to and including $60 billion

    0.3100  

Over $60 billion

    0.2945  

Prior to July 14, 2021, for its investment advisory services to each Fund, except for the iShares Focused Valued Factor ETF and iShares U.S. Infrastructure ETF, BFA was entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on each Fund’s allocable portion of the aggregate of the average daily net assets of the Fund and certain other iShares funds, as follows:

 

   
Aggregate Average Daily Net Assets   Investment Advisory Fee  

First $10 billion

    0.48

Over $10 billion, up to and including $20 billion

    0.43  

Over $20 billion, up to and including $30 billion

    0.38  

Over $30 billion, up to and including $40 billion

    0.34  

Over $40 billion, up to and including $50 billion

    0.33  

Over $50 billion

    0.31  

Distributor: BlackRock Investments, LLC, an affiliate of BFA, is the distributor for each Fund. Pursuant to the distribution agreement, BFA is responsible for any fees or expenses for distribution services provided to the Funds.

Securities Lending: The U.S. Securities and Exchange Commission (the “SEC”) has issued an exemptive order which permits BlackRock Institutional Trust Company, N.A. (“BTC”), an affiliate of BFA, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending, including any custodial costs. Each Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan (the “collateral investment fees”). The cash collateral is invested in a money market fund, BlackRock Cash Funds: Institutional or BlackRock Cash Funds: Treasury, managed by BFA, or its affiliates. However, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees each Fund bears to an annual rate of 0.04%. The SL Agency Shares of such money market fund will not be subject to a sales load, distribution fee or service fee. The money market fund in which the cash collateral has been invested may, under certain circumstances, impose a liquidity fee of up to 2% of the value redeemed or temporarily restrict redemptions for up to 10 business days during a 90 day period, in the event that the money market fund’s weekly liquid assets fall below certain thresholds.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment fees. Each Fund retains a portion of securities lending income and remits the remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, each Fund retains 81% of securities lending income (which excludes collateral investment fees) and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  107


Notes to Financial Statements  (continued)

 

In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all 1940 Act iShares exchange-traded funds (the “iShares ETF Complex”) in that calendar year exceeds a specified threshold, each Fund, pursuant to the securities lending agreement, will retain for the remainder of that calendar year 81% of securities lending income (which excludes collateral investment fees), and the amount retained can never be less than 70% of the total of securities lending income plus the collateral investment fees.

Prior to January 1, 2022, each Fund retained 77% of securities lending income (which excludes collateral investment fees) and the amount retained was not less than 70% of the total of securities lending income plus the collateral investment fees. In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across the iShares ETF Complex in a calendar year exceeded a specified threshold, each Fund, pursuant to the securities lending agreement, retained for the remainder of that calendar year 81% of securities lending income (which excludes collateral investment fees), and the amount retained could never be less than 70% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income – affiliated – net in its Statements of Operations. For the year ended March 31, 2022, the Funds paid BTC the following amounts for securities lending agent services:

 

   
iShares ETF  

Fees Paid  

to BTC  

 

Focused Value Factor

  $ 99    

U.S. Aerospace & Defense

    64,727    

U.S. Healthcare Providers

    50,039    

U.S. Home Construction

    33,641    

U.S. Infrastructure

    6,914    

U.S. Insurance

    1,179    

U.S. Medical Devices

    135,088    

U.S. Oil & Gas Exploration & Production

    3,142    

U.S. Oil Equipment & Services

    6,400    

U.S. Pharmaceuticals

    35,043    

U.S. Real Estate

    24,993    

U.S. Regional Banks

    5,220    

U.S. Telecommunications

    5,881    

Officers and Trustees: Certain officers and/or trustees of the Trust are officers and/or trustees of BlackRock or its affiliates.

Other Transactions: Cross trading is the buying or selling of portfolio securities between funds to which BFA (or an affiliate) serves as investment adviser. At its regularly scheduled quarterly meetings, the Board reviews such transactions as of the most recent calendar quarter for compliance with the requirements and restrictions set forth by Rule 17a-7.

For the year ended March 31, 2022, transactions executed by the Funds pursuant to Rule 17a-7 under the 1940 Act were as follows:

 

       
iShares ETF   Purchases      Sales     

Net Realized

Gain (Loss)

 

U.S. Aerospace & Defense

  $ 274,327,623      $ 97,597,503      $ (7,677,532

U.S. Broker-Dealers & Securities Exchanges

    50,124,331        59,827,409        (4,558,574

U.S. Healthcare Providers

    90,197,682        63,567,557        7,492,669  

U.S. Home Construction

    71,523,919        33,726,178        (5,503,667

U.S. Infrastructure

    14,705,734        22,630,486        (896,794

U.S. Insurance

    4,635,355        2,117,044        (96,898

U.S. Medical Devices

    249,201,910        157,350,885        (4,836,730

U.S. Oil & Gas Exploration & Production

    24,143,705        24,001,554        (15,935,653

U.S. Oil Equipment & Services

    7,995,580        57,859,493        3,923,790  

U.S. Pharmaceuticals

    26,786,627        22,552,661        (3,221,512

U.S. Real Estate

    59,087,797        104,330,992        (10,622,677

U.S. Regional Banks

    57,742,995        38,927,838        (2,575,479

U.S. Telecommunications

    141,706,571        105,496,455        840,650    

Each Fund may invest its positive cash balances in certain money market funds managed by BFA or an affiliate. The income earned on these temporary cash investments is shown as dividends – affiliated in the Statements of Operations.

A fund, in order to improve its portfolio liquidity and its ability to track its underlying index, may invest in shares of other iShares funds that invest in securities in the fund’s underlying index.

 

 

108  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

7.

PURCHASES AND SALES

For the year ended March 31, 2022, purchases and sales of investments, excluding short-term investments and in-kind transactions, were as follows:

 

     
iShares ETF   Purchases      Sales    

Focused Value Factor

  $ 51,313,555      $ 51,491,032    

U.S. Aerospace & Defense

    780,957,253        778,227,853    

U.S. Broker-Dealers & Securities Exchanges

    193,156,974        193,254,277    

U.S. Healthcare Providers

    295,967,606        296,348,798    

U.S. Home Construction

    129,725,599        131,300,565    

U.S. Infrastructure

    230,170,587        226,183,341    

U.S. Insurance

    13,496,661        12,014,633    

U.S. Medical Devices

    894,672,909        904,632,907    

U.S. Oil & Gas Exploration & Production

    69,242,301        66,895,214    

U.S. Oil Equipment & Services

    85,207,029        84,345,380    

U.S. Pharmaceuticals

    76,304,717        75,966,143    

U.S. Real Estate

    597,492,203        562,691,102    

U.S. Regional Banks

    159,187,628        156,927,213    

U.S. Telecommunications

    337,907,244        338,064,916    

For the year ended March 31, 2022, in-kind transactions were as follows:

 

     
iShares ETF  

In-kind

Purchases

    

In-kind  

Sales  

 

Focused Value Factor

  $ 29,312,560      $ 37,587,710    

U.S. Aerospace & Defense

    1,292,408,961        759,245,422    

U.S. Broker-Dealers & Securities Exchanges

    844,740,596        715,230,990    

U.S. Healthcare Providers

    571,350,645        527,159,589    

U.S. Home Construction

    5,257,438,347        5,818,097,340    

U.S. Infrastructure

    689,513,446        241,746,140    

U.S. Insurance

    139,136,090        61,258,869    

U.S. Medical Devices

    2,707,289,927        3,566,041,136    

U.S. Oil & Gas Exploration & Production

    603,955,495        272,185,312    

U.S. Oil Equipment & Services

    174,099,167        318,955,659    

U.S. Pharmaceuticals

    76,420,661        56,851,745    

U.S. Real Estate

    23,166,005,861        23,176,273,223    

U.S. Regional Banks

    995,285,317        301,561,561    

U.S. Telecommunications

    991,140,124        884,680,048    

 

8.

INCOME TAX INFORMATION

Each Fund is treated as an entity separate from the Trust’s other funds for federal income tax purposes. It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

Management has analyzed tax laws and regulations and their application to the Funds as of March 31, 2022, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  109


Notes to Financial Statements  (continued)

 

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAV per share. As of March 31, 2022, permanent differences attributable to distributions paid in excess of taxable income and realized gains (losses) from in-kind redemptions were reclassified to the following accounts:

 

     
iShares ETF   Paid-in Capital    

Accumulated

Earnings (Loss)

 

Focused Value Factor

  $ 5,264,657     $ (5,264,657

U.S. Aerospace & Defense

    137,834,633       (137,834,633

U.S. Broker-Dealers & Securities Exchanges

    114,146,807       (114,146,807

U.S. Healthcare Providers

    152,289,745       (152,289,745

U.S. Home Construction

    537,581,360       (537,581,360

U.S. Infrastructure

    51,070,062       (51,070,062

U.S. Insurance

    16,061,905       (16,061,905

U.S. Medical Devices

    1,187,520,810       (1,187,520,810

U.S. Oil & Gas Exploration & Production

    53,158,290       (53,158,290

U.S. Oil Equipment & Services

    (109,377     109,377  

U.S. Pharmaceuticals

    12,614,936       (12,614,936

U.S. Real Estate

    806,326,664       (806,326,664

U.S. Regional Banks

    63,816,514       (63,816,514

U.S. Telecommunications

    43,545,496       (43,545,496

The tax character of distributions paid was as follows:

 

 

 
iShares ETF  

Year Ended

03/31/22

          

Year Ended

03/31/21

 

 

 

Focused Value Factor

      

Ordinary income

  $ 1,163,130              $ 787,521  
 

 

 

      

 

 

 

U.S. Aerospace & Defense

      

Ordinary income

  $ 18,744,404        $ 30,040,535  
 

 

 

      

 

 

 

U.S. Broker-Dealers & Securities Exchanges

      

Ordinary income

  $ 14,480,571        $ 2,538,244  
 

 

 

      

 

 

 

U.S. Healthcare Providers

      

Ordinary income

  $ 7,445,339        $ 6,386,427  
 

 

 

      

 

 

 

U.S. Home Construction

      

Ordinary income

  $ 12,816,171        $ 9,561,991  
 

 

 

      

 

 

 

U.S. Infrastructure

      

Ordinary income

  $ 13,909,010        $ 1,833,932  
 

 

 

      

 

 

 

U.S. Insurance

      

Ordinary income

  $ 2,177,905        $ 1,644,120  
 

 

 

      

 

 

 

U.S. Medical Devices

      

Ordinary income

  $ 21,981,981        $ 21,882,239  
 

 

 

      

 

 

 

U.S. Oil & Gas Exploration & Production

      

Ordinary income

  $ 12,422,061        $ 5,431,832  
 

 

 

      

 

 

 

U.S. Oil Equipment & Services

      

Ordinary income

  $ 935,137        $ 3,559,832  
 

 

 

      

 

 

 

U.S. Pharmaceuticals

      

Ordinary income

  $ 6,432,724        $ 4,525,848  
 

 

 

      

 

 

 

U.S. Real Estate

      

Ordinary income

  $ 140,375,492        $ 102,538,797  
 

 

 

      

 

 

 

U.S. Regional Banks

      

Ordinary income

  $ 24,749,500        $ 9,060,857  
 

 

 

      

 

 

 

U.S. Telecommunications

      

Ordinary income

  $ 10,823,757        $ 10,690,881  
 

 

 

      

 

 

 

 

 

110  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

As of March 31, 2022, the tax components of accumulated net earnings (losses) were as follows:

 

         

iShares ETF

   

Undistributed

Ordinary Income

 

 

    

Non-expiring

Capital Loss

Carryforwards

 

 

(a) 

   

Net Unrealized

Gains (Losses)

 

(b) 

    Total  

Focused Value Factor

  $      $ (548,219   $ (212,014   $ (760,233

U.S. Aerospace & Defense

    178,994        (881,214,186     375,049,105       (505,986,087

U.S. Broker-Dealers & Securities Exchanges

           (52,873,436     (25,739,043     (78,612,479

U.S. Healthcare Providers

    153,767        (109,949,047     175,136,307       65,341,027  

U.S. Home Construction

           (161,538,130     (532,210,518     (693,748,648

U.S. Infrastructure

           (14,434,506     59,777,175       45,342,669  

U.S. Insurance

           (3,273,055     13,997,876       10,724,821  

U.S. Medical Devices

    6,385,455        (95,981,976     1,072,356,092       982,759,571  

U.S. Oil & Gas Exploration & Production

    309,594        (213,062,102     143,361,677       (69,390,831

U.S. Oil Equipment & Services

           (290,293,620     36,384,874       (253,908,746

U.S. Pharmaceuticals

    101,174        (186,461,269     41,303,082       (145,057,013

U.S. Real Estate

           (328,765,783     (522,641,557     (851,407,340

U.S. Regional Banks

    1,680,321        (29,318,265     (10,253,260     (37,891,204

U.S. Telecommunications

           (242,235,368     (60,636,865     (302,872,233

 

  (a) 

Amounts available to offset future realized capital gains.

 
  (b) 

The difference between book-basis and tax-basis unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales, the realization for tax purposes of unrealized gains (losses) on certain futures contracts, the timing and recognition of partnership income, the characterization of corporate actions and the realization for tax purposes of unrealized gains on investments in passive foreign investment companies.

 

For the year ended March 31, 2022, the Funds listed below utilized the following amounts of their respective capital loss carryforwards:

 

   
iShares ETF   Utilized   

Focused Value Factor

  $ 9,086,209   

U.S. Healthcare Providers

    12,294,134   

U.S. Insurance

    94,626   

U.S. Medical Devices

    37,244,980   

U.S. Pharmaceuticals

    3,200,175   

As of March 31, 2022, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

         
iShares ETF   Tax Cost     

Gross Unrealized

Appreciation

    

Gross Unrealized

Depreciation

   

Net Unrealized

Appreciation

(Depreciation)

 

Focused Value Factor

  $ 35,262,845      $ 1,847,695      $ (2,059,709   $ (212,014

U.S. Aerospace & Defense

    3,326,070,125        487,097,089        (112,047,984     375,049,105  

U.S. Broker-Dealers & Securities Exchanges

    599,849,378        18,310,929        (44,049,972     (25,739,043

U.S. Healthcare Providers

    1,202,994,883        263,273,316        (88,137,009     175,136,307  

U.S. Home Construction

    2,327,056,694        843,510        (533,054,028     (532,210,518

U.S. Infrastructure

    845,159,429        94,207,771        (34,430,265     59,777,506  

U.S. Insurance

    174,061,341        16,111,365        (2,113,489     13,997,876  

U.S. Medical Devices

    7,148,347,593        1,203,503,745        (131,147,653     1,072,356,092  

U.S. Oil & Gas Exploration & Production

    659,382,590        144,761,279        (1,399,602     143,361,677  

U.S. Oil Equipment & Services

    257,560,458        38,926,748        (2,541,874     36,384,874  

U.S. Pharmaceuticals

    378,044,692        73,632,615        (32,329,533     41,303,082  

U.S. Real Estate

    5,949,233,023        77,023,152        (599,664,709     (522,641,557

U.S. Regional Banks

    1,400,795,550        44,740,764        (54,994,024     (10,253,260

U.S. Telecommunications

    569,666,027        4,548,679        (65,185,544     (60,636,865

 

9.

PRINCIPAL RISKS

In the normal course of business, each Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including, among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate or price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which the Fund is subject.

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  111


Notes to Financial Statements  (continued)

 

BFA uses a “passive” or index approach to try to achieve each Fund’s investment objective following the securities included in its underlying index during upturns as well as downturns. BFA does not take steps to reduce market exposure or to lessen the effects of a declining market. Divergence from the underlying index and the composition of the portfolio is monitored by BFA.

The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to redemption gates or liquidity fees under certain circumstances.

Market Risk: An outbreak of respiratory disease caused by a novel coronavirus has developed into a global pandemic and has resulted in closing borders, quarantines, disruptions to supply chains and customer activity, as well as general concern and uncertainty. The impact of this pandemic, and other global health crises that may arise in the future, could affect the economies of many nations, individual companies and the market in general in ways that cannot necessarily be foreseen at the present time. This pandemic may result in substantial market volatility and may adversely impact the prices and liquidity of a fund’s investments. Although vaccines have been developed and approved for use by various governments, the duration of this pandemic and its effects cannot be determined with certainty.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A fund may invest in illiquid investments. An illiquid investment is any investment that a fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause a fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a fund may lose value, regardless of the individual results of the securities and other instruments in which a fund invests.

Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.

A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.

With exchange-traded futures, there is less counterparty credit risk to the Funds since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, a Fund does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded futures with respect to initial and variation margin that is held in a clearing broker’s customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing broker’s customers, potentially resulting in losses to the Funds.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its Schedule of Investments.

Certain Funds invest a significant portion of their assets in securities within a single or limited number of market sectors. When a Fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the fund and could affect the income from, or the value or liquidity of, the fund’s portfolio. Investment percentages in specific sectors are presented in the Schedule of Investments.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a Fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

LIBOR Transition Risk: The United Kingdom’s Financial Conduct Authority announced a phase out of the London Interbank Offered Rate (“LIBOR”). Although many LIBOR rates ceased to be published or no longer are representative of the underlying market they seek to measure after December 31, 2021, a selection of widely used USD LIBOR rates will continue to be published through June 2023 in order to assist with the transition. The Funds may be exposed to financial instruments tied to LIBOR to determine payment obligations, financing terms, hedging strategies or investment value. The transition process away from LIBOR might lead to increased volatility and illiquidity in markets for, and reduce the effectiveness of new hedges placed against instruments whose terms currently include LIBOR. The ultimate effect of the LIBOR transition process on the Funds is uncertain.

 

10.

CAPITAL SHARE TRANSACTIONS

Capital shares are issued and redeemed by each Fund only in aggregations of a specified number of shares or multiples thereof (“Creation Units”) at NAV. Except when aggregated in Creation Units, shares of each Fund are not redeemable.

 

 

112  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Notes to Financial Statements  (continued)

 

Transactions in capital shares were as follows:

 

 

 
   

Year Ended

03/31/22

   

Year Ended

03/31/21

 
 

 

 

      

 

 

 
iShares ETF   Shares     Amount     Shares     Amount  

 

 

Focused Value Factor

                 

Shares sold

    500,000     $ 29,481,775          300,000     $ 14,086,524  

Shares redeemed

    (650,000     (37,877,914        (150,000     (6,329,739
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    (150,000   $ (8,396,139        150,000     $ 7,756,785  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Aerospace & Defense

          

Shares sold

    11,950,000     $ 1,295,868,298          5,500,000 (a)    $ 482,427,995  

Shares redeemed

    (7,250,000     (761,119,382        (16,450,000 )(a)      (1,387,929,179
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    4,700,000     $ 534,748,916          (10,950,000   $ (905,501,184
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Broker-Dealers & Securities Exchanges

          

Shares sold

    8,250,000     $ 850,130,332          3,800,000     $ 318,826,662  

Shares redeemed

    (6,950,000     (721,494,986        (2,100,000     (133,095,346
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase

    1,300,000     $ 128,635,346          1,700,000     $ 185,731,316  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Healthcare Providers

          

Shares sold

    2,150,000     $ 574,705,197          1,650,000     $ 341,185,827  

Shares redeemed

    (2,000,000     (531,125,750        (1,800,000     (369,873,521
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    150,000     $ 43,579,447          (150,000   $ (28,687,694
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Home Construction

          

Shares sold

    74,150,000     $ 5,270,161,088          68,550,000     $ 3,615,477,819  

Shares redeemed

    (83,350,000     (5,831,575,507        (54,000,000     (2,871,749,293
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    (9,200,000   $ (561,414,419        14,550,000     $ 743,728,526  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Infrastructure

          

Shares sold

    19,100,000     $ 699,201,177          12,450,000     $ 390,893,717  

Shares redeemed

    (6,700,000     (246,703,534        (2,000,000     (64,997,926
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase

    12,400,000     $ 452,497,643          10,450,000     $ 325,895,791  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Insurance

          

Shares sold

    1,650,000     $ 141,976,398          650,000     $ 40,706,846  

Shares redeemed

    (750,000     (62,498,673        (750,000     (42,970,020
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    900,000     $ 79,477,725          (100,000   $ (2,263,174
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Medical Devices

          

Shares sold

    43,050,000 (b)    $ 2,720,563,100          97,800,000 (b)    $ 4,424,569,395  

Shares redeemed

    (59,600,000 )(b)      (3,595,291,144        (59,100,000 )(b)      (2,946,995,891
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    (16,550,000   $ (874,728,044        38,700,000     $ 1,477,573,504  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Oil & Gas Exploration & Production

          

Shares sold

    9,350,000     $ 609,032,867          8,800,000     $ 296,903,280  

Shares redeemed

    (4,850,000     (274,473,880        (7,750,000     (245,864,133
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase

    4,500,000     $ 334,558,987          1,050,000     $ 51,039,147  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Oil Equipment & Services

          

Shares sold

    10,850,000     $ 174,454,955          45,650,000     $ 517,881,759  

Shares redeemed

    (23,850,000     (319,293,801        (22,250,000     (203,752,984
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    (13,000,000   $ (144,838,846        23,400,000     $ 314,128,775  
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Pharmaceuticals

          

Shares sold

    400,000     $ 76,808,781          500,000     $ 76,959,841  

Shares redeemed

    (300,000     (57,100,571        (550,000     (90,463,741
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    100,000     $ 19,708,210          (50,000   $ (13,503,900
 

 

 

   

 

 

      

 

 

   

 

 

 

U.S. Real Estate

          

Shares sold

    223,400,000     $ 23,245,619,566          191,850,000     $ 15,911,291,202  

Shares redeemed

    (224,650,000     (23,255,569,795        (184,800,000     (15,236,112,943
 

 

 

   

 

 

      

 

 

   

 

 

 

Net increase (decrease)

    (1,250,000   $ (9,950,229        7,050,000     $ 675,178,259  
 

 

 

   

 

 

      

 

 

   

 

 

 

 

 

N O T E S   T O   F I N A N C I A L   S T A T E M E N T S

  113


Notes to Financial Statements  (continued)

 

 

 
   

Year Ended

03/31/22

        

Year Ended

03/31/21

 
 

 

 

      

 

 

 
iShares ETF   Shares      Amount          Shares     Amount  

 

 

U.S. Regional Banks

           

Shares sold

    16,600,000      $ 999,516,077          9,800,000     $ 486,698,861  

Shares redeemed

    (4,950,000      (303,184,875        (4,700,000     (191,538,957
 

 

 

    

 

 

      

 

 

   

 

 

 

Net increase

    11,650,000      $ 696,331,202          5,100,000     $       295,159,904  
 

 

 

    

 

 

      

 

 

   

 

 

 

U.S. Telecommunications

           

Shares sold

       32,050,000      $       993,515,548             14,000,000     $ 404,835,931  

Shares redeemed

    (28,350,000      (887,232,464        (12,600,000     (363,538,590
 

 

 

    

 

 

      

 

 

   

 

 

 

Net increase

    3,700,000      $ 106,283,084          1,400,000     $ 41,297,341  
 

 

 

    

 

 

      

 

 

   

 

 

 

 

  (a) 

Share transactions reflect a two-for-one stock split effective after the close of trading on December 4, 2020.

 
  (b) 

Share transactions reflect a six-for-one stock split effective after the close of trading on July 16, 2021.

 

The consideration for the purchase of Creation Units of a fund in the Trust generally consists of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Certain funds in the Trust may be offered in Creation Units solely or partially for cash in U.S. dollars. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to State Street Bank and Trust Company, the Trust’s administrator, to offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. Investors transacting in Creation Units for cash may also pay an additional variable charge to compensate the relevant fund for certain transaction costs (i.e., stamp taxes, taxes on currency or other financial transactions, and brokerage costs) and market impact expenses relating to investing in portfolio securities. Such variable charges, if any, are included in shares sold in the table above.

From time to time, settlement of securities related to in-kind contributions or in-kind redemptions may be delayed. In such cases, securities related to in-kind transactions are reflected as a receivable or a payable in the Statements of Assets and Liabilities.

The Board authorized a six-for-one stock split for the iShares U.S. Medical Devices ETF, effective after the close of trading on July 16, 2021, for the shareholders of record on July 14, 2021. The impact of the stock split was an increase in the number of shares outstanding by a factor of six, while decreasing the NAV per share by a factor of six, resulting in no effect on the net assets of the Fund. The financial statements for the Fund have been adjusted to reflect the stock split.

 

11.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were available to be issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

114  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees of iShares Trust and

Shareholders of iShares Focused Value Factor ETF, iShares U.S. Aerospace & Defense ETF, iShares U.S. Broker-Dealers & Securities Exchanges ETF, iShares U.S. Healthcare Providers ETF, iShares U.S. Home Construction ETF, iShares U.S. Infrastructure ETF, iShares U.S. Insurance ETF, iShares U.S. Medical Devices ETF, iShares U.S. Oil & Gas Exploration & Production ETF, iShares U.S. Oil Equipment & Services ETF, iShares U.S. Pharmaceuticals ETF, iShares U.S. Real Estate ETF, iShares U.S. Regional Banks ETF and iShares U.S. Telecommunications ETF

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of iShares Focused Value Factor ETF, iShares U.S. Aerospace & Defense ETF, iShares U.S. Broker-Dealers & Securities Exchanges ETF, iShares U.S. Healthcare Providers ETF, iShares U.S. Home Construction ETF, iShares U.S. Infrastructure ETF, iShares U.S. Insurance ETF, iShares U.S. Medical Devices ETF, iShares U.S. Oil & Gas Exploration & Production ETF, iShares U.S. Oil Equipment & Services ETF, iShares U.S. Pharmaceuticals ETF, iShares U.S. Real Estate ETF, iShares U.S. Regional Banks ETF and iShares U.S. Telecommunications ETF (fourteen of the funds constituting iShares Trust, hereafter collectively referred to as the “Funds”) as of March 31, 2022, the related statements of operations for the year ended March 31, 2022, the statements of changes in net assets for each of the two years in the period ended March 31, 2022, including the related notes, and the financial highlights for each of the periods indicated therein (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of March 31, 2022, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended March 31, 2022 and each of the financial highlights for each of the periods indicated therein in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinions

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of March 31, 2022 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

May 24, 2022

We have served as the auditor of one or more BlackRock investment companies since 2000.

 

 

R E P O R T   O F   I N D E P E N D E N T   R E G I S T E R E D   P U B L I C   A C C O U N T I N G   F I R M

  115


Important Tax Information (unaudited)

 

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified dividend income for individuals for the fiscal year ended March 31, 2022:

 

   
iShares ETF  

Qualified Dividend    

Income    

Focused Value Factor

  $ 1,149,434  

U.S. Aerospace & Defense

    29,487,831  

U.S. Broker-Dealers & Securities Exchanges

    16,504,253  

U.S. Healthcare Providers

    12,051,640  

U.S. Home Construction

    22,115,621  

U.S. Infrastructure

    15,358,244  

U.S. Insurance

    2,516,762  

U.S. Medical Devices

    54,933,479  

U.S. Oil & Gas Exploration & Production

    14,085,446  

U.S. Oil Equipment & Services

    1,343,097  

U.S. Pharmaceuticals

    7,360,204  

U.S. Real Estate

    1,446,647  

U.S. Regional Banks

    30,100,456  

U.S. Telecommunications

    11,961,435    

The following amounts, or maximum amounts allowable by law, are hereby designated as qualified business income for individuals for the fiscal year ended March 31, 2022:

 

   
iShares ETF  

Qualified Business    

Income    

 

U.S. Real Estate

  $ 82,755,446      

The following percentage, or maximum percentage allowable by law, of ordinary income distributions paid during the fiscal year ended March 31, 2022 qualified for the dividends-received deduction for corporate shareholders:

 

   
iShares ETF  

Dividends-Received

Deduction

 

Focused Value Factor

    100.00

U.S. Aerospace & Defense

    100.00

U.S. Broker-Dealers & Securities Exchanges

    100.00

U.S. Healthcare Providers

    100.00

U.S. Home Construction

    100.00

U.S. Infrastructure

    100.00

U.S. Insurance

    100.00

U.S. Medical Devices

    100.00

U.S. Oil & Gas Exploration & Production

    100.00

U.S. Oil Equipment & Services

    99.30

U.S. Pharmaceuticals

    100.00

U.S. Regional Banks

    100.00

U.S. Telecommunications

    100.00

 

 

116  

2 0 2 2   I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Statement Regarding Liquidity Risk Management Program (unaudited)

 

In compliance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), iShares Trust (the “Trust”) has adopted and implemented a liquidity risk management program (the “Program”) for iShares Focused Value Factor ETF, iShares U.S. Aerospace & Defense ETF, iShares U.S. Broker-Dealers & Securities Exchanges ETF, iShares U.S. Healthcare Providers ETF, iShares U.S. Home Construction ETF, iShares U.S. Infrastructure ETF, iShares U.S. Insurance ETF, iShares U.S. Medical Devices ETF, iShares U.S. Oil & Gas Exploration & Production ETF, iShares U.S. Oil Equipment & Services ETF, iShares U.S. Pharmaceuticals ETF, iShares U.S. Real Estate ETF, iShares U.S. Regional Banks ETF and iShares U.S. Telecommunications ETF (the “Funds” or “ETFs”), each a series of the Trust, which is reasonably designed to assess and manage each Fund’s liquidity risk.

The Board of Trustees (the “Board”) of the Trust, on behalf of the Funds, met on December 9, 2021 (the “Meeting”) to review the Program. The Board previously appointed BlackRock Fund Advisors (“BlackRock”), the investment adviser to the Funds, as the program administrator for each Fund’s Program. BlackRock also previously delegated oversight of the Program to the 40 Act Liquidity Risk Management Committee (the “Committee”). At the Meeting, the Committee, on behalf of BlackRock, provided the Board with a report that addressed the operation of the Program and assessed its adequacy and effectiveness of implementation, including the management of each Fund’s Highly Liquid Investment Minimum (“HLIM”) where applicable, and any material changes to the Program (the “Report”). The Report covered the period from October 1, 2020 through September 30, 2021 (the “Program Reporting Period”).

The Report described the Program’s liquidity classification methodology for categorizing each Fund’s investments (including derivative transactions) into one of four liquidity buckets. It also referenced the methodology used by BlackRock to establish each Fund’s HLIM and noted that the Committee reviews and ratifies the HLIM assigned to each Fund no less frequently than annually. The Report also discussed notable events affecting liquidity over the Program Reporting Period, including extended market holidays and the imposition of capital controls in certain non-U.S. countries.

The Report noted that the Program complied with the key factors for consideration under the Liquidity Rule for assessing, managing and periodically reviewing each Fund’s liquidity risk, as follows:

 

  a)

The Fund’s investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed whether each Fund’s strategy is appropriate for an open-end fund structure, with a focus on funds with more significant and consistent holdings of less liquid and illiquid assets. The Committee also factored a fund’s concentration in an issuer into the liquidity classification methodology by taking issuer position sizes into account. Derivative exposure was also considered in the calculation of a fund’s liquidity bucketing. Finally, a factor for consideration under the Liquidity Rule is a Fund’s use of borrowings for investment purposes. However, the Funds do not borrow for investment purposes.

 

  b)

Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed historical redemption activity and used this information as a component to establish each ETF’s reasonably anticipated trading size (“RATS”). The Committee may also take into consideration a fund’s shareholder ownership concentration (which, depending on product type and distribution channel, may or may not be available), a fund’s distribution channels, and the degree of certainty associated with a fund’s short-term and long-term cash flow projections.

 

  c)

Holdings of cash and cash equivalents, as well as borrowing arrangements. The Committee considered that ETFs generally do not hold more than de minimis amounts of cash. While the ETFs generally do not engage in borrowing, certain of the ETFs have the flexibility to draw on a line of credit to meet redemption requests or facilitate settlements.

 

  d)

The relationship between an ETF’s portfolio liquidity and the way in which, and the prices and spreads at which, ETF shares trade, including the efficiency of the arbitrage function and the level of active participation by market participants, including authorized participants. The Committee monitored the prevailing bid/ask spread and the ETF price premium (or discount) to NAV for all ETFs and reviewed any persistent deviations from long-term averages.

 

  e)

The effect of the composition of baskets on the overall liquidity of an ETF’s portfolio. In reviewing the linkage between the composition of custom baskets accepted by an ETF and any significant change in the liquidity profile of such ETF, the Committee reviewed changes in the proportion of each ETF’s portfolio comprised of less liquid and illiquid holdings to determine if applicable thresholds were met requiring enhanced review.

As part of BlackRock’s continuous review of the effectiveness of the Program, the Committee made the following material changes to the Program: (1) updates to certain model components in the Program’s methodology; and (2) certain iShares Funds entered into a $800 million credit agreement with a group of lenders that replaced a previous liquidity facility. The Report provided to the Board stated that the Committee concluded that based on the operation of the functions, as described in the Report, the Program is operating as intended and is effective in implementing the requirements of the Liquidity Rule.

 

 

S T A T E M E N T   R E G A R D I N G   L I Q U I D I T Y   R I S K   M A N A G E M E N T   P R O G R A M

  117


Supplemental Information (unaudited)

 

Regulation Regarding Derivatives

On October 28, 2020, the Securities and Exchange Commission (the “SEC”) adopted regulations governing the use of derivatives by registered investment companies (“Rule 18f-4”). The Funds will be required to implement and comply with Rule 18f-4 by August 19, 2022. Once implemented, Rule 18f-4 will impose limits on the amount of derivatives a fund can enter into, eliminate the asset segregation framework currently used by funds to comply with Section 18 of the 1940 Act, treat derivatives as senior securities and require funds whose use of derivatives is more than a limited specified exposure amount to establish and maintain a comprehensive derivatives risk management program and appoint a derivatives risk manager.

Section 19(a) Notices

The amounts and sources of distributions reported are estimates and are being provided pursuant to regulatory requirements and are not being provided for tax reporting purposes. The actual amounts and sources for tax reporting purposes will depend upon each Fund’s investment experience during the year and may be subject to changes based on tax regulations. Shareholders will receive a Form 1099-DIV each calendar year that will inform them how to report these distributions for federal income tax purposes.

March 31, 2022

 

       
    Total Cumulative Distributions
for the Fiscal Year
          % Breakdown of the Total Cumulative
Distributions for the Fiscal Year
 
iShares ETF  

Net

Investment

Income

        

Net Realized

Capital Gains

   

Return of

Capital

   

Total Per

Share

          

Net

Investment

Income

   

Net Realized

Capital Gains

   

Return of

Capital

   

Total Per

Share

 

Focused Value Factor

  $ 1.810679       $     $     $  1.810679         100             100

U.S. Infrastructure(a)

    0.690169               0.000689       0.690858         100             0 (b)      100  

U.S. Insurance

    1.632105                     1.632105         100                   100  

U.S. Medical Devices

    0.164675                     0.164675         100                   100  

U.S. Oil & Gas Exploration & Production

    1.912618                     1.912618         100                   100  

U.S. Pharmaceuticals

    3.136135                     3.136135         100                   100  

U.S. Real Estate(a)

    1.838946               0.544972       2.383918         77             23       100  

U.S. Regional Banks

    1.227215                       1.227215               100                   100  

 

  (a) 

The Fund estimates that it has distributed more than its net investment income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in the Fund is returned to the shareholder. A return of capital does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income”. When distributions exceed total return performance, the difference will incrementally reduce the Fund’s net asset value per share.

 
  (b) 

Rounds to less than 1%.

 

Premium/Discount Information

Information on the Fund’s net asset value, market price, premiums and discounts, and bid-ask spreads can be found at iShares.com.

Regulation under the Alternative Investment Fund Managers Directive

The Alternative Investment Fund Managers Directive and the Alternative Investment Fund Managers Regulations 2013 (as amended) and the “Guidelines on sound remuneration policies under the AIFMD” issued by the European Securities and Markets Authority (together the “Regulations”) impose detailed and prescriptive obligations on fund managers established in the European Union (the “EU”) and the UK. These do not currently apply to managers established outside of the EU or UK, such as BFA (the “Company”). Rather, non-EU and non-UK managers are only required to comply with certain disclosure, reporting and transparency obligations of the Regulations if such managers market a fund to EU investors.

The Company has registered the iShares U.S. Real Estate ETF and iShares U.S. Regional Banks ETF (each a “Fund”, collectively the “Funds”) to be marketed to United Kingdom and EU investors in the Netherlands, Finland and Sweden.

Report on Remuneration

The Company is required under the Regulations to make quantitative disclosures of remuneration. These disclosures are made in line with BlackRock’s interpretation of currently available regulatory guidance on quantitative remuneration disclosures. As market or regulatory practice develops BlackRock may consider it appropriate to make changes to the way in which quantitative remuneration disclosures are calculated. Where such changes are made, this may result in disclosures in relation to a fund not being comparable to the disclosures made in the prior year, or in relation to other BlackRock fund disclosures in that same year.

Disclosures are provided in relation to (a) the staff of the Company; (b) staff who are senior management; and (c) staff who have the ability to materially affect the risk profile of the Funds.

 

 

118  

2 0 2 2    I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Supplemental Information (unaudited) (continued)

 

All individuals included in the aggregated figures disclosed are rewarded in line with BlackRock’s remuneration policy for their responsibilities across the relevant BlackRock business area. As all individuals have a number of areas of responsibilities, only the portion of remuneration for those individuals’ services attributable to the Funds is included in the aggregate figures disclosed.

BlackRock has a clear and well defined pay-for-performance philosophy, and compensation programmes which support that philosophy.

BlackRock operates a total compensation model for remuneration which includes a base salary, which is contractual, and a discretionary bonus scheme. Although all employees are eligible to receive a discretionary bonus, there is no contractual obligation to make a discretionary bonus award to any employees. For senior management, a significant percentage of variable remuneration is deferred over time. All employees are subject to a claw-back policy.

Remuneration decisions for employees are made once annually in January following the end of the performance year, based on BlackRock’s full-year financial results and other non-financial goals and objectives. Alongside financial performance, individual total compensation is also based on strategic and operating results and other considerations such as management and leadership capabilities. No set formulas are established and no fixed benchmarks are used in determining annual incentive awards.

Annual incentive awards are paid from a bonus pool which is reviewed throughout the year by BlackRock’s independent compensation committee, taking into account both actual and projected financial information together with information provided by the Enterprise Risk and Regulatory Compliance departments in relation to any activities, incidents or events that warrant consideration in making compensation decisions. Individuals are not involved in setting their own remuneration.

Each of the control functions (Enterprise Risk, Legal & Compliance, and Internal Audit) each have their own organisational structures which are independent of the business units. Functional bonus pools for those control functions are determined with reference to the performance of each individual function and the remuneration of the senior members of control functions is directly overseen by BlackRock’s independent remuneration committee.

Members of staff and senior management of the Company typically provide both AIFMD and non-AIFMD related services in respect of multiple funds, clients and functions of the Company and across the broader BlackRock group. Therefore, the figures disclosed are a sum of each individual’s portion of remuneration attributable to the Funds according to an objective apportionment methodology which acknowledges the multiple-service nature of the Company. Accordingly the figures are not representative of any individual’s actual remuneration or their remuneration structure.

The amount of total & aggregate remuneration awarded by the Company to its staff which has been attributed to the Funds in respect of the Company’s financial year ending December 31, 2021 were as follows:

 

                       
iShares ETF  

Total

Remuneration

           

Fixed

Remuneration

            

Variable

Remuneration

            

No. of

Beneficiaries

            

Senior Management

Remuneration

            

Risk Taker    

Remuneration    

 

U.S. Real Estate

    $644,544          $301,366           $343,177           661           $78,893           $8,154      

U.S. Regional Banks

    122,033                57,059                 64,975                 661                 14,937                 1,544      

 

 

S U P P L E M E N T A L   I N F O R M A T I O N

  119


Trustee and Officer Information

 

The Board of Trustees has responsibility for the overall management and operations of the Funds, including general supervision of the duties performed by BFA and other service providers. Each Trustee serves until he or she resigns, is removed, dies, retires or becomes incapacitated. Each officer shall hold office until his or her successor is elected and qualifies or until his or her death, resignation or removal. Trustees who are not “interested persons” (as defined in the 1940 Act) of the Trust are referred to as independent trustees (“Independent Trustees”).

The registered investment companies advised by BFA or its affiliates (the “BlackRock-advised Funds”) are organized into one complex of open-end equity, multi-asset, index and money market funds and ETFs (the “BlackRock Multi-Asset Complex”), one complex of closed-end funds and open-end non-index fixed-income funds (including ETFs) (the “BlackRock Fixed-Income Complex”) and one complex of ETFs (“Exchange-Traded Fund Complex”) (each, a “BlackRock Fund Complex”). Each Fund is included in the Exchange-Traded Fund Complex. Each Trustee also serves as a Director of iShares, Inc. and a Trustee of iShares U.S. ETF Trust and, as a result, oversees all of the funds within the Exchange-Traded Fund Complex, which consists of 378 funds as of March 31, 2022. With the exception of Robert S. Kapito, Salim Ramji and Charles Park, the address of each Trustee and officer is c/o BlackRock, Inc., 400 Howard Street, San Francisco, CA 94105. The address of Mr. Kapito, Mr. Ramji and Mr. Park is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. The Board has designated John E. Kerrigan as its Independent Board Chair. Additional information about the Funds’ Trustees and officers may be found in the Funds’ combined Statement of Additional Information, which is available without charge, upon request, by calling toll-free 1-800-iShares (1-800-474-2737).

 

          Interested Trustees     
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

Robert S. Kapito(a)

(65)

  

Trustee

(since 2009).

   President, BlackRock, Inc. (since 2006); Vice Chairman of BlackRock, Inc. and Head of BlackRock’s Portfolio Management Group (since its formation in 1998) and BlackRock, Inc.’s predecessor entities (since 1988); Trustee, University of Pennsylvania (since 2009); President of Board of Directors, Hope & Heroes Children’s Cancer Fund (since 2002).    Director of BlackRock, Inc. (since 2006); Director of iShares, Inc. (since 2009); Trustee of iShares U.S. ETF Trust (since 2011); Trustee of iShares Trust (since 2009).

Salim Ramji(b)

(51)

  

Trustee

(since 2019).

   Senior Managing Director, BlackRock, Inc. (since 2014); Global Head of BlackRock’s ETF and Index Investments Business (since 2019); Head of BlackRock’s U.S. Wealth Advisory Business (2015-2019); Global Head of Corporate Strategy, BlackRock, Inc. (2014-2015); Senior Partner, McKinsey & Company (2010-2014).    Director of iShares, Inc. (since 2019); Trustee of iShares U.S. ETF Trust (since 2019); Trustee of iShares Trust (since 2019).

(a) Robert S. Kapito is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its  affiliates.

(b) Salim Ramji is deemed to be an “interested person” (as defined in the 1940 Act) of the Trust due to his affiliations with BlackRock, Inc. and its affiliates.

          Independent Trustees     
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

John E.

Kerrigan (66)

  

Trustee (since 2005);

Independent Board Chair

(since 2022).

   Chief Investment Officer, Santa Clara University (since 2002).    Director of iShares, Inc. (since 2005); Trustee of iShares U.S. ETF Trust (since 2011); Trustee of iShares Trust (since 2005); Independent Board Chair of iShares, Inc. and iShares Trust and iShares U.S. ETF Trust (since 2022).

Jane D.

Carlin (66)

  

Trustee (since 2015);

Risk Committee Chair

(since 2016).

   Consultant (since 2012); Member of the Audit Committee (2012-2018), Chair of the Nominating and Governance Committee (2017-2018) and Director of PHH Corporation (mortgage solutions) (2012-2018); Managing Director and Global Head of Financial Holding Company Governance & Assurance and the Global Head of Operational Risk Management of Morgan Stanley (2006-2012).    Director of iShares, Inc. (since 2015); Trustee of iShares U.S. ETF Trust (since 2015); Trustee of iShares Trust (since 2015); Member of the Audit Committee (since 2016), Chair of the Audit Committee (since 2020) and Director of The Hanover Insurance Group, Inc. (since 2016).

Richard L.

Fagnani (67)

  

Trustee (since 2017);

Audit Committee Chair

(since 2019).

   Partner, KPMG LLP (2002-2016).    Director of iShares, Inc. (since 2017); Trustee of iShares U.S. ETF Trust (since 2017); Trustee of iShares Trust (since 2017).

 

 

120  

2 0 2 2    I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


Trustee and Officer Information  (continued)

 

Independent Trustees (continued)
       
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

   Other Directorships Held by Trustee

Cecilia H.

Herbert (73)

   Trustee (since 2005); Nominating and Governance and Equity Plus Committee Chairs (since 2022).    Chair of the Finance Committee (since 2019) and Trustee and Member of the Finance, Audit and Quality Committees of Stanford Health Care (since 2016); Trustee of WNET, New York’s public media company (since 2011) and Member of the Audit Committee (since 2018) and Investment Committee (since 2011); Chair (1994-2005) and Member (since 1992) of the Investment Committee, Archdiocese of San Francisco; Trustee of Forward Funds (14 portfolios) (2009-2018); Trustee of Salient MF Trust (4 portfolios) (2015-2018); Director (1998-2013) and President (2007-2011) of the Board of Directors, Catholic Charities CYO; Trustee (2002-2011) and Chair of the Finance and Investment Committee (2006-2010) of the Thacher School; Director of the Senior Center of Jackson Hole (since 2020).    Director of iShares, Inc. (since 2005); Trustee of iShares U.S. ETF Trust (since 2011); Trustee of iShares Trust (since 2005); Trustee of Thrivent Church Loan and Income Fund (since 2019).

Drew E.

Lawton (63)

   Trustee (since 2017); 15(c) Committee Chair (since 2017).    Senior Managing Director of New York Life Insurance Company (2010-2015).    Director of iShares, Inc. (since 2017); Trustee of iShares U.S. ETF Trust (since 2017); Trustee of iShares Trust (since 2017).

John E.

Martinez (60)

   Trustee (since 2003); Securities Lending Committee Chair (since 2019).    Director of Real Estate Equity Exchange, Inc. (since 2005); Director of Cloudera Foundation (2017-2020); and Director of Reading Partners (2012-2016).    Director of iShares, Inc. (since 2003); Trustee of iShares U.S. ETF Trust (since 2011); Trustee of iShares Trust (since 2003).

Madhav V.

Rajan (57)

   Trustee (since 2011); Fixed Income Plus Committee Chair (since 2019).    Dean, and George Pratt Shultz Professor of Accounting, University of Chicago Booth School of Business (since 2017); Advisory Board Member (since 2016) and Director (since 2020) of C.M. Capital Corporation; Chair of the Board for the Center for Research in Security Prices, LLC (since 2020); Robert K. Jaedicke Professor of Accounting, Stanford University Graduate School of Business (2001-2017); Professor of Law (by courtesy), Stanford Law School (2005-2017); Senior Associate Dean for Academic Affairs and Head of MBA Program, Stanford University Graduate School of Business (2010-2016).    Director of iShares, Inc. (since 2011); Trustee of iShares U.S. ETF Trust (since 2011); Trustee of iShares Trust (since 2011).
Officers
     
Name (Age)    Position(s)   

Principal Occupation(s)

During the Past 5 Years

Armando

Senra (50)

   President (since 2019).    Managing Director, BlackRock, Inc. (since 2007); Head of U.S., Canada and Latam iShares, BlackRock, Inc. (since 2019); Head of Latin America Region, BlackRock, Inc. (2006-2019); Managing Director, Bank of America Merrill Lynch (1994-2006).

Trent

Walker (47)

   Treasurer and Chief Financial Officer (since 2020).    Managing Director, BlackRock, Inc. (since September 2019); Chief Financial Officer of iShares Delaware Trust Sponsor LLC, BlackRock Funds, BlackRock Funds II, BlackRock Funds IV, BlackRock Funds V and BlackRock Funds VI (since 2021); Executive Vice President of PIMCO (2016-2019); Senior Vice President of PIMCO (2008-2015); Treasurer (2013-2019) and Assistant Treasurer (2007-2017) of PIMCO Funds, PIMCO Variable Insurance Trust, PIMCO ETF Trust, PIMCO Equity Series, PIMCO Equity Series VIT, PIMCO Managed Accounts Trust, 2 PIMCO-sponsored interval funds and 21 PIMCO-sponsored closed-end funds.

Charles

Park (54)

   Chief Compliance Officer (iShares, Inc. and iShares Trust, since 2006; iShares U.S. ETF Trust, since 2011).    Chief Compliance Officer of BlackRock Advisors, LLC and the BlackRock-advised Funds in the BlackRock Multi-Asset Complex and the BlackRock Fixed-Income Complex (since 2014); Chief Compliance Officer of BFA (since 2006).

Deepa Damre

Smith (46)

   Secretary (since 2019).    Managing Director, BlackRock, Inc. (since 2014); Director, BlackRock, Inc. (2009-2013).

Rachel

Aguirre (39)

   Executive Vice President (since 2022).    Managing Director, BlackRock, Inc. (since 2018); Director, BlackRock, Inc. (2009-2018); Head of U.S. iShares Product (since 2022); Head of EII U.S. Product Engineering (since 2021); Co-Head of EII’s Americas Portfolio Engineering (2020-2021); Head of Developed Markets Portfolio Engineering 2021); Head of Developed Markets Portfolio Engineering (2016-2019).

Jennifer

Hsui (45)

   Executive Vice President (since 2022).    Managing Director, BlackRock, Inc. (since 2009); Co-Head of Index Equity (since 2022).

 

 

T R U S T E E   A N D   O F F I C E R   I N F O R M A T I O N

  121


Trustee and Officer Information  (continued)

 

Officers (continued)
     
Name (Age)    Position(s)           

Principal Occupation(s)

During the Past 5 Years

James

Mauro (51)

   Executive Vice President (since 2021).    Managing Director, BlackRock, Inc. (since 2010); Head of Fixed Income Index Investments in the Americas and Head of San Francisco Core Portfolio Management (since 2020).

 

 

 

Effective March 18, 2022, Rachel Aguirre, Jennifer Hsui, and James Mauro have replaced Scott Radell, Alan Mason, and Marybeth Leithead as Executive Vice Presidents.

 

 

 

122  

2 0 2 2    I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


General Information

 

Electronic Delivery

Shareholders can sign up for e-mail notifications announcing that the shareholder report or prospectus has been posted on the iShares website at iShares.com. Once you have enrolled, you will no longer receive prospectuses and shareholder reports in the mail.

To enroll in electronic delivery:

 

   

Go to icsdelivery.com.

   

If your brokerage firm is not listed, electronic delivery may not be available. Please contact your broker-dealer or financial advisor.

Householding

Householding is an option available to certain fund investors. Householding is a method of delivery, based on the preference of the individual investor, in which a single copy of certain shareholder documents and Rule 30e-3 notices can be delivered to investors who share the same address, even if their accounts are registered under different names. Please contact your broker-dealer if you are interested in enrolling in householding and receiving a single copy of prospectuses and other shareholder documents, or if you are currently enrolled in householding and wish to change your householding status.

Availability of Quarterly Schedule of Investments

The Funds file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-PORT are available on the SEC’s website at sec.gov. Additionally, each Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at iShares.com/fundreports.

Availability of Proxy Voting Policies and Proxy Voting Records

A description of the policies and procedures that the iShares Funds use to determine how to vote proxies relating to portfolio securities and information about how the iShares Funds voted proxies relating to portfolio securities during the most recent twelve-month period ending June 30 is available without charge, upon request (1) by calling toll-free 1-800-474-2737; (2) on the iShares website at iShares.com; and (3) on the SEC website at sec.gov.

A description of the Trust’s policies and procedures with respect to the disclosure of the Fund’s portfolio securities is available in the Fund Prospectus. The Fund discloses its portfolio holdings daily and provides information regarding its top holdings in Fund fact sheets at iShares.com.

 

 

G E N E R A L   I N F O R M A T I O N

  123


Glossary of Terms Used in this Report

 

Portfolio Abbreviations - Equity
NVS    Non-Voting Shares
REIT    Real Estate Investment Trust

 

 

124  

2 0 2 2    I S H A R E S   A N N U A L   R E P O R T   T O   S H A R E H O L D E R S


    

 

    

 

Want to know more?

iShares.com   |   1-800-474-2737

This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by the current prospectus.

Investing involves risk, including possible loss of principal.

The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).

The iShares Funds are not sponsored, endorsed, issued, sold or promoted by FTSE Russell, ICE Data Indices, LLC or S&P Dow Jones Indices LLC, nor do these companies make any representation regarding the advisability of investing in the iShares Funds. BlackRock is not affiliated with the companies listed above

©2022 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc. or its subsidiaries. All other marks are the property of their respective owners.

iS-AR-311-0322

 

 

LOGO

   LOGO